<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Oxycodone</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Oxycodone">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Oxycodone</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Oxycodone</b>, sold under the brand name <b>OxyContin</b> (which is the extended release form) among others, is an opioid medication used for treatment of moderate to severe pain, and a common drug of abuse.<span class="mw-ref" id="cite_ref-AHFS2018_12-0"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Per2018_13-0"><a href="#cite_note-Per2018-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It is usually taken by mouth, and is available in immediate-release and controlled-release formulations.<span class="mw-ref" id="cite_ref-AHFS2018_12-1"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Onset of pain relief typically begins within fifteen minutes and lasts for up to six hours with the immediate-release formulation.<span class="mw-ref" id="cite_ref-AHFS2018_12-2"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In the United Kingdom, it is available by injection.<span class="mw-ref" id="cite_ref-BNF74_14-0"><a href="#cite_note-BNF74-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Combination products are also available with paracetamol (acetaminophen), ibuprofen, naloxone, and aspirin.<span class="mw-ref" id="cite_ref-AHFS2018_12-3"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>



<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Oxycodone</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Oxycodone.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Oxycodone.svg.png" data-file-width="460" data-file-height="420" data-file-type="drawing" height="205" width="225"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Oxycodone_structure.png" tppabs="https://ptable.com/wiki/compounds/I/m/Oxycodone_structure.png" data-file-width="5000" data-file-height="3000" data-file-type="bitmap" height="135" width="225"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td>ɒksɪˈkəʊdəʊn<span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>OxyContin, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Eukodal, eucodal; dihydrohydroxycodeinone, 7,8-dihydro-14-hydroxycodeinone, 6-deoxy-7,8-dihydro-14-hydroxy-3-O-methyl-6-oxomorphine<span class="mw-ref" id="cite_ref-MerckIndex_1-0"><a href="#cite_note-MerckIndex-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/oxycodone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/oxycodone.html'" tppabs="https://www.drugs.com/monograph/oxycodone.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a682132.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a682132.html'" tppabs="https://medlineplus.gov/druginfo/meds/a682132.html" class="external text external">a682132</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Oxycodone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Oxycodone'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Oxycodone" class="external text external">Oxycodone</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>C<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_2-0"><a href="#cite_note-Drugs.com_pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>N (Not classified yet)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_2-1"><a href="#cite_note-Drugs.com_pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Dependence<br>liability</th><td>High<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, sublingual, intramuscular, intravenous, intranasal, subcutaneous, transdermal, rectal, epidural<span class="mw-ref" id="cite_ref-Kalso_4-0"><a href="#cite_note-Kalso-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N02AA05<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N02AA05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N02AA05'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N02AA05" class="external text external">WHO</a></span>)<span> </span><br>N02AA55<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N02AA55  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N02AA55'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N02AA55" class="external text external">WHO</a></span>) N02AJ18<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N02AJ18  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N02AJ18'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N02AJ18" class="external text external">WHO</a></span>) N02AJ19<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N02AJ19  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N02AJ19'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N02AJ19" class="external text external">WHO</a></span>) N02AA56<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N02AA56  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N02AA56'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N02AA56" class="external text external">WHO</a></span>) N02AJ17<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N02AJ17  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N02AJ17'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N02AJ17" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S8 (Controlled drug)<span> </span></li>
<li><small><abbr class="country-name">DE</abbr></small>:<span> </span>Anlage III (Special prescription form required)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>Class A<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>Schedule II<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>By mouth: 60–87%<span class="mw-ref" id="cite_ref-MSR_5-0"><a href="#cite_note-MSR-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-ElliottSmith2016_6-0"><a href="#cite_note-ElliottSmith2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>45%<span class="mw-ref" id="cite_ref-MSR_5-1"><a href="#cite_note-MSR-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver: mainly CYP3A, and, to a much lesser extent, CYP2D6 (~5%);<span class="mw-ref" id="cite_ref-MSR_5-2"><a href="#cite_note-MSR-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> 95% metabolized (i.e., 5% excreted unchanged)<span class="mw-ref" id="cite_ref-SmithPassik2008_7-0"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• Noroxycodone (25%) <span class="mw-ref" id="cite_ref-Medscape_8-0"><a href="#cite_note-Medscape-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-SmithPassik2008_7-1"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><br>• Noroxymorphone (15%, free and conjugated)<span class="mw-ref" id="cite_ref-Medscape_8-1"><a href="#cite_note-Medscape-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-SmithPassik2008_7-2"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><br>• <a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a> (11%, conjugated)<span class="mw-ref" id="cite_ref-Medscape_8-2"><a href="#cite_note-Medscape-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-SmithPassik2008_7-3"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><br>• Others (e.g., minor metabolites)<span class="mw-ref" id="cite_ref-SmithPassik2008_7-4"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Onset of action</th><td><abbr>IR</abbr>: 10–30 minutes<span class="mw-ref" id="cite_ref-ElliottSmith2016_6-1"><a href="#cite_note-ElliottSmith2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-SmithPassik2008_7-5"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><br><abbr>CR</abbr>: 1 hour<span class="mw-ref" id="cite_ref-YarbroWujcik2010_9-0"><a href="#cite_note-YarbroWujcik2010-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>By mouth (IR): 2–3 hrs (same <abbr>t<sub>1/2</sub></abbr> for all <abbr>ROAs</abbr>)<span class="mw-ref" id="cite_ref-SmithPassik2008_7-6"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-ElliottSmith2016_6-2"><a href="#cite_note-ElliottSmith2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><br>By mouth (CR): 4.5 hrs<span class="mw-ref" id="cite_ref-McPhersonPincus2016_10-0"><a href="#cite_note-McPhersonPincus2016-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Duration of action</th><td>By mouth (IR): 3–6 hrs<span class="mw-ref" id="cite_ref-SmithPassik2008_7-7"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><br>By mouth (CR): 10–12 hrs<span class="mw-ref" id="cite_ref-sunshine1996_11-0"><a href="#cite_note-sunshine1996-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine (83%)<span class="mw-ref" id="cite_ref-MSR_5-3"><a href="#cite_note-MSR-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(5<i>R</i>,9<i>R</i>,13<i>S</i>,14<i>S</i>)-4,5α-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=76-42-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=76-42-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=76-42-6" class="external text external">76-42-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5284603  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5284603'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5284603" class="external text external">5284603</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7093  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7093'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7093" class="external text external">7093</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00497'" tppabs="https://www.drugbank.ca/drugs/DB00497" class="external text external">DB00497</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4447649.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4447649.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4447649.html" class="external text external">4447649</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=CD35PMG570  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=CD35PMG570'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=CD35PMG570" class="external text external">CD35PMG570</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D05312  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D05312'" tppabs="https://www.kegg.jp/entry/D05312" class="external text external">D05312</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7852  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7852'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7852" class="external text external">CHEBI:7852</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL656'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL656" class="external text external">ChEMBL656</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID5023407  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID5023407'" tppabs="https://comptox.epa.gov/dashboard/DTXSID5023407" class="external text external">DTXSID5023407</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.000.874  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.000.874'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.874" class="external text external">100.000.874</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>18</sub><span>H</span><sub>21</sub><span>N</span><span>O</span><sub>4</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">315.369</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC%40%40H%5D5Oc1c2c%28ccc1OC%29C%5BC%40H%5D3N%28CC%5BC%40%5D25%5BC%40%40%5D3%28O%29CC4%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC%40%40H%5D5Oc1c2c%28ccc1OC%29C%5BC%40H%5D3N%28CC%5BC%40%5D25%5BC%40%40%5D3%28O%29CC4%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC4%5BC%40%40H%5D5Oc1c2c%28ccc1OC%29C%5BC%40H%5D3N%28CC%5BC%40%5D25%5BC%40%40%5D3%28O%29CC4%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>219<span>&nbsp;</span>°C (426<span>&nbsp;</span>°F)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Solubility in water</th><td>HCl: 166</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C4[C@@H]5Oc1c2c(ccc1OC)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:BRUQQQPBMZOVGD-XFKAJCMBSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464196835&page2=Oxycodone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464196835&page2=Oxycodone'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464196835&page2=Oxycodone" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include euphoria, constipation, nausea, vomiting, loss of appetite, drowsiness, dizziness, itching, dry mouth, and sweating.<span class="mw-ref" id="cite_ref-AHFS2018_12-4"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Severe side effects may include addiction, dependence, hallucinations, respiratory depression (a reduction in breathing), bradycardia, and low blood pressure.<span class="mw-ref" id="cite_ref-AHFS2018_12-5"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Those allergic to <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">codeine</a> may also be allergic to oxycodone.<span class="mw-ref" id="cite_ref-AHFS2018_12-6"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Use of oxycodone in early pregnancy appears relatively safe.<span class="mw-ref" id="cite_ref-AHFS2018_12-7"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Opioid withdrawal may occur if rapidly stopped.<span class="mw-ref" id="cite_ref-AHFS2018_12-8"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Oxycodone acts by activating the μ-opioid receptor.<span class="mw-ref" id="cite_ref-TalleyFrankum2015_15-0"><a href="#cite_note-TalleyFrankum2015-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> When taken by mouth, it has roughly 1.5 times the effect of the equivalent amount of <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


<p>Oxycodone was first made in Germany in 1916 from <a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">thebaine</a>.<span class="mw-ref" id="cite_ref-Oxysynthesis2005_17-0"><a href="#cite_note-Oxysynthesis2005-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2018_12-9"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In 2017, it was the 52nd most commonly prescribed medication in the United States, with more than fifteen million prescriptions.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> A number of abuse-deterrent formulations are available, such as in combination with naloxone.<span class="mw-ref" id="cite_ref-Per2018_13-1"><a href="#cite_note-Per2018-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Oxycodone is used for managing moderate to severe acute or chronic pain when other treatments are not sufficient.<span class="mw-ref" id="cite_ref-AHFS2018_12-10"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It may improve quality of life in certain types of pain.<span class="mw-ref" id="cite_ref-Riley2008_21-0"><a href="#cite_note-Riley2008-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> It is unclear if use in chronic pain results in improved quality of life or ongoing pain relief.<span class="mw-ref" id="cite_ref-AHFS2018_12-11"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Oxycodone is available as controlled-release tablet, intended to be taken every 12 hours.<span class="mw-ref" id="cite_ref-Biancofiore_20060901_22-0"><a href="#cite_note-Biancofiore_20060901-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> A July 1996 study independent of Purdue Pharma, the drug's originator, found the controlled-release formulation had a variable duration of action ranging from 10–12 hours.<span class="mw-ref" id="cite_ref-sunshine1996_11-1"><a href="#cite_note-sunshine1996-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> A 2006 review found that controlled-release oxycodone is comparable to immediate-release oxycodone, <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>, and <a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">hydromorphone</a> in management of moderate to severe cancer pain, with fewer side effects than morphine. The author concluded that the controlled-release form is a valid alternative to morphine and a first-line treatment for cancer pain.<span class="mw-ref" id="cite_ref-Biancofiore_20060901_22-1"><a href="#cite_note-Biancofiore_20060901-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> In 2014, the European Association for Palliative Care recommended oxycodone by mouth as a second-line alternative to morphine by mouth for cancer pain.<span class="mw-ref" id="cite_ref-pmid11237376_23-0"><a href="#cite_note-pmid11237376-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>In the U.S., extended-release oxycodone is approved for use in children as young as eleven years old. The approved uses is for relief of cancer pain, trauma pain, or pain due to major surgery, in children already treated with opioids, who can tolerate at least 20<span>&nbsp;</span>mg per day of oxycodone; this provides an alternative to Duragesic (<a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">fentanyl</a>), the only other extended-release opioid analgesic approved for children.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    

<style data-mw-deduplicate="TemplateStyles:r923042769/mw-parser-output/.tmulti">.mw-parser-output .tmulti .thumbinner{display:flex;flex-direction:column}.mw-parser-output .tmulti .trow{display:flex;flex-direction:row;clear:left;flex-wrap:wrap;width:100%;box-sizing:border-box}.mw-parser-output .tmulti .tsingle{margin:1px;float:left}.mw-parser-output .tmulti .theader{clear:both;font-weight:bold;text-align:center;align-self:center;background-color:transparent;width:100%}.mw-parser-output .tmulti .thumbcaption{text-align:left;background-color:transparent}.mw-parser-output .tmulti .thumbcaption-center{text-align:center;background-color:transparent}.mw-parser-output .tmulti .text-align-left{text-align:left}.mw-parser-output .tmulti .text-align-right{text-align:right}.mw-parser-output .tmulti .text-align-center{text-align:center}@media all and (max-width:720px){.mw-parser-output .tmulti .thumbinner{width:100%!important;box-sizing:border-box;max-width:none!important;align-items:center}.mw-parser-output .tmulti .trow{justify-content:center}.mw-parser-output .tmulti .tsingle{float:none!important;max-width:100%!important;box-sizing:border-box;text-align:center}.mw-parser-output .tmulti .thumbcaption{text-align:center}}</style><div class="thumb tmulti tright"><div class="thumbinner" style="width:258px;max-width:258px"><div class="trow"><div class="tsingle" style="width:127px;max-width:127px"><div class="thumbimage"><figure-inline><img src="../I/m/OxyContin_branded_oxycodone_10mg_(OC_side).jpg" tppabs="https://ptable.com/wiki/compounds/I/m/OxyContin_branded_oxycodone_10mg_(OC_side).jpg" data-file-width="1600" data-file-height="1200" data-file-type="bitmap" height="94" width="125"></figure-inline></div></div><div class="tsingle" style="width:127px;max-width:127px"><div class="thumbimage"><figure-inline><img src="../I/m/OxyContin_branded_oxycodone_10mg_(number_side).jpg" tppabs="https://ptable.com/wiki/compounds/I/m/OxyContin_branded_oxycodone_10mg_(number_side).jpg" data-file-width="1600" data-file-height="1200" data-file-type="bitmap" height="94" width="125"></figure-inline></div></div></div><div class="trow" style="display:flex"><div class="thumbcaption" style="background-color:transparent">Both sides of a single 10mg OxyContin pill.</div></div></div></div>

<p>Oxycodone is available in a variety of formulations for by mouth or under the tongue:<span class="mw-ref" id="cite_ref-ElliottSmith2016_6-3"><a href="#cite_note-ElliottSmith2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-PhD2006_25-0"><a href="#cite_note-PhD2006-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Graves2015_26-0"><a href="#cite_note-Graves2015-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-Skidmore-Roth2015_27-0"><a href="#cite_note-Skidmore-Roth2015-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<ul><li>Immediate-release oxycodone (OxyFast, OxyIR, OxyNorm, Roxicodone)</li>
<li>Controlled-release oxycodone (OxyContin, Xtampza ER) – 10-12 hour duration<span class="mw-ref" id="cite_ref-sunshine1996_11-2"><a href="#cite_note-sunshine1996-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></li>
<li>Oxycodone tamper-resistant (OxyContin OTR)<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></li>
<li>Immediate-release oxycodone with <a href="Paracetamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Paracetamol" title="Paracetamol">paracetamol</a> (acetaminophen) (Percocet, Endocet, Roxicet, Tylox)</li>
<li>Immediate-release oxycodone with <a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">aspirin</a> (Endodan, Oxycodan, Percodan, Roxiprin)</li>
<li>Immediate-release oxycodone with <a href="Ibuprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibuprofen" title="Ibuprofen">ibuprofen</a> (Combunox)<span class="mw-ref" id="cite_ref-SinatraLeon-Cassasola2009_29-0"><a href="#cite_note-SinatraLeon-Cassasola2009-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></li>
<li>Controlled-release oxycodone with <a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">naloxone</a> (Targin, Targiniq, Targinact)<span class="mw-ref" id="cite_ref-StaatsSilverman2016_30-0"><a href="#cite_note-StaatsSilverman2016-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> – 10-12 hour duration<span class="mw-ref" id="cite_ref-sunshine1996_11-3"><a href="#cite_note-sunshine1996-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></li>
<li>Controlled-release oxycodone with <a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">naltrexone</a> (Troxyca) – 10-12 hour duration<span class="mw-ref" id="cite_ref-sunshine1996_11-4"><a href="#cite_note-sunshine1996-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Pfizer2018_31-0"><a href="#cite_note-Pfizer2018-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li></ul>

<p>In the US, oxycodone is only approved for use by mouth, available as tablets and oral solutions. Parenteral formulations of oxycodone (brand name OxyNorm) are also available in other parts of the world however, and are widely used in the European Union.<span class="mw-ref" id="cite_ref-Davis2009_32-0"><a href="#cite_note-Davis2009-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Forbes2007_33-0"><a href="#cite_note-Forbes2007-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-BradburyHodge2013_34-0"><a href="#cite_note-BradburyHodge2013-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> In Spain, the Netherlands and the United Kingdom, oxycodone is approved for intravenous (IV) and intramuscular (IM) use. When first introduced in Germany during World War I, both IV and IM administrations of oxycodone were commonly used for postoperative pain management of Central Powers soldiers.<span class="mw-ref" id="cite_ref-Kalso_4-1"><a href="#cite_note-Kalso-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:332px"><img src="../I/m/Side_effects_of_Oxycodone.png" tppabs="https://ptable.com/wiki/compounds/I/m/Side_effects_of_Oxycodone.png" data-file-width="2382" data-file-height="2520" data-file-type="bitmap" height="349" width="330"><div class="thumbcaption" style="text-align: left">Main side effects of oxycodone<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/GT-Oxycodon-Sicherheitsblister.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/GT-Oxycodon-Sicherheitsblister.jpg" data-file-width="2407" data-file-height="1952" data-file-type="bitmap" height="178" width="220"><div class="thumbcaption" style="text-align: left">Two tablets (10 mg) of oxycodone and safety blisters</div></div></div>

<p>Serious side effects of oxycodone include reduced sensitivity to pain (beyond the pain the drug is taken to reduce), euphoria, anxiolysis, feelings of relaxation, and respiratory depression.<span class="mw-ref" id="cite_ref-FitzgibbonLoeser2012_36-0"><a href="#cite_note-FitzgibbonLoeser2012-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> Common side effects of oxycodone include constipation (23%), nausea (23%), vomiting (12%), somnolence (23%), dizziness (13%), itching (13%), dry mouth (6%), and sweating (5%).<span class="mw-ref" id="cite_ref-FitzgibbonLoeser2012_36-1"><a href="#cite_note-FitzgibbonLoeser2012-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-drugscomSE_37-0"><a href="#cite_note-drugscomSE-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> Less common side effects (experienced by less than 5% of patients) include loss of appetite, nervousness, abdominal pain, diarrhea, urine retention, dyspnea, and hiccups.<span class="mw-ref" id="cite_ref-OxyContinInsertUS_38-0"><a href="#cite_note-OxyContinInsertUS-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Most side effects generally become less intense over time, although issues related to constipation are likely to continue for the duration of use.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> Oxycodone in combination with <a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">naloxone</a> in managed-release tablets, has been formulated to both deter abuse and reduce "opioid-induced constipation".<span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Dependence_and_withdrawal">Dependence and withdrawal</h3></summary>
    


<p>The risk of experiencing severe withdrawal symptoms is high if a patient has become physically dependent and discontinues oxycodone abruptly. Medically, when the drug has been taken regularly over an extended period, it is withdrawn gradually rather than abruptly. People who regularly use oxycodone recreationally or at higher than prescribed doses are at even higher risk of severe withdrawal symptoms. The symptoms of oxycodone withdrawal, as with other opioids, may include "anxiety, panic attack, nausea, insomnia, muscle pain, muscle weakness, fevers, and other flu-like symptoms".<span class="mw-ref" id="cite_ref-CESAR2005_41-0"><a href="#cite_note-CESAR2005-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>Withdrawal symptoms have also been reported in newborns whose mothers had been either injecting or orally taking oxycodone during pregnancy.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Hormone_levels">Hormone levels</h3></summary>
    


<p>As with other opioids, chronic use of oxycodone (particularly with higher doses) often causes concurrent hypogonadism (low sex hormone levels).<span class="mw-ref" id="cite_ref-pmid23414717_43-0"><a href="#cite_note-pmid23414717-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>In high doses, overdoses, or in some persons not tolerant to opioids, oxycodone can cause shallow breathing, slowed heart rate, cold/clammy skin, pauses in breathing, low blood pressure, constricted pupils, circulatory collapse, respiratory arrest, and death.<span class="mw-ref" id="cite_ref-OxyContinInsertUS_38-1"><a href="#cite_note-OxyContinInsertUS-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>

<p>In 2011, it was the leading cause of drug-related deaths in the U.S.<span class="mw-ref" id="cite_ref-CDC2018Death_44-0"><a href="#cite_note-CDC2018Death-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> However, from 2012 onwards, <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a> and fentanyl have become more common causes of drug-related deaths.<span class="mw-ref" id="cite_ref-CDC2018Death_44-1"><a href="#cite_note-CDC2018Death-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>

<p>Oxycodone overdose has also been described to cause spinal cord infarction in high doses and ischemic damage to the brain, due to prolonged hypoxia from suppressed breathing.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Oxycodone is metabolized by the enzymes CYP3A4 and CYP2D6, and its clearance therefore can be altered by inhibitors and inducers of these enzymes, increasing and decreasing half-life, respectively.<span class="mw-ref" id="cite_ref-Forbes2007_33-1"><a href="#cite_note-Forbes2007-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> (For lists of CYP3A4 and CYP2D6 inhibitors and inducers, see here and here, respectively.) Natural genetic variation in these enzymes can also influence the clearance of oxycodone, which may be related to the wide inter-individual variability in its half-life and potency.<span class="mw-ref" id="cite_ref-Forbes2007_33-2"><a href="#cite_note-Forbes2007-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>

<p><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir</a> or lopinavir/ritonavir greatly increase plasma concentrations of oxycodone in healthy human volunteers due to inhibition of CYP3A4 and CYP2D6.<span class="mw-ref" id="cite_ref-NieminenHagelberg2010_46-0"><a href="#cite_note-NieminenHagelberg2010-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">Rifampicin</a> greatly reduces plasma concentrations of oxycodone due to strong induction of CYP3A4.<span class="mw-ref" id="cite_ref-NieminenHagelberg2009_47-0"><a href="#cite_note-NieminenHagelberg2009-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> There is also a case report of <a href="Fosphenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosphenytoin" title="Fosphenytoin">fosphenytoin</a>, a CYP3A4 inducer, dramatically reducing the analgesic effects of oxycodone in a chronic pain patient.<span class="mw-ref" id="cite_ref-Pon,_Hwang,_2015_48-0"><a href="#cite_note-Pon,_Hwang,_2015-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> Dosage or medication adjustments may be necessary in each case.<span class="mw-ref" id="cite_ref-NieminenHagelberg2010_46-1"><a href="#cite_note-NieminenHagelberg2010-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-NieminenHagelberg2009_47-1"><a href="#cite_note-NieminenHagelberg2009-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span><span class="mw-ref" id="cite_ref-Pon,_Hwang,_2015_48-1"><a href="#cite_note-Pon,_Hwang,_2015-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<table class="wikitable floatright" style="text-align: center;">
<caption>Oxycodone (and metabolite) at opioid receptors</caption>
<tbody><tr>
<th rowspan="2">Compound</th><th colspan="3">Affinities (<abbr>K<sub>i</sub></abbr>)</th><th>Ratio</th><th rowspan="2"><abbr>Ref.</abbr></th></tr>
<tr>
<th><abbr>MOR</abbr></th><th><abbr>DOR</abbr></th><th><abbr>KOR</abbr></th><th>MOR:DOR:KOR</th></tr>
<tr>
<td>Oxycodone</td><td>18 nM</td><td>958 nM</td><td>677 nM</td><td>1:53:38</td><td><span class="mw-ref" id="cite_ref-Kalso2005_49-0"><a href="#cite_note-Kalso2005-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></td></tr>
<tr>
<td>Oxymorphone</td><td>0.78 nM</td><td>50 nM</td><td>137 nM</td><td>1:64:176</td><td><span class="mw-ref" id="cite_ref-CorbettPaterson1993_50-0"><a href="#cite_note-CorbettPaterson1993-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></td></tr>
</tbody></table>

<table class="wikitable floatright">
<caption><br>Equianalgesic doses<span class="mw-ref" id="cite_ref-King2010_51-0"><a href="#cite_note-King2010-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-ChestnutWong2014_52-0"><a href="#cite_note-ChestnutWong2014-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-Tiziani2013_53-0"><a href="#cite_note-Tiziani2013-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></caption>
<tbody><tr>
<th>Compound</th><th>Route</th><th>Dose</th></tr>
<tr>
<td><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></td><td><abbr>PO</abbr></td><td>200<span>&nbsp;</span>mg</td></tr>
<tr>
<td><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></td><td><abbr>PO</abbr></td><td>20–30<span>&nbsp;</span>mg</td></tr>
<tr>
<td><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></td><td><abbr>PO</abbr></td><td>7.5<span>&nbsp;</span>mg</td></tr>
<tr>
<td><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></td><td><abbr>IV</abbr></td><td>1.5<span>&nbsp;</span>mg</td></tr>
<tr>
<td><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></td><td><abbr>PO</abbr></td><td>30<span>&nbsp;</span>mg</td></tr>
<tr>
<td><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></td><td><abbr>IV</abbr></td><td>10<span>&nbsp;</span>mg</td></tr>
<tr>
<td>Oxycodone</td><td><abbr>PO</abbr></td><td>20<span>&nbsp;</span>mg</td></tr>
<tr>
<td>Oxycodone</td><td><abbr>IV</abbr></td><td>10<span>&nbsp;</span>mg</td></tr>
<tr>
<td><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></td><td><abbr>PO</abbr></td><td>10<span>&nbsp;</span>mg</td></tr>
<tr>
<td><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></td><td><abbr>IV</abbr></td><td>1<span>&nbsp;</span>mg</td></tr>
</tbody></table>

<p>Oxycodone, a semi-synthetic opioid, is a highly selective full agonist of the μ-opioid receptor (MOR).<span class="mw-ref" id="cite_ref-Davis2009_32-1"><a href="#cite_note-Davis2009-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Forbes2007_33-3"><a href="#cite_note-Forbes2007-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> This is the main biological target of the endogenous opioid neuropeptide β-endorphin.<span class="mw-ref" id="cite_ref-TalleyFrankum2015_15-1"><a href="#cite_note-TalleyFrankum2015-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Oxycodone has low affinity for the δ-opioid receptor (DOR) and the κ-opioid receptor (KOR), where it is an agonist similarly.<span class="mw-ref" id="cite_ref-Davis2009_32-2"><a href="#cite_note-Davis2009-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Forbes2007_33-4"><a href="#cite_note-Forbes2007-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> After oxycodone binds to the MOR, a G protein-complex is released, which inhibits the release of neurotransmitters by the cell by decreasing the amount of <a href="Cyclic_adenosine_monophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a> produced, closing calcium channels, and opening potassium channels.<span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> Opioids like oxycodone are thought to produce their analgesic effects via activation of the MOR in the midbrain periaqueductal gray (PAG) and rostral ventromedial medulla (RVM).<span class="mw-ref" id="cite_ref-Stein1999_55-0"><a href="#cite_note-Stein1999-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> Conversely, they are thought to produce reward and addiction via activation of the MOR in the mesolimbic reward pathway, including in the ventral tegmental area, nucleus accumbens, and ventral pallidum.<span class="mw-ref" id="cite_ref-SquireBerg2012_56-0"><a href="#cite_note-SquireBerg2012-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-KringelbachBerridge2010_57-0"><a href="#cite_note-KringelbachBerridge2010-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> Tolerance to the analgesic and rewarding effects of opioids is complex and occurs due to receptor-level tolerance (e.g., MOR downregulation), cellular-level tolerance (e.g., cAMP upregulation), and system-level tolerance (e.g., neural adaptation due to induction of ΔFosB expression).<span class="mw-ref" id="cite_ref-SinatraJahr2010_58-0"><a href="#cite_note-SinatraJahr2010-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>

<p>Taken orally, 20<span>&nbsp;</span>mg of immediate-release oxycodone is considered to be equivalent in analgesic effect to 30<span>&nbsp;</span>mg of morphine,<span class="mw-ref" id="cite_ref-Merck_59-0"><a href="#cite_note-Merck-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-FerrellPasero2010_60-0"><a href="#cite_note-FerrellPasero2010-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> while extended release oxycodone is considered to be twice as potent as oral morphine.<span class="mw-ref" id="cite_ref-LevyVictor2007_61-0"><a href="#cite_note-LevyVictor2007-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>

<p>Similarly to most other opioids, oxycodone increases prolactin secretion, but its influence on <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> levels is unknown.<span class="mw-ref" id="cite_ref-Davis2009_32-3"><a href="#cite_note-Davis2009-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Unlike morphine, oxycodone lacks immunosuppressive activity (measured by natural killer cell activity and <a href="Interleukin_2.htm" tppabs="https://ptable.com/wiki/compounds/A/Interleukin_2" title="Interleukin 2">interleukin 2</a> production <i>in vitro</i>); the clinical relevance of this has not been clarified.<span class="mw-ref" id="cite_ref-Davis2009_32-4"><a href="#cite_note-Davis2009-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Active_metabolites">Active metabolites</h4></summary>
    
<p>A few of the metabolites of oxycodone have also been found to be active as MOR agonists, some of which notably have much higher affinity for (as well as higher efficacy at) the MOR in comparison.<span class="mw-ref" id="cite_ref-LalovicKharasch2006_62-0"><a href="#cite_note-LalovicKharasch2006-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-KlimasWitticke2013_63-0"><a href="#cite_note-KlimasWitticke2013-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-LembergSiiskonen2008_64-0"><a href="#cite_note-LembergSiiskonen2008-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> <a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a> possesses 3- to 5-fold higher affinity for the MOR than does oxycodone,<span class="mw-ref" id="cite_ref-SmithPassik2008_7-8"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> while noroxycodone and noroxymorphone possess one-third of and 3-fold higher affinity for the MOR, respectively,<span class="mw-ref" id="cite_ref-SmithPassik2008_7-9"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-LembergSiiskonen2008_64-1"><a href="#cite_note-LembergSiiskonen2008-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> and MOR activation is 5- to 10-fold less with noroxycodone but 2-fold higher with noroxymorphone relative to oxycodone.<span class="mw-ref" id="cite_ref-Preedy2016_65-0"><a href="#cite_note-Preedy2016-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> Noroxycodone, noroxymorphone, and oxymorphone also have longer biological half-lives than oxycodone.<span class="mw-ref" id="cite_ref-LalovicKharasch2006_62-1"><a href="#cite_note-LalovicKharasch2006-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-FiresteinBudd2016_66-0"><a href="#cite_note-FiresteinBudd2016-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></p>

<table class="wikitable">
<caption>Pharmacology of oxycodone and metabolites<span class="mw-ref" id="cite_ref-FitzgibbonLoeser2012_36-2"><a href="#cite_note-FitzgibbonLoeser2012-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-Preedy2016_65-1"><a href="#cite_note-Preedy2016-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></caption>
<tbody><tr>
<th>Compound</th><th><abbr>K<sub>i</sub></abbr></th><th><abbr>EC<sub>50</sub></abbr></th><th><abbr>C<sub>max</sub></abbr></th><th><abbr>AUC</abbr></th></tr>
<tr>
<td>Oxycodone</td><td>16.0 nM</td><td>343 nM</td><td>23.2 ± 8.6<span>&nbsp;</span>ng/mL</td><td>236 ± 102<span>&nbsp;</span>ng/h/mL</td></tr>
<tr>
<td><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></td><td>0.36 nM</td><td>42.8 nM</td><td>0.82 ± 0.85<span>&nbsp;</span>ng/mL</td><td>12.3 ± 12<span>&nbsp;</span>ng/h/mL</td></tr>
<tr>
<td>Noroxycodone</td><td>57.1 nM</td><td>1930 nM</td><td>15.2 ± 4.5<span>&nbsp;</span>ng/mL</td><td>233 ± 102<span>&nbsp;</span>ng/h/mL</td></tr>
<tr>
<td>Noroxymorphone</td><td>5.69 nM</td><td>167 nM</td><td><abbr>ND</abbr></td><td><abbr>ND</abbr></td></tr>
<tr class="sortbottom">
<td colspan="5" style="width: 1px;"><span style="font-size:85%;">K<sub>i</sub> is for [<sup>3</sup>H]diprenorphine displacement. (Note that diprenorphine is a non-selective opioid receptor ligand, so this is not MOR-specific.) EC<sub>50</sub> is for hMOR1 GTPyS binding. C<sub>max</sub> and AUC levels are for 20<span>&nbsp;</span>mg CR oxycodone.</span></td></tr>
</tbody></table>

<p>However, despite the greater <i>in vitro</i> activity of some of its metabolites, it has been determined that oxycodone itself is responsible for 83.0% and 94.8% of its analgesic effect following oral and intravenous administration, respectively.<span class="mw-ref" id="cite_ref-KlimasWitticke2013_63-1"><a href="#cite_note-KlimasWitticke2013-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Oxymorphone plays only a minor role, being responsible for 15.8% and 4.5% of the analgesic effect of oxycodone after oral and intravenous administration, respectively.<span class="mw-ref" id="cite_ref-KlimasWitticke2013_63-2"><a href="#cite_note-KlimasWitticke2013-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Although the CYP2D6 genotype and the route of administration result in differential rates of oxymorphone formation, the unchanged parent compound remains the major contributor to the overall analgesic effect of oxycodone.<span class="mw-ref" id="cite_ref-KlimasWitticke2013_63-3"><a href="#cite_note-KlimasWitticke2013-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> In contrast to oxycodone and oxymorphone, noroxycodone and noroxymorphone, while also potent MOR agonists, poorly cross the blood–brain barrier into the central nervous system, and for this reason are only minimally analgesic in comparison.<span class="mw-ref" id="cite_ref-LalovicKharasch2006_62-2"><a href="#cite_note-LalovicKharasch2006-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Preedy2016_65-2"><a href="#cite_note-Preedy2016-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-KlimasWitticke2013_63-4"><a href="#cite_note-KlimasWitticke2013-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-LembergSiiskonen2008_64-2"><a href="#cite_note-LembergSiiskonen2008-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="κ-opioid_receptor">κ-opioid receptor</h4></summary>
    
<p>In 1997, a group of Australian researchers proposed (based on a study in rats) that oxycodone acts on KORs, unlike morphine, which acts upon MORs.<span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> Further research by this group indicated the drug appears to be a high-affinity κ<sub>2b</sub>-opioid receptor agonist.<span class="mw-ref" id="cite_ref-68"><a href="#cite_note-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> However, this conclusion has been disputed, primarily on the basis that oxycodone produces effects that are typical of MOR agonists.<span class="mw-ref" id="cite_ref-pmid17961923_69-0"><a href="#cite_note-pmid17961923-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> In 2006, research by a Japanese group suggested the effect of oxycodone is mediated by different receptors in different situations.<span class="mw-ref" id="cite_ref-pmid16533506_70-0"><a href="#cite_note-pmid16533506-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span> Specifically in diabetic mice, the KOR appears to be involved in the antinociceptive effects of oxycodone, while in nondiabetic mice, the μ<sub>1</sub>-opioid receptor seems to be primarily responsible for these effects.<span class="mw-ref" id="cite_ref-pmid16533506_70-1"><a href="#cite_note-pmid16533506-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span><span class="mw-ref" id="cite_ref-pmid17292346_71-0"><a href="#cite_note-pmid17292346-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Instant-release_absorption_profile">Instant-release absorption profile</h4></summary>
    
<p>Oxycodone can be administered orally, intranasally, via intravenous, intramuscular, or subcutaneous injection, or rectally. The bioavailability of oral administration of oxycodone averages within a range of 60 to 87%, with rectal administration yielding the same results; intranasal varies between individuals with a mean of 46%.<span class="mw-ref" id="cite_ref-72"><a href="#cite_note-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span></p>

<p>After a dose of conventional (instant-release) oral oxycodone, the onset of action is 10 to 30 minutes,<span class="mw-ref" id="cite_ref-SmithPassik2008_7-10"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-ElliottSmith2016_6-4"><a href="#cite_note-ElliottSmith2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> and peak plasma levels of the drug are attained within roughly 30 to 60 minutes;<span class="mw-ref" id="cite_ref-SmithPassik2008_7-11"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-ElliottSmith2016_6-5"><a href="#cite_note-ElliottSmith2016-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-LalovicKharasch2006_62-3"><a href="#cite_note-LalovicKharasch2006-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> in contrast, after a dose of OxyContin (an oral controlled-release formulation), peak plasma levels of oxycodone occur in about three hours.<span class="mw-ref" id="cite_ref-OxyContinInsertUS_38-2"><a href="#cite_note-OxyContinInsertUS-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> The duration of instant-release oxycodone is 3 to 6 hours, although this can be variable depending on the individual.<span class="mw-ref" id="cite_ref-SmithPassik2008_7-12"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Distribution">Distribution</h4></summary>
    
<p>Oxycodone has a volume of distribution of 2.6L/kg,<span class="mw-ref" id="cite_ref-Oxycodone_73-0"><a href="#cite_note-Oxycodone-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> in the blood it is distributed to skeletal muscle, liver, intestinal tract, lungs, spleen, and brain.<span class="mw-ref" id="cite_ref-OxyContinInsertUS_38-3"><a href="#cite_note-OxyContinInsertUS-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Conventional oral preparations start to reduce pain within 10 to 15 minutes on an empty stomach; in contrast, OxyContin starts to reduce pain within one hour.<span class="mw-ref" id="cite_ref-AHFS2018_12-12"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Metabolism">Metabolism</h4></summary>
    
<p>The metabolism of oxycodone in humans occurs in the liver mainly via the cytochrome P450 system and is extensive (about 95%) and complex, with many minor pathways and resulting metabolites.<span class="mw-ref" id="cite_ref-SmithPassik2008_7-13"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-pmid14516487_74-0"><a href="#cite_note-pmid14516487-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> Around 10% (range 8–14%) of a dose of oxycodone is excreted essentially unchanged (unconjugated or conjugated) in the urine.<span class="mw-ref" id="cite_ref-SmithPassik2008_7-14"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> The major metabolites of oxycodone are noroxycodone (70%), noroxymorphone ("relatively high concentrations"),<span class="mw-ref" id="cite_ref-FitzgibbonLoeser2012_36-3"><a href="#cite_note-FitzgibbonLoeser2012-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> and <a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">oxymorphone</a> (5%).<span class="mw-ref" id="cite_ref-LalovicKharasch2006_62-4"><a href="#cite_note-LalovicKharasch2006-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Preedy2016_65-3"><a href="#cite_note-Preedy2016-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> The immediate metabolism of oxycodone in humans is as follows:<span class="mw-ref" id="cite_ref-SmithPassik2008_7-15"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-McPhersonPincus2016_10-1"><a href="#cite_note-McPhersonPincus2016-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-AnzenbacherZanger2012_75-0"><a href="#cite_note-AnzenbacherZanger2012-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span></p>

<ul><li>N-Demethylation to noroxycodone predominantly via CYP3A4</li>
<li>O-Demethylation to <a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">oxymorphone</a> predominantly via CYP2D6</li>
<li>6-<a href="javascript:if(confirm('https://en.wiktionary.org/wiki/ketoreduction  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wiktionary.org/wiki/ketoreduction'" tppabs="https://en.wiktionary.org/wiki/ketoreduction" title="wikt:ketoreduction" class="external">Ketoreduction</a> to <span class="new">6α-</span> and <span class="new">6β-oxycodol</span></li>
<li>N-Oxidation to <span class="new">oxycodone-N-oxide</span></li></ul>

<p>In humans, N-demethylation of oxycodone to noroxycodone by CYP3A4 is the major metabolic pathway, accounting for 45% ± 21% of a dose of oxycodone, while O-demethylation of oxycodone into oxymorphone by CYP2D6 and 6-ketoreduction of oxycodone into 6-oxycodols represent relatively minor metabolic pathways, accounting for 11% ± 6% and 8% ± 6% of a dose of oxycodone, respectively.<span class="mw-ref" id="cite_ref-SmithPassik2008_7-16"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Davis2009_32-5"><a href="#cite_note-Davis2009-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>

<p>Several of the immediate metabolites of oxycodone are subsequently conjugated with <a href="Glucuronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucuronic_acid" title="Glucuronic acid">glucuronic acid</a> and excreted in the urine.<span class="mw-ref" id="cite_ref-SmithPassik2008_7-17"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> 6α-Oxycodol and 6β-oxycodol are further metabolized by N-demethylation to <span class="new">nor-6α-oxycodol</span> and <span class="new">nor-6β-oxycodol</span>, respectively, and by N-oxidation to <span class="new">6α-oxycodol-N-oxide</span> and <span class="new">6β-oxycodol-N-oxide</span> (which can subsequently be glucuronidated as well).<span class="mw-ref" id="cite_ref-SmithPassik2008_7-18"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-McPhersonPincus2016_10-2"><a href="#cite_note-McPhersonPincus2016-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Oxymorphone is also further metabolized, as follows:<span class="mw-ref" id="cite_ref-SmithPassik2008_7-19"><a href="#cite_note-SmithPassik2008-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-McPhersonPincus2016_10-3"><a href="#cite_note-McPhersonPincus2016-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-AnzenbacherZanger2012_75-1"><a href="#cite_note-AnzenbacherZanger2012-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span></p>

<ul><li>3-Glucuronidation to <span class="new">oxymorphone-3-glucuronide</span> predominantly via UGT2B7</li>
<li>6-Ketoreduction to 6α-oxymorphol and 6β-oxymorphol</li>
<li>N-Demethylation to noroxymorphone</li></ul>

<p>The first pathway of the above three accounts for 40% of the metabolism of oxymorphone, making oxymorphone-3-glucuronide the main metabolite of oxymorphone, while the latter two pathways account for less than 10% of the metabolism of oxymorphone.<span class="mw-ref" id="cite_ref-AnzenbacherZanger2012_75-2"><a href="#cite_note-AnzenbacherZanger2012-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> After N-demethylation of oxymorphone, noroxymorphone is further glucuronidated to <span class="new">noroxymorphone-3-glucuronide</span>.<span class="mw-ref" id="cite_ref-AnzenbacherZanger2012_75-3"><a href="#cite_note-AnzenbacherZanger2012-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span></p>

<p>Because oxycodone is metabolized by the cytochrome P450 system in the liver, its pharmacokinetics can be influenced by genetic polymorphisms and drug interactions concerning this system, as well as by liver function.<span class="mw-ref" id="cite_ref-OxyContinInsertUS_38-4"><a href="#cite_note-OxyContinInsertUS-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Some people are fast metabolizers of oxycodone, resulting in reduced effects, while others are slow metabolizers, resulting in increased effects and toxicity.<span class="mw-ref" id="cite_ref-pmid15625333_76-0"><a href="#cite_note-pmid15625333-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span><span class="mw-ref" id="cite_ref-pmid8477556_77-0"><a href="#cite_note-pmid8477556-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> While higher CYP2D6 activity increases the effects of oxycodone (owing to increased conversion into oxymorphone), higher CYP3A4 activity has the opposite effect and decreases the effects of oxycodone (owing to increased metabolism into noroxycodone and noroxymorphone).<span class="mw-ref" id="cite_ref-SamerDaali2010_78-0"><a href="#cite_note-SamerDaali2010-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> The dose of oxycodone must be reduced in patients with reduced liver function.<span class="mw-ref" id="cite_ref-AHFS_79-0"><a href="#cite_note-AHFS-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Elimination">Elimination</h4></summary>
    
<p>The clearance of oxycodone is 0.8<span>&nbsp;</span>L/min.<span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> Oxycodone and its metabolites are mainly excreted in urine.<span class="mw-ref" id="cite_ref-DavisCladis2016_81-0"><a href="#cite_note-DavisCladis2016-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span> Therefore, oxycodone accumulates in patients with kidney impairment.<span class="mw-ref" id="cite_ref-AHFS_79-1"><a href="#cite_note-AHFS-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> Oxycodone is eliminated in the urine 10% as unchanged oxycodone, 45% ± 21% as <i>N</i>-demethylated metabolites (noroxycodone, noroxymorphone, noroxycodols), 11 ± 6% as <i>O</i>-demethylated metabolites (oxymorphone, oxymorphols), and 8% ± 6% as 6-keto-reduced metabolites (oxycodols).<span class="mw-ref" id="cite_ref-DavisCladis2016_81-1"><a href="#cite_note-DavisCladis2016-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-pmid16678548_82-0"><a href="#cite_note-pmid16678548-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Duration_of_action">Duration of action</h4></summary>
    
<p>Oxycodone has a half-life of 4.5 hours.<span class="mw-ref" id="cite_ref-Oxycodone_73-1"><a href="#cite_note-Oxycodone-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2018_12-13"><a href="#cite_note-AHFS2018-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Its manufacturer Purdue Pharma claimed in their 1992 patent application that the duration of action of OxyContin, oxycodone's controlled-release preparation, is 12 hours in "90% of patients." It has never performed any clinical studies in which OxyContin was given at more frequent intervals. In a separate filing, Purdue claims that controlled-release oxycodone "provides pain relief in said patient for at least 12 hours after administration."<span class="mw-ref" id="cite_ref-latimes2016_83-0"><a href="#cite_note-latimes2016-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> However, in 2016 an investigation by the <i>Los Angeles Times</i> found that "the drug weans off hours early in many people," inducing symptoms of opiate withdrawal and intense cravings for OxyContin. One doctor Lawrence Robbins told journalists that over 70% of his patients would report that OxyContin would only provide 4–7 hours of relief. Doctors in the 1990s often would switch their patients to a dosing schedule of once every eight hours when they complained that the duration of action for OxyContin was too short to be only taken twice a day.<span class="mw-ref" id="cite_ref-latimes2016_83-1"><a href="#cite_note-latimes2016-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span><span class="mw-ref" id="cite_ref-oxycontinfiles_84-0"><a href="#cite_note-oxycontinfiles-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></p>

<p>Purdue strongly discouraged the practice: Purdue's medical director Robert Reder wrote to one doctor in 1995 that "OxyContin has been developed for [12-hour] dosing...I request that you not use a [8-hourly] dosing regimen." Purdue repeatedly released memos to its sales representatives ordering them to remind doctors not to deviate from a 12-hour dosing schedule. One such memo read, "There is no Q8 dosing with OxyContin... [8-hour dosing] needs to be nipped in the bud. NOW!!"<span class="mw-ref" id="cite_ref-latimes2016_83-2"><a href="#cite_note-latimes2016-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> The journalists who covered the investigation argue that Purdue Pharma has insisted on a 12-hour duration of action for nearly all patients, despite evidence to the contrary, in order to protect the reputation of OxyContin as a 12-hour drug and the willingness of health insurance and managed care companies to cover OxyContin despite its high cost relative to generic opiates such as morphine.<span class="mw-ref" id="cite_ref-latimes2016_83-3"><a href="#cite_note-latimes2016-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>

<p>Purdue sales representatives were instructed to encourage doctors to write prescriptions for larger 12-hour doses instead of more frequent dosing. An August 1996 memo to Purdue sales representatives in Tennessee entitled "$$$$$$$ It’s Bonus Time in the Neighborhood!" reminded the representatives that their commissions would dramatically increase if they were successful in convincing doctors to prescribe larger doses. <i>Los Angeles Times</i>  journalists argue using interviews from opioid addiction experts that such high doses of OxyContin spaced 12 hours apart create a combination of agony during opiate withdrawal (lower lows) and a schedule of reinforcement that relieves this agony, fostering addiction.<span class="mw-ref" id="cite_ref-latimes2016_83-4"><a href="#cite_note-latimes2016-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    


<p>Oxycodone's chemical name is derived from <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">codeine</a>. The chemical structures are very similar, differing only in that</p>

<ul><li>Oxycodone has a hydroxy group at carbon-14 (codeine has just a hydrogen in its place)</li>
<li>Oxycodone has a 7,8-dihydro feature. Codeine has a double bond between those two carbons; and</li>
<li>Oxycodone has a carbonyl group (as in ketones) in place of the hydroxyl group of codeine.</li></ul>

<p>It is also similar to <a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">hydrocodone</a>, differing only in that it has a hydroxyl group at carbon-14.<span class="mw-ref" id="cite_ref-AHFS_79-2"><a href="#cite_note-AHFS-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span></p>

<p>Oxycodone is marketed as various salts, most commonly as the hydrochloride salt. The free base conversion ratios of different salts are: hydrochloride (0.896), bitartrate (0.667), tartrate (0.750), camphosulfonate (0.576), pectinate (0.588), phenylpriopionate (0.678), sulfate (0.887), phosphate (0.763), and terephthalate (0.792). The hydrochloride salt is the basis of most American oxycodone products whilst bitartrate, tartrate, pectinate, terephthalate and phosphate salts are also available in European Union products. Methyiodide and hydroiodide are mentioned in older European Union publications.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Biosynthesis">Biosynthesis</h3></summary>
    
<p>In terms of biosynthesis, oxycodone has been found naturally in nectar extracts from the orchid family <i>Epipactis helleborine</i>; together along with another opioid: 3-{2-{3-{3-benzyloxypropyl}-3-indol, 7,8-didehydro- 4,5-epoxy-3,6-d-morphinan.<span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Detection_in_biological_fluids">Detection in biological fluids</h3></summary>
    
<p>Oxycodone and/or its major metabolites may be measured in blood or urine to monitor for clearance, abuse, confirm a diagnosis of poisoning, or assist in a medicolegal death investigation. Many commercial opiate screening tests cross-react appreciably with oxycodone and its metabolites, but chromatographic techniques can easily distinguish oxycodone from other opiates.<span class="mw-ref" id="cite_ref-86"><a href="#cite_note-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p><span class="new">Martin Freund</span> and (Jakob) <span class="new">Edmund Speyer</span> of the University of Frankfurt in Germany published the first synthesis of oxycodone from <a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">thebaine</a> in 1916.<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span><span class="mw-ref" id="cite_ref-Oxysynthesis2005_17-1"><a href="#cite_note-Oxysynthesis2005-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> When Freund died, in 1920, Speyer wrote his obituary.<span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span> Speyer, born to a Jewish family in Frankfurt am Main in 1878, became a victim of the Holocaust. He died on 5 May 1942, the second day of deportations from the Lodz Ghetto; his death was noted in the ghetto's chronicle.<span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span></p>

<p>The first clinical use of the drug was documented in 1917, the year after it was first developed.<span class="mw-ref" id="cite_ref-Oxysynthesis2005_17-2"><a href="#cite_note-Oxysynthesis2005-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-sunshine1996_11-5"><a href="#cite_note-sunshine1996-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It was first introduced to the U.S. market in May 1939. In early 1928, Merck introduced a combination product containing scopolamine, oxycodone, and <a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">ephedrine</a> under the German initials for the ingredients SEE, which was later renamed Scophedal (SCOpolamine, ePHEDrine and eukodAL) in 1942. It was last manufactured in 1987, but can be compounded. This combination is essentially an oxycodone analogue of the morphine-based "twilight sleep", with ephedrine added to reduce circulatory and respiratory effects.<span class="mw-ref" id="cite_ref-ReferenceA_90-0"><a href="#cite_note-ReferenceA-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> The drug became known as the "Miracle Drug of the 1930s" in Continental Europe and elsewhere and it was the Wehrmacht's choice for a battlefield analgesic for a time. The drug was expressly designed to provide what the patent application and package insert referred to as "very deep analgesia and profound and intense euphoria" as well as tranquillisation and anterograde amnesia useful for surgery and battlefield wounding cases. Oxycodone was allegedly chosen over morphine, hydromorphone, and hydrocodone for this product because of oxycodone having subjective elements in its side effect profile similar to cocaine.<span class="mw-ref" id="cite_ref-91"><a href="#cite_note-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span></p>

<p>During Operation Himmler, Skophedal was also reportedly injected in massive overdose into the prisoners dressed in Polish Army uniforms in the staged incident on 1 September 1939 which opened the Second World War.<span class="mw-ref" id="cite_ref-ReferenceA_90-1"><a href="#cite_note-ReferenceA-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-92"><a href="#cite_note-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p>

<p>The personal notes of Adolf Hitler's physician, Theodor Morell, indicate Hitler received repeated injections of "eukodal" (oxycodone) and Scophedal, as well as Dolantin (<a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine</a>) codeine, and <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a> less frequently; oxycodone could not be obtained after late January 1945.<span class="mw-ref" id="cite_ref-93"><a href="#cite_note-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span><span class="mw-ref" id="cite_ref-94"><a href="#cite_note-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span></p>

<p>In the early 1970s, the U.S. government classified oxycodone as a schedule II drug.</p>

<p>Purdue Pharma — a privately held company based in Stamford, Connecticut, developed the prescription painkiller OxyContin. Upon its release in 1995, OxyContin was hailed as a medical breakthrough, a long-lasting narcotic that could help patients suffering from moderate to severe pain. The drug became a blockbuster, and has reportedly generated some US$35 billion in revenue for Purdue.<span class="mw-ref" id="cite_ref-eop_95-0"><a href="#cite_note-eop-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Lawsuits">Lawsuits</h3></summary>
    
<p>In October 2017, <i>The New Yorker</i> published a story on Mortimer Sackler and Purdue Pharma regarding their ties to the production and manipulation of the oxycodone markets.<span class="mw-ref" id="cite_ref-eop_95-1"><a href="#cite_note-eop-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> The article links Raymond and Arthur Sackler's business practices with the rise of direct pharmaceutical marketing and eventually to the rise of addiction to oxycodone in the United States. The article implies that Sackler bears some responsibility for the opioid epidemic in the United States.<span class="mw-ref" id="cite_ref-NewYorker_Keefe_20171023_96-0"><a href="#cite_note-NewYorker_Keefe_20171023-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span> In 2019 the New York Times ran a piece confirming Sackler told company officials in 2008 to “measure our performance by Rx’s by strength, giving higher measures to higher strengths.”<span class="mw-ref" id="cite_ref-97"><a href="#cite_note-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> This was verified with documents tied to a lawsuit <span>–</span> which was filed by the Massachusetts attorney general, Maura Healey <span>–</span> claiming that Purdue Pharma and members of the Sackler family knew that high doses of OxyContin over long periods would increase the risk of serious side effects, including addiction.<span class="mw-ref" id="cite_ref-98"><a href="#cite_note-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> Despite Purdue Pharma's proposal for a US$12 billion settlement of the lawsuit, the attorneys general of 23 states, including Massachusetts, rejected the settlement offer in September, 2019.<span class="mw-ref" id="cite_ref-99"><a href="#cite_note-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    

</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="General">General</h4></summary>
    
<p>Oxycodone is subject to international conventions on narcotic drugs. In addition, oxycodone is subject to national laws that differ by country. The 1931 Convention for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs of the League of Nations included oxycodone.<span class="mw-ref" id="cite_ref-100"><a href="#cite_note-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> The 1961 Single Convention on Narcotic Drugs of the United Nations, which replaced the 1931 convention, categorized oxycodone in Schedule I.<span class="mw-ref" id="cite_ref-SingleConvention_101-0"><a href="#cite_note-SingleConvention-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> Global restrictions on Schedule I drugs include "limit[ing] exclusively to medical and scientific purposes the production, manufacture, export, import, distribution of, trade in, use and possession of" these drugs; "requir[ing] medical prescriptions for the supply or dispensation of [these] drugs to individuals"; and "prevent[ing] the accumulation" of quantities of these drugs "in excess of those required for the normal conduct of business".<span class="mw-ref" id="cite_ref-SingleConvention_101-1"><a href="#cite_note-SingleConvention-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Australia">Australia</h4></summary>
    
<p>Oxycodone is in Schedule I (derived from the Single Convention on Narcotic Drugs) of the Commonwealth's Narcotic Drugs Act 1967.<span class="mw-ref" id="cite_ref-102"><a href="#cite_note-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> In addition, it is in Schedule 8 of the Australian Standard for the Uniform Scheduling of Drugs and Poisons ("Poisons Standard"), meaning it is a "controlled drug... which should be available for use but require[s] restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence".<span class="mw-ref" id="cite_ref-103"><a href="#cite_note-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Canada">Canada</h4></summary>
    
<p>Oxycodone is a controlled substance under Schedule I of the Controlled Drugs and Substances Act (CDSA).<span class="mw-ref" id="cite_ref-CanadaCDSA_104-0"><a href="#cite_note-CanadaCDSA-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span></p>


</details>
<details data-level="5" open="">
    <summary class="section-heading"><h5 id="Canadian_legislative_changes">Canadian legislative changes</h5></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Oxycocet.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Oxycocet.jpg" data-file-width="2431" data-file-height="2692" data-file-type="bitmap" height="244" width="220"><div class="thumbcaption" style="text-align: left">Canadian oxycodone HCL/acetaminophen 5/325 mg tablet</div></div></div>

<p>In February 2012, Ontario passed legislation to allow the expansion of an already existing drug-tracking system for publicly funded drugs to include those that are privately insured. This database will function to identify and monitor patient's attempts to seek prescriptions from multiple doctors or retrieve from multiple pharmacies. Other provinces have proposed similar legislation, while some, such as Nova Scotia, have legislation already in effect for monitoring prescription drug use. These changes have coincided with other changes in Ontario's legislation to target the misuse of painkillers and high addiction rates to drugs such as oxycodone. As of February 29, 2012, Ontario passed legislation delisting oxycodone from the province's public drug benefit program. This was a first for any province to delist a drug based on addictive properties. The new law prohibits prescriptions for OxyNeo except to certain patients under the Exceptional Access Program including palliative care and in other extenuating circumstances. Patients already prescribed oxycodone will receive coverage for an additional year for OxyNeo, and after that, it will be disallowed unless designated under the exceptional access program.<span class="mw-ref" id="cite_ref-105"><a href="#cite_note-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span></p>

<p>Much of the legislative activity has stemmed from Purdue Pharma's decision in 2011 to begin a modification of Oxycontin's composition to make it more difficult to crush for snorting or injecting. The new formulation, OxyNeo, is intended to be preventive in this regard and retain its effectiveness as a painkiller. Since introducing its <i>Narcotics Safety and Awareness Act</i>, Ontario has committed to focusing on drug addiction, particularly in the monitoring and identification of problem opioid prescriptions, as well as the education of patients, doctors, and pharmacists.<span class="mw-ref" id="cite_ref-106"><a href="#cite_note-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span> This Act, introduced in 2010, commits to the establishment of a unified database to fulfil this intention.<span class="mw-ref" id="cite_ref-107"><a href="#cite_note-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span> Both the public and medical community have received the legislation positively, though concerns about the ramifications of legal changes have been expressed. Because laws are largely provincially regulated, many speculate a national strategy is needed to prevent smuggling across provincial borders from jurisdictions with looser restrictions.<span class="mw-ref" id="cite_ref-108"><a href="#cite_note-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span></p>

<p>In 2015, Purdue Pharma's abuse-resistant OxyNEO and six generic versions of OxyContin had been on the Canada-wide approved list for prescriptions since 2012. In June 2015, then federal Minister of Health Rona Ambrose announced that within three years all oxycodone products sold in Canada would need to be tamper-resistant. Some experts warned that the generic product manufacturers may not have the technology to achieve that goal, possibly giving Purdue Pharma a monopoly on this opiate.<span class="mw-ref" id="cite_ref-109"><a href="#cite_note-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></p>


</details>
<details data-level="5" open="">
    <summary class="section-heading"><h5 id="Canadian_lawsuits">Canadian lawsuits</h5></summary>
    
<p>Several class action suits across Canada have been launched against the Purdue group of companies and affiliates. Claimants argue the pharmaceutical manufacturers did not meet a standard of care and were negligent in doing so. These lawsuits reference earlier judgments in the United States, which held that Purdue was liable for wrongful marketing practices and misbranding. Since 2007, the Purdue companies have paid over CAN$650 million in settling litigation or facing criminal fines.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Germany">Germany</h4></summary>
    
<p>The drug is in Appendix III of the Narcotics Act (<i>Betäubungsmittelgesetz</i> or BtMG).<span class="mw-ref" id="cite_ref-GermanNarcoticsAct_110-0"><a href="#cite_note-GermanNarcoticsAct-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span> The law allows only physicians, dentists, and veterinarians to prescribe oxycodone and the federal government to regulate the prescriptions (e.g., by requiring reporting).<span class="mw-ref" id="cite_ref-GermanNarcoticsAct_110-1"><a href="#cite_note-GermanNarcoticsAct-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Hong_Kong">Hong Kong</h4></summary>
    
<p>Oxycodone is regulated under Part I of Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance.<span class="mw-ref" id="cite_ref-HKOrdinance_111-0"><a href="#cite_note-HKOrdinance-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Japan">Japan</h4></summary>
    
<p>Oxycodone is a restricted drug in Japan. Its import and export is strictly restricted to specially designated organizations having prior permit to import it. In a high-profile case an American who was a top Toyota executive living in Tokyo, who claimed to be unaware of the law, was arrested for importing oxycodone into Japan.<span class="mw-ref" id="cite_ref-112"><a href="#cite_note-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span><span class="mw-ref" id="cite_ref-113"><a href="#cite_note-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Singapore">Singapore</h4></summary>
    
<p>Oxycodone is listed as a Class A drug in the Misuse of Drugs Act of Singapore, which means offences in relation to the drug attract the most severe level of punishment. A conviction for unauthorized manufacture of the drug attracts a minimum sentence of 10 years of imprisonment and corporal punishment of 5 strokes of the cane, and a maximum sentence of life imprisonment or 30 years of imprisonment and 15 strokes of the cane.<span class="mw-ref" id="cite_ref-114"><a href="#cite_note-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span> The minimum and maximum penalties for unauthorized trafficking in the drug are respectively 5 years of imprisonment and 5 strokes of the cane, and 20 years of imprisonment and 15 strokes of the cane.<span class="mw-ref" id="cite_ref-115"><a href="#cite_note-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_Kingdom">United Kingdom</h4></summary>
    
<p>Oxycodone is a Class A drug under the Misuse of Drugs Act.<span class="mw-ref" id="cite_ref-UKAct_116-0"><a href="#cite_note-UKAct-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span> For Class A drugs, which are "considered to be the most likely to cause harm", possession without a prescription is punishable by up to seven years in prison, an unlimited fine, or both.<span class="mw-ref" id="cite_ref-UKClassABC_117-0"><a href="#cite_note-UKClassABC-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span> Dealing of the drug illegally is punishable by up to life imprisonment, an unlimited fine, or both.<span class="mw-ref" id="cite_ref-UKClassABC_117-1"><a href="#cite_note-UKClassABC-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span> In addition, oxycodone is a Schedule 2 drug per the Misuse of Drugs Regulations 2001 which "provide certain exemptions from the provisions of the Misuse of Drugs Act 1971".<span class="mw-ref" id="cite_ref-UKRegs_118-0"><a href="#cite_note-UKRegs-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_States">United States</h4></summary>
    
<p>Under the Controlled Substances Act, oxycodone is a Schedule II controlled substance whether by itself or part of a multi-ingredient medication.<span class="mw-ref" id="cite_ref-119"><a href="#cite_note-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> The DEA lists oxycodone both for sale and for use in manufacturing other opioids as ACSCN 9143 and in 2013 approved the following annual aggregate manufacturing quotas: 131.5 metric tons for sale, down from 153.75 in 2012, and 10.25 metric tons for conversion, unchanged from the previous year.<span class="mw-ref" id="cite_ref-Examples_120-0"><a href="#cite_note-Examples-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Recreational_use">Recreational use</h3></summary>
    



</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Effects">Effects</h4></summary>
    
<p>Oxycodone, like other opioid analgesics, tends to induce feelings of euphoria, relaxation and reduced anxiety in those who are occasional users.<span class="mw-ref" id="cite_ref-121"><a href="#cite_note-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span> These effects make it one of the most commonly abused pharmaceutical drugs in the United States.<span class="mw-ref" id="cite_ref-122"><a href="#cite_note-122" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Preventive_measures">Preventive measures</h4></summary>
    
<p>In August 2010, Purdue Pharma reformulated their long-acting oxycodone line, marketed as OxyContin, using a polymer, Intac,<span class="mw-ref" id="cite_ref-123"><a href="#cite_note-123" style="counter-reset: mw-Ref 123;"><span class="mw-reflink-text">[123]</span></a></span> to make the pills extremely difficult to crush or dissolve<span class="mw-ref" id="cite_ref-124"><a href="#cite_note-124" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> in water to reduce OxyContin abuse.<span class="mw-ref" id="cite_ref-125"><a href="#cite_note-125" style="counter-reset: mw-Ref 125;"><span class="mw-reflink-text">[125]</span></a></span> The FDA approved relabeling the reformulated version as abuse-resistant in April 2013.<span class="mw-ref" id="cite_ref-126"><a href="#cite_note-126" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span></p>

<p>Pfizer manufactures a preparation of short-acting oxycodone, marketed as Oxecta, which contains inactive ingredients, referred to as tamper-resistant Aversion Technology.<span class="mw-ref" id="cite_ref-127"><a href="#cite_note-127" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span> It does not deter oral abuse. Approved by the FDA in the U.S. in June 2011, the new formulation makes crushing, chewing, snorting, or injecting the opioid impractical because of a change in its chemical properties.<span class="mw-ref" id="cite_ref-128"><a href="#cite_note-128" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Australia_2">Australia</h4></summary>
    
<p>The non-medical use of oxycodone existed from the early 1970s, but by 2015, 91% of a national sample of injecting drug users in Australia had reported using oxycodone, and 27% had injected it in the last six months.<span class="mw-ref" id="cite_ref-129"><a href="#cite_note-129" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Canada_2">Canada</h4></summary>
    
<p>Opioid-related deaths in Ontario had increased by 242% from 1969 to 2014.<span class="mw-ref" id="cite_ref-The_Star_2014_130-0"><a href="#cite_note-The_Star_2014-130" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span> By 2009 in Ontario there were more deaths from oxycodone overdose than from cocaine overdose.<span class="mw-ref" id="cite_ref-The_Star_2009_131-0"><a href="#cite_note-The_Star_2009-131" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span> Deaths from opioid pain relievers had increased from 13.7 deaths per million residents in 1991 to 27.2 deaths per million residents in 2004.<span class="mw-ref" id="cite_ref-132"><a href="#cite_note-132" style="counter-reset: mw-Ref 132;"><span class="mw-reflink-text">[132]</span></a></span> The abuse of oxycodone in Canada became a problem. Areas where oxycodone is most problematic are Atlantic Canada and Ontario, where its abuse is prevalent in rural towns, and in many smaller to medium-sized cities.<span class="mw-ref" id="cite_ref-Oxyabuse_133-0"><a href="#cite_note-Oxyabuse-133" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span> Oxycodone is also widely available across Western Canada, but <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a> and <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a> are more serious problems in the larger cities, while oxycodone is more common in rural towns. Oxycodone is diverted through doctor shopping, prescription forgery, pharmacy theft, and overprescribing.<span class="mw-ref" id="cite_ref-Oxyabuse_133-1"><a href="#cite_note-Oxyabuse-133" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span><span class="mw-ref" id="cite_ref-134"><a href="#cite_note-134" style="counter-reset: mw-Ref 134;"><span class="mw-reflink-text">[134]</span></a></span></p>

<p>The recent formulations of oxycodone, particularly Purdue Pharma's crush-, chew-, injection- and dissolve-resistant OxyNEO<span class="mw-ref" id="cite_ref-135"><a href="#cite_note-135" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> which replaced the banned OxyContin product in Canada in early 2012, have led to a decline in the abuse of this opiate but have increased the abuse of the more potent drug fentanyl.<span class="mw-ref" id="cite_ref-136"><a href="#cite_note-136" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span> According to a Canadian Centre on Substance Abuse study quoted in Maclean's magazine, there were at least 655 fentanyl-related deaths in Canada in a five-year period.<span class="mw-ref" id="cite_ref-137"><a href="#cite_note-137" style="counter-reset: mw-Ref 137;"><span class="mw-reflink-text">[137]</span></a></span></p>
 
<p>In Alberta, the Blood Tribe police claimed that from the fall of 2014 through January 2015, oxycodone pills or a lethal fake variation referred to as Oxy 80s<span class="mw-ref" id="cite_ref-Southwick_138-0"><a href="#cite_note-Southwick-138" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span> containing <a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">fentanyl</a> made in illegal labs by members of organized crime were responsible for ten deaths on the Blood Reserve, which is located southwest of Lethbridge, Alberta.<span class="mw-ref" id="cite_ref-Calgary_Herald_2015_139-0"><a href="#cite_note-Calgary_Herald_2015-139" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span> Province-wide, approximately 120 Albertans died from fentanyl-related overdoses in 2014.<span class="mw-ref" id="cite_ref-Southwick_138-1"><a href="#cite_note-Southwick-138" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_Kingdom_2">United Kingdom</h4></summary>
    
<p>Abuse and diversion of oxycodone in the UK commenced in the early- to mid-2000s.<span class="mw-ref" id="cite_ref-140"><a href="#cite_note-140" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span> The first known death due to overdose in the UK occurred in 2002.<span class="mw-ref" id="cite_ref-141"><a href="#cite_note-141" style="counter-reset: mw-Ref 141;"><span class="mw-reflink-text">[141]</span></a></span> However, recreational use remains relatively rare.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_States_2">United States</h4></summary>
    


<p>In the United States, more than 12 million people use opioid drugs recreationally.<span class="mw-ref" id="cite_ref-Girioin_142-0"><a href="#cite_note-Girioin-142" style="counter-reset: mw-Ref 142;"><span class="mw-reflink-text">[142]</span></a></span> Opioids were responsible for 49,000 of the 72,000 drug overdose deaths in the U.S. in 2017.<span class="mw-ref" id="cite_ref-NIDA-deaths_143-0"><a href="#cite_note-NIDA-deaths-143" style="counter-reset: mw-Ref 143;"><span class="mw-reflink-text">[143]</span></a></span> In September 2013, the FDA released new labeling guidelines for long acting and extended release opioids requiring manufacturers to remove moderate pain as indication for use, instead stating the drug is for "pain severe enough to require daily, around-the-clock, long term opioid treatment."<span class="mw-ref" id="cite_ref-144"><a href="#cite_note-144" style="counter-reset: mw-Ref 144;"><span class="mw-reflink-text">[144]</span></a></span> The updated labeling will not restrict physicians from prescribing opioids for moderate, as needed use.<span class="mw-ref" id="cite_ref-Girioin_142-1"><a href="#cite_note-Girioin-142" style="counter-reset: mw-Ref 142;"><span class="mw-reflink-text">[142]</span></a></span></p>

<p>Oxycodone is the most widely recreationally used opioid in America. The U.S. Department of Health and Human Services estimates that about 11 million people in the U.S. consume oxycodone in a non-medical way annually.<span class="mw-ref" id="cite_ref-145"><a href="#cite_note-145" style="counter-reset: mw-Ref 145;"><span class="mw-reflink-text">[145]</span></a></span> In 2007, about 42,800 emergency room visits occurred due to "episodes" involving oxycodone.<span class="mw-ref" id="cite_ref-146"><a href="#cite_note-146" style="counter-reset: mw-Ref 146;"><span class="mw-reflink-text">[146]</span></a></span> Diverted oxycodone may be taken orally or ingested through insufflation; used intravenously, or the heated vapors inhaled. In 2008, recreational use of oxycodone and hydrocodone were involved in 14,800 deaths. Some of the cases were due to overdoses of the acetaminophen component, resulting in fatal liver damage.<span class="mw-ref" id="cite_ref-147"><a href="#cite_note-147" style="counter-reset: mw-Ref 147;"><span class="mw-reflink-text">[147]</span></a></span></p>

<p>Reformulated OxyContin is causing some recreational users to change to <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a>, which is cheaper and easier to obtain.<span class="mw-ref" id="cite_ref-148"><a href="#cite_note-148" style="counter-reset: mw-Ref 148;"><span class="mw-reflink-text">[148]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Economics">Economics</h3></summary>
    
<p>The International Narcotics Control Board estimated <span>11.5 short tons (10.4</span><span>&nbsp;</span><span>t)</span> of oxycodone were manufactured worldwide in 1998;<span class="mw-ref" id="cite_ref-INCB2009_149-0"><a href="#cite_note-INCB2009-149" style="counter-reset: mw-Ref 149;"><span class="mw-reflink-text">[149]</span></a></span> by 2007 this figure had grown to <span>75.2 short tons (68.2</span><span>&nbsp;</span><span>t)</span>.<span class="mw-ref" id="cite_ref-INCB2009_149-1"><a href="#cite_note-INCB2009-149" style="counter-reset: mw-Ref 149;"><span class="mw-reflink-text">[149]</span></a></span> United States accounted for 82% of consumption in 2007 at <span>51.6 short tons (46.8</span><span>&nbsp;</span><span>t)</span>. Canada, Germany, Australia, and France combined accounted for 13% of consumption in 2007.<span class="mw-ref" id="cite_ref-INCB2009_149-2"><a href="#cite_note-INCB2009-149" style="counter-reset: mw-Ref 149;"><span class="mw-reflink-text">[149]</span></a></span><span class="mw-ref" id="cite_ref-UNPainpolicy_150-0"><a href="#cite_note-UNPainpolicy-150" style="counter-reset: mw-Ref 150;"><span class="mw-reflink-text">[150]</span></a></span> In 2010, <span>1.3 short tons (1.2</span><span>&nbsp;</span><span>t)</span> of oxycodone were illegally manufactured using a fake pill imprint. This accounted for 0.8% of consumption. These illicit tablets were later seized by the U.S. Drug Enforcement Administration, according to the International Narcotics Control Board.<span class="mw-ref" id="cite_ref-151"><a href="#cite_note-151" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span> The board also reported <span>122.5 short tons (111.1</span><span>&nbsp;</span><span>t)</span> manufactured in 2010. This number had decreased from a record high of <span>135.9 short tons (123.3</span><span>&nbsp;</span><span>t)</span> in 2009.<span class="mw-ref" id="cite_ref-152"><a href="#cite_note-152" style="counter-reset: mw-Ref 152;"><span class="mw-reflink-text">[152]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Names">Names</h3></summary>
    
<p>Expanded expressions for the compound oxycodone in the academic literature include "dihydrohydroxycodeinone",<span class="mw-ref" id="cite_ref-MerckIndex_1-1"><a href="#cite_note-MerckIndex-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Eddy1973_153-0"><a href="#cite_note-Eddy1973-153" style="counter-reset: mw-Ref 153;"><span class="mw-reflink-text">[153]</span></a></span><span class="mw-ref" id="cite_ref-MayJacobson_154-0"><a href="#cite_note-MayJacobson-154" style="counter-reset: mw-Ref 154;"><span class="mw-reflink-text">[154]</span></a></span> "Eucodal",<span class="mw-ref" id="cite_ref-Eddy1973_153-1"><a href="#cite_note-Eddy1973-153" style="counter-reset: mw-Ref 153;"><span class="mw-reflink-text">[153]</span></a></span><span class="mw-ref" id="cite_ref-MayJacobson_154-1"><a href="#cite_note-MayJacobson-154" style="counter-reset: mw-Ref 154;"><span class="mw-reflink-text">[154]</span></a></span> "Eukodal",<span class="mw-ref" id="cite_ref-Kalso_4-2"><a href="#cite_note-Kalso-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-sunshine1996_11-6"><a href="#cite_note-sunshine1996-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> "14-hydroxydihydrocodeinone",<span class="mw-ref" id="cite_ref-MerckIndex_1-2"><a href="#cite_note-MerckIndex-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Eddy1973_153-2"><a href="#cite_note-Eddy1973-153" style="counter-reset: mw-Ref 153;"><span class="mw-reflink-text">[153]</span></a></span> and "Nucodan".<span class="mw-ref" id="cite_ref-Eddy1973_153-3"><a href="#cite_note-Eddy1973-153" style="counter-reset: mw-Ref 153;"><span class="mw-reflink-text">[153]</span></a></span><span class="mw-ref" id="cite_ref-MayJacobson_154-2"><a href="#cite_note-MayJacobson-154" style="counter-reset: mw-Ref 154;"><span class="mw-reflink-text">[154]</span></a></span> In a UNESCO convention, the translations of "oxycodone" are <i>oxycodon</i> (Dutch), <i>oxycodone</i> (French), <i>oxicodona</i> (Spanish), <style data-mw-deduplicate="TemplateStyles:r886218846">.mw-parser-output .script-arabic,.mw-parser-output .script-Arab{font-family:Scheherazade,Lateef,LateefGR,Amiri,"Noto Naskh Arabic","Droid Arabic Naskh",Harmattan,"Arabic Typesetting","Traditional Arabic","Simplified Arabic","Times New Roman",Arial,"Sakkal Majalla","Microsoft Uighur",Calibri,"Microsoft Sans Serif","Segoe UI",serif,sans-serif;font-weight:normal}</style><span class="script-arabic script-Arab" dir="rtl" style="font-size: 125%; ">الأوكسيكودون</span><span>‎</span> (Arabic), <style data-mw-deduplicate="TemplateStyles:r886214503">.mw-parser-output .script-Cprt{font-size:1.25em;font-family:"Segoe UI Historic","Noto Sans Cypriot",Code2001}.mw-parser-output .script-Hano{font-size:125%;font-family:"Noto Sans Hanunoo",FreeSerif,Quivira}.mw-parser-output .script-Latf,.mw-parser-output .script-de-Latf{font-size:1.25em;font-family:"Breitkopf Fraktur",UnifrakturCook,UniFrakturMaguntia,MarsFraktur,"MarsFraktur OT",KochFraktur,"KochFraktur OT",OffenbacherSchwabOT,"LOB.AlteSchwabacher","LOV.AlteSchwabacher","LOB.AtlantisFraktur","LOV.AtlantisFraktur","LOB.BreitkopfFraktur","LOV.BreitkopfFraktur","LOB.FetteFraktur","LOV.FetteFraktur","LOB.Fraktur3","LOV.Fraktur3","LOB.RochFraktur","LOV.RochFraktur","LOB.PostFraktur","LOV.PostFraktur","LOB.RuelhscheFraktur","LOV.RuelhscheFraktur","LOB.RungholtFraktur","LOV.RungholtFraktur","LOB.TheuerbankFraktur","LOV.TheuerbankFraktur","LOB.VinetaFraktur","LOV.VinetaFraktur","LOB.WalbaumFraktur","LOV.WalbaumFraktur","LOB.WeberMainzerFraktur","LOV.WeberMainzerFraktur","LOB.WieynckFraktur","LOV.WieynckFraktur","LOB.ZentenarFraktur","LOV.ZentenarFraktur"}.mw-parser-output .script-en-Latf{font-size:1.25em;font-family:Cankama,"Old English Text MT","Textura Libera","Textura Libera Tenuis",London}.mw-parser-output .script-it-Latf{font-size:1.25em;font-family:"Rotunda Pommerania",Rotunda,"Typographer Rotunda"}.mw-parser-output .script-Lina{font-size:1.25em;font-family:"Noto Sans Linear A"}.mw-parser-output .script-Linb{font-size:1.25em;font-family:"Noto Sans Linear B"}.mw-parser-output .script-Ugar{font-size:1.25em;font-family:"Segoe UI Historic","Noto Sans Ugaritic",Aegean}.mw-parser-output .script-Xpeo{font-size:1.25em;font-family:"Segoe UI Historic","Noto Sans Old Persian",Artaxerxes,Xerxes,Aegean}</style><span class="Unicode">羟考酮</span> (Chinese), and <span class="Unicode">оксикодон</span> (Russian).<span class="mw-ref" id="cite_ref-155"><a href="#cite_note-155" style="counter-reset: mw-Ref 155;"><span class="mw-reflink-text">[155]</span></a></span> The word "oxycodone" should not be confused with "<a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">oxandrolone</a>", "<a href="Oxazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxazepam" title="Oxazepam">oxazepam</a>", "<a href="Oxybutynin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxybutynin" title="Oxybutynin">oxybutynin</a>", "<a href="Oxytocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxytocin" title="Oxytocin">oxytocin</a>", or "<a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Roxanol" title="Roxanol" class="mw-redirect">Roxanol</a>".<span class="mw-ref" id="cite_ref-MEDMARX_156-0"><a href="#cite_note-MEDMARX-156" style="counter-reset: mw-Ref 156;"><span class="mw-reflink-text">[156]</span></a></span></p>

<p>Other brand names include Longtec and Shortec.<span class="mw-ref" id="cite_ref-157"><a href="#cite_note-157" style="counter-reset: mw-Ref 157;"><span class="mw-reflink-text">[157]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-MerckIndex-1"> <span id="mw-reference-text-cite_note-MerckIndex-1" class="mw-reference-text"><cite id="CITEREFO'Neil,_Maryadele_J.2006" class="citation book cs1">O'Neil, Maryadele J., ed. (2006). <i>The Merck index</i> (14 ed.). Whitehouse Station, NJ: Merck &amp; Co. ISBN<span>&nbsp;</span><bdi>978-0-911910-00-1</bdi>.</cite></span></li><li id="cite_note-Drugs.com_pregnancy-2"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/oxycodone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/oxycodone.html'" tppabs="https://www.drugs.com/pregnancy/oxycodone.html" class="external text external">"Oxycodone Use During Pregnancy"</a>. <i>Drugs.com</i>. 14 October 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">12 April</span> 2020</span>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFBonewit-WestHuntApplegate2012" class="citation book cs1">Bonewit-West, Kathy; Hunt, Sue A.; Applegate, Edith (2012). <a href="javascript:if(confirm('https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571'" tppabs="https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571" class="external text external"><i>Today's Medical Assistant: Clinical and Administrative Procedures</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>571. ISBN<span>&nbsp;</span><bdi>9781455701506</bdi>.</cite></span></li><li id="cite_note-Kalso-4"> <span id="mw-reference-text-cite_note-Kalso-4" class="mw-reference-text"><cite id="CITEREFKalso_E2005" class="citation journal cs1">Kalso E (2005). <a href="javascript:if(confirm('https://doi.org/10.1016/j.jpainsymman.2005.01.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.jpainsymman.2005.01.010'" tppabs="https://doi.org/10.1016/j.jpainsymman.2005.01.010" class="external text external">"Oxycodone"</a>. <i>Journal of Pain and Symptom Management</i>. <b>29</b> (5S): S47–S56. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jpainsymman.2005.01.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jpainsymman.2005.01.010'" tppabs="https://doi.org/10.1016%2Fj.jpainsymman.2005.01.010" class="external text external">10.1016/j.jpainsymman.2005.01.010</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15907646  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15907646'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15907646" class="external text external">15907646</a>.</cite></span></li><li id="cite_note-MSR-5"> <span id="mw-reference-text-cite_note-MSR-5" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall'" tppabs="http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall" class="external text external">"Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">8 April</span> 2014</span>.</cite></span></li><li id="cite_note-ElliottSmith2016-6"> <span id="mw-reference-text-cite_note-ElliottSmith2016-6" class="mw-reference-text"><cite id="CITEREFJennifer_A._ElliottHoward_S._Smith2016" class="citation book cs1">Jennifer A. Elliott; Howard S. Smith (19 April 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=Em7OBQAAQBAJ&pg=PA82  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Em7OBQAAQBAJ&pg=PA82'" tppabs="https://books.google.com/books?id=Em7OBQAAQBAJ&pg=PA82" class="external text external"><i>Handbook of Acute Pain Management</i></a>. CRC Press. pp.<span>&nbsp;</span>82–. ISBN<span>&nbsp;</span><bdi>978-1-4665-9635-1</bdi>.</cite></span></li><li id="cite_note-SmithPassik2008-7"> <span id="mw-reference-text-cite_note-SmithPassik2008-7" class="mw-reference-text"><cite id="CITEREFHoward_SmithSteven_Passik2008" class="citation book cs1">Howard Smith; Steven Passik (25 April 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195'" tppabs="https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195" class="external text external"><i>Pain and Chemical Dependency</i></a>. Oxford University Press USA. pp.<span>&nbsp;</span>195–. ISBN<span>&nbsp;</span><bdi>978-0-19-530055-0</bdi>.</cite></span></li><li id="cite_note-Medscape-8"> <span id="mw-reference-text-cite_note-Medscape-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall'" tppabs="http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#showall" class="external text external">"Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">4 January</span> 2019</span>.</cite></span></li><li id="cite_note-YarbroWujcik2010-9"> <span id="mw-reference-text-cite_note-YarbroWujcik2010-9" class="mw-reference-text"><cite id="CITEREFConnie_Henke_YarbroDebra_WujcikBarbara_Holmes_Gobel2010" class="citation book cs1">Connie Henke Yarbro; Debra Wujcik; Barbara Holmes Gobel (15 November 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=Ub6FWXVU7pQC&pg=PA695  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Ub6FWXVU7pQC&pg=PA695'" tppabs="https://books.google.com/books?id=Ub6FWXVU7pQC&pg=PA695" class="external text external"><i>Cancer Nursing: Principles and Practice</i></a>. Jones &amp; Bartlett Publishers. pp.<span>&nbsp;</span>695–. ISBN<span>&nbsp;</span><bdi>978-1-4496-1829-2</bdi>.</cite></span></li><li id="cite_note-McPhersonPincus2016-10"> <span id="mw-reference-text-cite_note-McPhersonPincus2016-10" class="mw-reference-text"><cite id="CITEREFRichard_A._McPhersonMatthew_R._Pincus2016" class="citation book cs1">Richard A. McPherson; Matthew R. Pincus (31 March 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=xAzhCwAAQBAJ&pg=PA336  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=xAzhCwAAQBAJ&pg=PA336'" tppabs="https://books.google.com/books?id=xAzhCwAAQBAJ&pg=PA336" class="external text external"><i>Henry's Clinical Diagnosis and Management by Laboratory Methods</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>336–. ISBN<span>&nbsp;</span><bdi>978-0-323-41315-2</bdi>.</cite></span></li><li id="cite_note-sunshine1996-11"> <span id="mw-reference-text-cite_note-sunshine1996-11" class="mw-reference-text"><cite id="CITEREFSunshineOlsonColonRivera1996" class="citation journal cs1">Sunshine, Abraham; Olson, Nancy Z.; Colon, Ariel; Rivera, Juana; Kaiko, Robert F.; Fitzmartin, Ronald D.; Reder, Robert F.; Goldenheim, Paul D. (July 1996). "Analgesic Efficacy of Controlled-Release Oxycodone in Postoperative Pain". <i>Journal of Clinical Pharmacology</i>. <b>36</b> (7): 595–603. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fj.1552-4604.1996.tb04223.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fj.1552-4604.1996.tb04223.x'" tppabs="https://doi.org/10.1002%2Fj.1552-4604.1996.tb04223.x" class="external text external">10.1002/j.1552-4604.1996.tb04223.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8844441  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8844441'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8844441" class="external text external">8844441</a>. <q>Treatment with CR oxycodone was safe and effective in this study, and its characteristics will be beneficial in the treatment of pain.</q></cite></span></li><li id="cite_note-AHFS2018-12"> <span id="mw-reference-text-cite_note-AHFS2018-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/oxycodone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/oxycodone.html'" tppabs="https://www.drugs.com/monograph/oxycodone.html" class="external text external">"Oxycodone Monograph for Professionals"</a>. <i>Drugs.com</i>. AHFS<span class="reference-accessdate">. Retrieved <span class="nowrap">28 December</span> 2018</span>.</cite></span></li><li id="cite_note-Per2018-13"> <span id="mw-reference-text-cite_note-Per2018-13" class="mw-reference-text"><cite id="CITEREFPergolizzi_JVTaylor_RLeQuangRaffa2018" class="citation journal cs1">Pergolizzi JV, Jr; Taylor R, Jr; LeQuang, JA; Raffa, RB (2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810535  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810535'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810535" class="external text external">"Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product"</a>. <i>Journal of Pain Research</i>. <b>11</b>: 301–311. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FJPR.S127602  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FJPR.S127602'" tppabs="https://doi.org/10.2147%2FJPR.S127602" class="external text external">10.2147/JPR.S127602</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810535  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810535'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810535" class="external text external">5810535</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29445297  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29445297'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29445297" class="external text external">29445297</a>.</cite></span></li><li id="cite_note-BNF74-14"> <span id="mw-reference-text-cite_note-BNF74-14" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 74</i> (74 ed.). British Medical Association. 2017. p.<span>&nbsp;</span>442. ISBN<span>&nbsp;</span><bdi>978-0857112989</bdi>.</cite></span></li><li id="cite_note-TalleyFrankum2015-15"> <span id="mw-reference-text-cite_note-TalleyFrankum2015-15" class="mw-reference-text"><cite id="CITEREFNicholas_J_TalleyBrad_FrankumDavid_Currow2015" class="citation book cs1">Nicholas J Talley; Brad Frankum; David Currow (10 February 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=0Zq9BwAAQBAJ&pg=PA491  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0Zq9BwAAQBAJ&pg=PA491'" tppabs="https://books.google.com/books?id=0Zq9BwAAQBAJ&pg=PA491" class="external text external"><i>Essentials of Internal Medicine 3e</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>491–. ISBN<span>&nbsp;</span><bdi>978-0-7295-8081-6</bdi>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://palliative.stanford.edu/opioid-conversion/equivalency-table/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://palliative.stanford.edu/opioid-conversion/equivalency-table/'" tppabs="https://palliative.stanford.edu/opioid-conversion/equivalency-table/" class="external text external">"Stanford School of Medicine, Palliative Care, Opioid Conversion / Equivalency Table"</a>. 2013-04-20.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-Oxysynthesis2005-17"> <span id="mw-reference-text-cite_note-Oxysynthesis2005-17" class="mw-reference-text"><cite id="CITEREFSneader,_W.2005" class="citation book cs1">Sneader, W. (2005). <span class="cs1-lock-limited"><a href="javascript:if(confirm('https://archive.org/details/drugdiscoveryhis00snea  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/drugdiscoveryhis00snea'" tppabs="https://archive.org/details/drugdiscoveryhis00snea" class="external text external"><i>Drug discovery: a history</i></a></span>. Hoboken, NJ: Wiley. p.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/drugdiscoveryhis00snea/page/n132  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/drugdiscoveryhis00snea/page/n132'" tppabs="https://archive.org/details/drugdiscoveryhis00snea/page/n132" class="external text external">119</a>. ISBN<span>&nbsp;</span><bdi>978-0-471-89980-8</bdi>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Oxycodone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Oxycodone'" tppabs="https://clincalc.com/DrugStats/Drugs/Oxycodone" class="external text external">"Oxycodone - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFDartIwanickiDasguptaCicero2017" class="citation journal cs1">Dart, RC; Iwanicki, JL; Dasgupta, N; Cicero, TJ; Schnoll, SH (2017). "Do abuse deterrent opioid formulations work?". <i>Journal of Opioid Management</i>. <b>13</b> (6): 365–378. doi:<a href="javascript:if(confirm('https://doi.org/10.5055%2Fjom.2017.0415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5055%2Fjom.2017.0415'" tppabs="https://doi.org/10.5055%2Fjom.2017.0415" class="external text external">10.5055/jom.2017.0415</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29308584  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29308584'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29308584" class="external text external">29308584</a>.</cite></span></li><li id="cite_note-Riley2008-21"> <span id="mw-reference-text-cite_note-Riley2008-21" class="mw-reference-text"><cite id="CITEREFRileyEisenbergMüller-SchwefeDrewes2008" class="citation journal cs1">Riley J, Eisenberg E, Müller-Schwefe G, Drewes AM, Arendt-Nielsen L (2008). "Oxycodone: a review of its use in the management of pain". <i>Curr Med Res Opin</i>. <b>24</b> (1): 175–192. doi:<a href="javascript:if(confirm('https://doi.org/10.1185%2F030079908X253708  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1185%2F030079908X253708'" tppabs="https://doi.org/10.1185%2F030079908X253708" class="external text external">10.1185/030079908X253708</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18039433  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18039433'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18039433" class="external text external">18039433</a>.</cite></span></li><li id="cite_note-Biancofiore_20060901-22"> <span id="mw-reference-text-cite_note-Biancofiore_20060901-22" class="mw-reference-text"><cite id="CITEREFBiancofiore2006" class="citation journal cs1">Biancofiore, Giandomenico Luigi (September 1, 2006). <a href="javascript:if(confirm('https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC1936259&blobtype=pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC1936259&blobtype=pdf'" tppabs="https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC1936259&blobtype=pdf" class="external text external">"Oxycodone controlled release in cancer pain management"</a> <span class="cs1-format">(PDF)</span>. <i>Therapeutics and Clinical Risk Management</i>. <b>2</b> (3): 229–34. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2Ftcrm.2006.2.3.229  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2Ftcrm.2006.2.3.229'" tppabs="https://doi.org/10.2147%2Ftcrm.2006.2.3.229" class="external text external">10.2147/tcrm.2006.2.3.229</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936259  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936259'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936259" class="external text external">1936259</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18360598  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18360598'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18360598" class="external text external">18360598</a><span class="reference-accessdate">. Retrieved <span class="nowrap">January 30,</span> 2019</span>.</cite></span></li><li id="cite_note-pmid11237376-23"> <span id="mw-reference-text-cite_note-pmid11237376-23" class="mw-reference-text"><cite id="CITEREFHanksConnoChernyHanna2001" class="citation journal cs1">Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V (March 2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363790  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363790'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363790" class="external text external">"Morphine and alternative opioids in cancer pain: the EAPC recommendations"</a>. <i>Br. J. Cancer</i>. <b>84</b> (5): 587–93. doi:<a href="javascript:if(confirm('https://doi.org/10.1054%2Fbjoc.2001.1680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1054%2Fbjoc.2001.1680'" tppabs="https://doi.org/10.1054%2Fbjoc.2001.1680" class="external text external">10.1054/bjoc.2001.1680</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363790  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363790'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363790" class="external text external">2363790</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11237376  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11237376'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11237376" class="external text external">11237376</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20170630065901/http://www.msn.com/en-us/news/us/fda-approves-oxycontin-for-kids-11-to-16/ar-BBlK3zS?ocid=spartandhp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170630065901/http://www.msn.com/en-us/news/us/fda-approves-oxycontin-for-kids-11-to-16/ar-BBlK3zS?ocid=spartandhp'" tppabs="https://web.archive.org/web/20170630065901/http://www.msn.com/en-us/news/us/fda-approves-oxycontin-for-kids-11-to-16/ar-BBlK3zS?ocid=spartandhp" class="external text external">"FDA approves OxyContin for kids 11 to 16"</a>. <i>www.msn.com</i>. Archived from <a href="javascript:if(confirm('https://www.msn.com/en-us/news/us/fda-approves-oxycontin-for-kids-11-to-16/ar-BBlK3zS?ocid=spartandhp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.msn.com/en-us/news/us/fda-approves-oxycontin-for-kids-11-to-16/ar-BBlK3zS?ocid=spartandhp'" tppabs="https://www.msn.com/en-us/news/us/fda-approves-oxycontin-for-kids-11-to-16/ar-BBlK3zS?ocid=spartandhp" class="external text external">the original</a> on 30 June 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">11 February</span> 2018</span>.</cite></span></li><li id="cite_note-PhD2006-25"> <span id="mw-reference-text-cite_note-PhD2006-25" class="mw-reference-text"><cite id="CITEREFHarry_J._Gould_III2006" class="citation book cs1">Harry J. Gould III (11 December 2006). <a href="javascript:if(confirm('https://books.google.com/books?id=eKPudFvllpsC&pg=PA71  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=eKPudFvllpsC&pg=PA71'" tppabs="https://books.google.com/books?id=eKPudFvllpsC&pg=PA71" class="external text external"><i>Understanding Pain: What It Is, Why It Happens, and How It's Managed</i></a>. Demos Medical Publishing. pp.<span>&nbsp;</span>71–. ISBN<span>&nbsp;</span><bdi>978-1-934559-82-6</bdi>.</cite></span></li><li id="cite_note-Graves2015-26"> <span id="mw-reference-text-cite_note-Graves2015-26" class="mw-reference-text"><cite id="CITEREFKeith_Graves2015" class="citation book cs1">Keith Graves (29 September 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=yGyfCgAAQBAJ&pg=PT99  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=yGyfCgAAQBAJ&pg=PT99'" tppabs="https://books.google.com/books?id=yGyfCgAAQBAJ&pg=PT99" class="external text external"><i>Drug I.D. &amp; Symptom Guide 6th Edition QWIK-CODE</i></a>. LawTech Publishing Group. pp.<span>&nbsp;</span>99–. ISBN<span>&nbsp;</span><bdi>978-1-56325-225-9</bdi>.</cite></span></li><li id="cite_note-Skidmore-Roth2015-27"> <span id="mw-reference-text-cite_note-Skidmore-Roth2015-27" class="mw-reference-text"><cite id="CITEREFLinda_Skidmore-Roth2015" class="citation book cs1">Linda Skidmore-Roth (16 July 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=g_BwCgAAQBAJ&pg=PA789  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=g_BwCgAAQBAJ&pg=PA789'" tppabs="https://books.google.com/books?id=g_BwCgAAQBAJ&pg=PA789" class="external text external"><i>Mosby's Drug Guide for Nursing Students, with 2016 Update</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>789–. ISBN<span>&nbsp;</span><bdi>978-0-323-17297-4</bdi>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/022272Orig1s014ClinPharmR.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/022272Orig1s014ClinPharmR.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/022272Orig1s014ClinPharmR.pdf" class="external text external">"accessdata.fda.gov"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">11 February</span> 2018</span>.</cite></span></li><li id="cite_note-SinatraLeon-Cassasola2009-29"> <span id="mw-reference-text-cite_note-SinatraLeon-Cassasola2009-29" class="mw-reference-text"><cite id="CITEREFRaymond_S._SinatraOscar_A._de_Leon-Cassasola2009" class="citation book cs1">Raymond S. Sinatra; Oscar A. de Leon-Cassasola (27 April 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=ORpBaZnBSaQC&pg=PA198  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ORpBaZnBSaQC&pg=PA198'" tppabs="https://books.google.com/books?id=ORpBaZnBSaQC&pg=PA198" class="external text external"><i>Acute Pain Management</i></a>. Cambridge University Press. pp.<span>&nbsp;</span>198–. ISBN<span>&nbsp;</span><bdi>978-0-521-87491-5</bdi>.</cite></span></li><li id="cite_note-StaatsSilverman2016-30"> <span id="mw-reference-text-cite_note-StaatsSilverman2016-30" class="mw-reference-text"><cite id="CITEREFPeter_S._StaatsSanford_M._Silverman2016" class="citation book cs1">Peter S. Staats; Sanford M. Silverman (28 May 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=-WxBDAAAQBAJ&pg=PA172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=-WxBDAAAQBAJ&pg=PA172'" tppabs="https://books.google.com/books?id=-WxBDAAAQBAJ&pg=PA172" class="external text external"><i>Controlled Substance Management in Chronic Pain: A Balanced Approach</i></a>. Springer. pp.<span>&nbsp;</span>172–. ISBN<span>&nbsp;</span><bdi>978-3-319-30964-4</bdi>.</cite></span></li><li id="cite_note-Pfizer2018-31"> <span id="mw-reference-text-cite_note-Pfizer2018-31" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.pfizer.com/news/press-release/press-release-detail/fda_approves_troxyca_er_oxycodone_hydrochloride_and_naltrexone_hydrochloride_extended_release_capsules_cii_with_abuse_deterrent_properties_for_the_management_of_pain  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pfizer.com/news/press-release/press-release-detail/fda_approves_troxyca_er_oxycodone_hydrochloride_and_naltrexone_hydrochloride_extended_release_capsules_cii_with_abuse_deterrent_properties_for_the_management_of_pain'" tppabs="https://www.pfizer.com/news/press-release/press-release-detail/fda_approves_troxyca_er_oxycodone_hydrochloride_and_naltrexone_hydrochloride_extended_release_capsules_cii_with_abuse_deterrent_properties_for_the_management_of_pain" class="external text external">"FDA Approves Troxyca® ER (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-release Capsules CII with Abuse-deterrent Properties for the Management of Pain"</a>. 19 August 2016.</cite></span></li><li id="cite_note-Davis2009-32"> <span id="mw-reference-text-cite_note-Davis2009-32" class="mw-reference-text"><cite id="CITEREFMellar_P._Davis2009" class="citation book cs1">Mellar P. Davis (28 May 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=aEzg6i2nPMQC&pg=PA158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=aEzg6i2nPMQC&pg=PA158'" tppabs="https://books.google.com/books?id=aEzg6i2nPMQC&pg=PA158" class="external text external"><i>Opioids in Cancer Pain</i></a>. OUP Oxford. pp.<span>&nbsp;</span>155–158. ISBN<span>&nbsp;</span><bdi>978-0-19-923664-0</bdi>.</cite></span></li><li id="cite_note-Forbes2007-33"> <span id="mw-reference-text-cite_note-Forbes2007-33" class="mw-reference-text"><cite id="CITEREFKaren_Forbes2007" class="citation book cs1">Karen Forbes (29 November 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=X7PjroLnaYQC&pg=PA64  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=X7PjroLnaYQC&pg=PA64'" tppabs="https://books.google.com/books?id=X7PjroLnaYQC&pg=PA64" class="external text external"><i>Opioids in Cancer Pain</i></a>. OUP Oxford. pp.<span>&nbsp;</span>64–65. ISBN<span>&nbsp;</span><bdi>978-0-19-921880-6</bdi>.</cite></span></li><li id="cite_note-BradburyHodge2013-34"> <span id="mw-reference-text-cite_note-BradburyHodge2013-34" class="mw-reference-text"><cite id="CITEREFHelen_BradburyBarry_Strickland_Hodge2013" class="citation book cs1">Helen Bradbury; Barry Strickland Hodge (8 November 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=U5L3AgAAQBAJ&pg=PT93  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=U5L3AgAAQBAJ&pg=PT93'" tppabs="https://books.google.com/books?id=U5L3AgAAQBAJ&pg=PT93" class="external text external"><i>Practical Prescribing for Medical Students</i></a>. SAGE Publications. pp.<span>&nbsp;</span>93–. ISBN<span>&nbsp;</span><bdi>978-1-4462-9753-7</bdi>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFAmerican_Society_of_Health-System_Pharmacists2009" class="citation web cs1">American Society of Health-System Pharmacists (2009-03-23). <a href="javascript:if(confirm('https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682132.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682132.html'" tppabs="https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682132.html" class="external text external">"Oxycodone"</a>. U.S. National Library of Medicine, MedlinePlus<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-03-27</span></span>.</cite></span></li><li id="cite_note-FitzgibbonLoeser2012-36"> <span id="mw-reference-text-cite_note-FitzgibbonLoeser2012-36" class="mw-reference-text"><cite id="CITEREFDermot_R._FitzgibbonJohn_D._Loeser2012" class="citation book cs1">Dermot R. Fitzgibbon; John D. Loeser (28 March 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=17vaJQVtDN0C&pg=PA198  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=17vaJQVtDN0C&pg=PA198'" tppabs="https://books.google.com/books?id=17vaJQVtDN0C&pg=PA198" class="external text external"><i>Cancer Pain</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>198–. ISBN<span>&nbsp;</span><bdi>978-1-4511-5279-1</bdi>.</cite></span></li><li id="cite_note-drugscomSE-37"> <span id="mw-reference-text-cite_note-drugscomSE-37" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/sfx/oxycodone-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/sfx/oxycodone-side-effects.html'" tppabs="https://www.drugs.com/sfx/oxycodone-side-effects.html" class="external text external">"Oxycodone Side Effects"</a>. Drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">22 May</span> 2013</span>.</cite></span></li><li id="cite_note-OxyContinInsertUS-38"> <span id="mw-reference-text-cite_note-OxyContinInsertUS-38" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20090326125214/http://www.purduepharma.com/PI/Prescription/Oxycontin.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090326125214/http://www.purduepharma.com/PI/Prescription/Oxycontin.pdf'" tppabs="https://web.archive.org/web/20090326125214/http://www.purduepharma.com/PI/Prescription/Oxycontin.pdf" class="external text external"><i>1. Package insert Oxycontin</i></a> <span class="cs1-format">(PDF)</span>. Stamford, CT: Purdue Pharma L.P. 2007-11-05. Archived from <a href="javascript:if(confirm('http://www.purduepharma.com/PI/Prescription/Oxycontin.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.purduepharma.com/PI/Prescription/Oxycontin.pdf'" tppabs="http://www.purduepharma.com/PI/Prescription/Oxycontin.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2009-03-26<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-03-23</span></span>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFOrdóñez_GallegoGonzález_BarónEspinosa_Arranz2007" class="citation journal cs1">Ordóñez Gallego, A; González Barón, M; Espinosa Arranz, E (May 2007). "Oxycodone: a pharmacological and clinical review". <i>Clinical &amp; Translational Oncology</i>. <b>9</b> (5): 298–307. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs12094-007-0057-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs12094-007-0057-9'" tppabs="https://doi.org/10.1007%2Fs12094-007-0057-9" class="external text external">10.1007/s12094-007-0057-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17525040  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17525040'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17525040" class="external text external">17525040</a>.</cite></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite id="CITEREFSimpson2008" class="citation journal cs1">Simpson K,  et al. (December 2008). "Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain". <i>Curr Med Res Opin</i>. <b>24</b> (12): 3503–3512. doi:<a href="javascript:if(confirm('https://doi.org/10.1185%2F03007990802584454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1185%2F03007990802584454'" tppabs="https://doi.org/10.1185%2F03007990802584454" class="external text external">10.1185/03007990802584454</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19032132  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19032132'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19032132" class="external text external">19032132</a>.</cite></span></li><li id="cite_note-CESAR2005-41"> <span id="mw-reference-text-cite_note-CESAR2005-41" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cesar.umd.edu/cesar/drugs/oxycodone.asp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cesar.umd.edu/cesar/drugs/oxycodone.asp'" tppabs="http://www.cesar.umd.edu/cesar/drugs/oxycodone.asp" class="external text external">"Oxycodone"</a>. Center for Substance Abuse Research. 2005-05-02<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-03-25</span></span>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFRaoDesai2002" class="citation journal cs1">Rao R, Desai NS (June 2002). <a href="javascript:if(confirm('https://doi.org/10.1038/sj.jp.7210744  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038/sj.jp.7210744'" tppabs="https://doi.org/10.1038/sj.jp.7210744" class="external text external">"OxyContin and neonatal abstinence syndrome"</a>. <i>J Perinatol</i>. <b>22</b> (4): 324–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.jp.7210744  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.jp.7210744'" tppabs="https://doi.org/10.1038%2Fsj.jp.7210744" class="external text external">10.1038/sj.jp.7210744</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12032797  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12032797'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12032797" class="external text external">12032797</a>.</cite></span></li><li id="cite_note-pmid23414717-43"> <span id="mw-reference-text-cite_note-pmid23414717-43" class="mw-reference-text"><cite id="CITEREFBrennan_MJ2013" class="citation journal cs1">Brennan MJ (2013). "The effect of opioid therapy on endocrine function". <i>The American Journal of Medicine</i>. <b>126</b> (3 Suppl 1): S12–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.amjmed.2012.12.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.amjmed.2012.12.001'" tppabs="https://doi.org/10.1016%2Fj.amjmed.2012.12.001" class="external text external">10.1016/j.amjmed.2012.12.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23414717  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23414717'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23414717" class="external text external">23414717</a>.</cite></span></li><li id="cite_note-CDC2018Death-44"> <span id="mw-reference-text-cite_note-CDC2018Death-44" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf'" tppabs="https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf" class="external text external">"Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011–2016"</a> <span class="cs1-format">(PDF)</span>. <i>CDC</i>. 12 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2018</span>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFNtranosShoirahDhamoonHahn2017" class="citation journal cs1">Ntranos, Achilles; Shoirah, Hazem; Dhamoon, Mandip S.; Hahn, David; Naidich, Thomas P.; Shin, Susan (2017). <a href="javascript:if(confirm('https://www.researchgate.net/publication/314274959  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.researchgate.net/publication/314274959'" tppabs="https://www.researchgate.net/publication/314274959" class="external text external">"Clinical Reasoning: A young woman with respiratory failure, hearing loss, and paraplegia"</a>. <i>Neurology</i>. <b>88</b> (10): e78–e84. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1212%2FWNL.0000000000003684  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2FWNL.0000000000003684'" tppabs="https://doi.org/10.1212%2FWNL.0000000000003684" class="external text external">10.1212/WNL.0000000000003684</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28265044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28265044'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28265044" class="external text external">28265044</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-03-09</span></span>.</cite></span></li><li id="cite_note-NieminenHagelberg2010-46"> <span id="mw-reference-text-cite_note-NieminenHagelberg2010-46" class="mw-reference-text"><cite id="CITEREFNieminenHagelbergSaariNeuvonen2010" class="citation journal cs1">Nieminen, Tuija H.; Hagelberg, Nora M.; Saari, Teijo I.; Neuvonen, Mikko; Neuvonen, Pertti J.; Laine, Kari; Olkkola, Klaus T. (2010). <a href="javascript:if(confirm('https://hal.archives-ouvertes.fr/hal-00614173  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hal.archives-ouvertes.fr/hal-00614173'" tppabs="https://hal.archives-ouvertes.fr/hal-00614173" class="external text external">"Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir"</a>. <i>European Journal of Clinical Pharmacology</i>. <b>66</b> (10): 977–985. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00228-010-0879-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00228-010-0879-1'" tppabs="https://doi.org/10.1007%2Fs00228-010-0879-1" class="external text external">10.1007/s00228-010-0879-1</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0031-6970  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0031-6970'" tppabs="https://www.worldcat.org/issn/0031-6970" class="external text external">0031-6970</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20697700  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20697700'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20697700" class="external text external">20697700</a>.</cite></span></li><li id="cite_note-NieminenHagelberg2009-47"> <span id="mw-reference-text-cite_note-NieminenHagelberg2009-47" class="mw-reference-text"><cite id="CITEREFNieminenHagelbergSaariPertovaara2009" class="citation journal cs1">Nieminen, Tuija H.; Hagelberg, Nora M.; Saari, Teijo I.; Pertovaara, Antti; Neuvonen, Mikko; Laine, Kari; Neuvonen, Pertti J.; Olkkola, Klaus T. (2009). <a href="javascript:if(confirm('https://doi.org/10.1097/ALN.0b013e31819faa54  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097/ALN.0b013e31819faa54'" tppabs="https://doi.org/10.1097/ALN.0b013e31819faa54" class="external text external">"Rifampin Greatly Reduces the Plasma Concentrations of Intravenous and Oral Oxycodone"</a>. <i>Anesthesiology</i>. <b>110</b> (6): 1371–1378. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1097%2FALN.0b013e31819faa54  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FALN.0b013e31819faa54'" tppabs="https://doi.org/10.1097%2FALN.0b013e31819faa54" class="external text external">10.1097/ALN.0b013e31819faa54</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0003-3022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0003-3022'" tppabs="https://www.worldcat.org/issn/0003-3022" class="external text external">0003-3022</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19417618  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19417618'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19417618" class="external text external">19417618</a>.</cite></span></li><li id="cite_note-Pon,_Hwang,_2015-48"> <span id="mw-reference-text-cite_note-Pon,_Hwang,_2015-48" class="mw-reference-text"><cite id="CITEREFPonHwangLoVan_Zyl2015" class="citation journal cs1">Pon, Doreen; Hwang, Joon; Lo, Teresa; Van Zyl, Carin (2015). "Case study. Decreased responsiveness to oxycodone: A case of a pharmacokinetic drug interaction?". <i>Journal of Opioid Management</i>. <b>11</b> (4): 357–361. doi:<a href="javascript:if(confirm('https://doi.org/10.5055%2Fjom.2015.0284  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5055%2Fjom.2015.0284'" tppabs="https://doi.org/10.5055%2Fjom.2015.0284" class="external text external">10.5055/jom.2015.0284</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1551-7489  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1551-7489'" tppabs="https://www.worldcat.org/issn/1551-7489" class="external text external">1551-7489</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26312962  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26312962'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26312962" class="external text external">26312962</a>.</cite></span></li><li id="cite_note-Kalso2005-49"> <span id="mw-reference-text-cite_note-Kalso2005-49" class="mw-reference-text"><cite id="CITEREFKalso2005" class="citation journal cs1">Kalso, Eija (2005). <a href="javascript:if(confirm('https://doi.org/10.1016/j.jpainsymman.2005.01.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.jpainsymman.2005.01.010'" tppabs="https://doi.org/10.1016/j.jpainsymman.2005.01.010" class="external text external">"Oxycodone"</a>. <i>Journal of Pain and Symptom Management</i>. <b>29</b> (5): 47–56. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jpainsymman.2005.01.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jpainsymman.2005.01.010'" tppabs="https://doi.org/10.1016%2Fj.jpainsymman.2005.01.010" class="external text external">10.1016/j.jpainsymman.2005.01.010</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0885-3924  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0885-3924'" tppabs="https://www.worldcat.org/issn/0885-3924" class="external text external">0885-3924</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15907646  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15907646'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15907646" class="external text external">15907646</a>.</cite></span></li><li id="cite_note-CorbettPaterson1993-50"> <span id="mw-reference-text-cite_note-CorbettPaterson1993-50" class="mw-reference-text"><cite id="CITEREFCorbettPatersonKosterlitz1993" class="citation book cs1">Corbett, A. D.; Paterson, S. J.; Kosterlitz, H. W. (1993). <i>Opioids</i>. Handbook of Experimental Pharmacology. <b>104</b>. pp.<span>&nbsp;</span>645–679. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-642-77460-7_26  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-642-77460-7_26'" tppabs="https://doi.org/10.1007%2F978-3-642-77460-7_26" class="external text external">10.1007/978-3-642-77460-7_26</a>. ISBN<span>&nbsp;</span><bdi>978-3-642-77462-1</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0171-2004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0171-2004'" tppabs="https://www.worldcat.org/issn/0171-2004" class="external text external">0171-2004</a>.</cite></span></li><li id="cite_note-King2010-51"> <span id="mw-reference-text-cite_note-King2010-51" class="mw-reference-text"><cite id="CITEREFKing2010" class="citation book cs1">King (25 October 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=o_rHHCsIpckC&pg=PA332  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=o_rHHCsIpckC&pg=PA332'" tppabs="https://books.google.com/books?id=o_rHHCsIpckC&pg=PA332" class="external text external"><i>Pharmacology for Women's Health</i></a>. Jones &amp; Bartlett Publishers. pp.<span>&nbsp;</span>332–. ISBN<span>&nbsp;</span><bdi>978-1-4496-1073-9</bdi>.</cite></span></li><li id="cite_note-ChestnutWong2014-52"> <span id="mw-reference-text-cite_note-ChestnutWong2014-52" class="mw-reference-text"><cite id="CITEREFDavid_H._ChestnutCynthia_A_WongLawrence_C_TsenWarwick_D_Ngan_Kee2014" class="citation book cs1">David H. Chestnut; Cynthia A Wong; Lawrence C Tsen; Warwick D Ngan Kee; Yaakov Beilin; Jill Mhyre (28 February 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=FMU0AwAAQBAJ&pg=PA611  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FMU0AwAAQBAJ&pg=PA611'" tppabs="https://books.google.com/books?id=FMU0AwAAQBAJ&pg=PA611" class="external text external"><i>Chestnut's Obstetric Anesthesia: Principles and Practice E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>611–. ISBN<span>&nbsp;</span><bdi>978-0-323-11374-8</bdi>.</cite></span></li><li id="cite_note-Tiziani2013-53"> <span id="mw-reference-text-cite_note-Tiziani2013-53" class="mw-reference-text"><cite id="CITEREFAdriana_P._Tiziani2013" class="citation book cs1">Adriana P. Tiziani (1 June 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=XpzQAgAAQBAJ&pg=PA933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=XpzQAgAAQBAJ&pg=PA933'" tppabs="https://books.google.com/books?id=XpzQAgAAQBAJ&pg=PA933" class="external text external"><i>Havard's Nursing Guide to Drugs</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>933–. ISBN<span>&nbsp;</span><bdi>978-0-7295-8162-2</bdi>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite id="CITEREFChahl_L1996" class="citation journal cs1">Chahl L (1996). <a href="javascript:if(confirm('https://doi.org/10.18773/austprescr.1996.063  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18773/austprescr.1996.063'" tppabs="https://doi.org/10.18773/austprescr.1996.063" class="external text external">"Opioids- mechanism of action"</a>. <i>Aust Prescr</i>. <b>19</b> (3): 63–65. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.18773%2Faustprescr.1996.063  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18773%2Faustprescr.1996.063'" tppabs="https://doi.org/10.18773%2Faustprescr.1996.063" class="external text external">10.18773/austprescr.1996.063</a></span>.</cite></span></li><li id="cite_note-Stein1999-55"> <span id="mw-reference-text-cite_note-Stein1999-55" class="mw-reference-text"><cite id="CITEREFChristoph_Stein1999" class="citation book cs1">Christoph Stein (1999). <a href="javascript:if(confirm('https://books.google.com/books?id=4Rfr8cQayvgC&pg=PA46  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=4Rfr8cQayvgC&pg=PA46'" tppabs="https://books.google.com/books?id=4Rfr8cQayvgC&pg=PA46" class="external text external"><i>Opioids in Pain Control: Basic and Clinical Aspects</i></a>. Cambridge University Press. pp.<span>&nbsp;</span>46–. ISBN<span>&nbsp;</span><bdi>978-0-521-62269-1</bdi>.</cite></span></li><li id="cite_note-SquireBerg2012-56"> <span id="mw-reference-text-cite_note-SquireBerg2012-56" class="mw-reference-text"><cite id="CITEREFLarry_SquireDarwin_BergFloyd_E._BloomSascha_du_Lac2012" class="citation book cs1">Larry Squire; Darwin Berg; Floyd E. Bloom; Sascha du Lac; Anirvan Ghosh; Nicholas C. Spitzer (17 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=QGzJFu_NyzcC&pg=PA884  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=QGzJFu_NyzcC&pg=PA884'" tppabs="https://books.google.com/books?id=QGzJFu_NyzcC&pg=PA884" class="external text external"><i>Fundamental Neuroscience</i></a>. Academic Press. pp.<span>&nbsp;</span>884–. ISBN<span>&nbsp;</span><bdi>978-0-12-385871-9</bdi>.</cite></span></li><li id="cite_note-KringelbachBerridge2010-57"> <span id="mw-reference-text-cite_note-KringelbachBerridge2010-57" class="mw-reference-text"><cite id="CITEREFMorten_L._KringelbachKent_C._Berridge2010" class="citation book cs1">Morten L. Kringelbach; Kent C. Berridge (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=yl2yAwAAQBAJ&pg=PA33  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=yl2yAwAAQBAJ&pg=PA33'" tppabs="https://books.google.com/books?id=yl2yAwAAQBAJ&pg=PA33" class="external text external"><i>Pleasures of the Brain</i></a>. Oxford University Press. pp.<span>&nbsp;</span>33–. ISBN<span>&nbsp;</span><bdi>978-0-19-533102-8</bdi>.</cite></span></li><li id="cite_note-SinatraJahr2010-58"> <span id="mw-reference-text-cite_note-SinatraJahr2010-58" class="mw-reference-text"><cite id="CITEREFRaymond_S._SinatraJonathan_S._JahrJ._Michael_Watkins-Pitchford2010" class="citation book cs1">Raymond S. Sinatra; Jonathan S. Jahr; J. Michael Watkins-Pitchford (14 October 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=ZwPIjKg0XukC&pg=PA167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ZwPIjKg0XukC&pg=PA167'" tppabs="https://books.google.com/books?id=ZwPIjKg0XukC&pg=PA167" class="external text external"><i>The Essence of Analgesia and Analgesics</i></a>. Cambridge University Press. pp.<span>&nbsp;</span>167–. ISBN<span>&nbsp;</span><bdi>978-1-139-49198-3</bdi>.</cite></span></li><li id="cite_note-Merck-59"> <span id="mw-reference-text-cite_note-Merck-59" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.merckmanuals.com/professional/neurologic-disorders/pain/treatment-of-pain  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.merckmanuals.com/professional/neurologic-disorders/pain/treatment-of-pain'" tppabs="http://www.merckmanuals.com/professional/neurologic-disorders/pain/treatment-of-pain" class="external text external">"Treatment of Pain"</a>. <i>Merck Manuals Professional Edition</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2016-04-24</span></span>.</cite></span></li><li id="cite_note-FerrellPasero2010-60"> <span id="mw-reference-text-cite_note-FerrellPasero2010-60" class="mw-reference-text"><cite id="CITEREFFerrellPaseroMcCaffery2010" class="citation book cs1">Ferrell, Betty Rolling; Pasero, Chris; McCaffery, Margo (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=Q5iNSuBma0AC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Q5iNSuBma0AC'" tppabs="https://books.google.com/books?id=Q5iNSuBma0AC" class="external text external">"Table 16-1 Equianalgesic Dose Chart"</a>. <i>Pain Assessment and Pharmacologic Management</i>. Elsevier Health Sciences. ISBN<span>&nbsp;</span><bdi>978-0323082631</bdi>.</cite></span></li><li id="cite_note-LevyVictor2007-61"> <span id="mw-reference-text-cite_note-LevyVictor2007-61" class="mw-reference-text"><cite id="CITEREFLevy2007" class="citation book cs1">Levy, Enno Freye (2007). <a href="javascript:if(confirm('https://books.google.com/books?id=ybtX0GZGhk8C&pg=PA371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ybtX0GZGhk8C&pg=PA371'" tppabs="https://books.google.com/books?id=ybtX0GZGhk8C&pg=PA371" class="external text external"><i>Opioids in medicine a comprehensive review on the mode of action and the use of analgesics in different clinical pain states</i></a>. Collaboration with Joseph Victor. New York: Springer Science+Business Media B.V. p.<span>&nbsp;</span>371. ISBN<span>&nbsp;</span><bdi>978-1402059476</bdi>.</cite></span></li><li id="cite_note-LalovicKharasch2006-62"> <span id="mw-reference-text-cite_note-LalovicKharasch2006-62" class="mw-reference-text"><cite id="CITEREFLalovicKharaschHofferRisler2006" class="citation journal cs1">Lalovic, B; Kharasch, E; Hoffer, C; Risler, L; Liuchen, L; Shen, D (2006). "Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites". <i>Clinical Pharmacology &amp; Therapeutics</i>. <b>79</b> (5): 461–479. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clpt.2006.01.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clpt.2006.01.009'" tppabs="https://doi.org/10.1016%2Fj.clpt.2006.01.009" class="external text external">10.1016/j.clpt.2006.01.009</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0009-9236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0009-9236'" tppabs="https://www.worldcat.org/issn/0009-9236" class="external text external">0009-9236</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16678548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16678548'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16678548" class="external text external">16678548</a>.</cite></span></li><li id="cite_note-KlimasWitticke2013-63"> <span id="mw-reference-text-cite_note-KlimasWitticke2013-63" class="mw-reference-text"><cite id="CITEREFKlimasWittickeEl_FallahMikus2013" class="citation journal cs1">Klimas, Romina; Witticke, Diana; El Fallah, Sarah; Mikus, Gerd (2013). "Contribution of oxycodone and its metabolites to the overall analgesic effect after oxycodone administration". <i>Expert Opinion on Drug Metabolism &amp; Toxicology</i>. <b>9</b> (5): 517–528. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F17425255.2013.779669  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F17425255.2013.779669'" tppabs="https://doi.org/10.1517%2F17425255.2013.779669" class="external text external">10.1517/17425255.2013.779669</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1742-5255  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1742-5255'" tppabs="https://www.worldcat.org/issn/1742-5255" class="external text external">1742-5255</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23488585  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23488585'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23488585" class="external text external">23488585</a>.</cite></span></li><li id="cite_note-LembergSiiskonen2008-64"> <span id="mw-reference-text-cite_note-LembergSiiskonen2008-64" class="mw-reference-text"><cite id="CITEREFLembergSiiskonenKontinenYli-Kauhaluoma2008" class="citation journal cs1">Lemberg, Kim K.; Siiskonen, Antti O.; Kontinen, Vesa K.; Yli-Kauhaluoma, Jari T.; Kalso, Eija A. (2008). <a href="javascript:if(confirm('https://semanticscholar.org/paper/0d0a802acff3976f86e165e7966c5a40ea3cc250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/0d0a802acff3976f86e165e7966c5a40ea3cc250'" tppabs="https://semanticscholar.org/paper/0d0a802acff3976f86e165e7966c5a40ea3cc250" class="external text external">"Pharmacological Characterization of Noroxymorphone as a New Opioid for Spinal Analgesia"</a>. <i>Anesthesia &amp; Analgesia</i>. <b>106</b> (2): 463–470. doi:<a href="javascript:if(confirm('https://doi.org/10.1213%2Fane.0b013e3181605a15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1213%2Fane.0b013e3181605a15'" tppabs="https://doi.org/10.1213%2Fane.0b013e3181605a15" class="external text external">10.1213/ane.0b013e3181605a15</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0003-2999  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0003-2999'" tppabs="https://www.worldcat.org/issn/0003-2999" class="external text external">0003-2999</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18227301  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18227301'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18227301" class="external text external">18227301</a>.</cite></span></li><li id="cite_note-Preedy2016-65"> <span id="mw-reference-text-cite_note-Preedy2016-65" class="mw-reference-text"><cite id="CITEREFVictor_R._Preedy2016" class="citation book cs1">Victor R. Preedy (25 April 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=Yu9eBwAAQBAJ&pg=PA462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Yu9eBwAAQBAJ&pg=PA462'" tppabs="https://books.google.com/books?id=Yu9eBwAAQBAJ&pg=PA462" class="external text external"><i>Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions</i></a>. Elsevier Science. pp.<span>&nbsp;</span>462–464. ISBN<span>&nbsp;</span><bdi>978-0-12-800677-1</bdi>.</cite></span></li><li id="cite_note-FiresteinBudd2016-66"> <span id="mw-reference-text-cite_note-FiresteinBudd2016-66" class="mw-reference-text"><cite id="CITEREFFiresteinBuddGabrielMcInnes2016" class="citation book cs1">Firestein, Gary S.; Budd, Ralph C.; Gabriel, Sherine E.; McInnes, Iain B.; O'Dell, James R. (21 June 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=kBZ6DAAAQBAJ&pg=PA1080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=kBZ6DAAAQBAJ&pg=PA1080'" tppabs="https://books.google.com/books?id=kBZ6DAAAQBAJ&pg=PA1080" class="external text external"><i>Kelley and Firestein's Textbook of Rheumatology</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>1080–. ISBN<span>&nbsp;</span><bdi>978-0-323-31696-5</bdi>. LCCN<span>&nbsp;</span><a href="javascript:if(confirm('https://lccn.loc.gov/2016009254  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://lccn.loc.gov/2016009254'" tppabs="https://lccn.loc.gov/2016009254" class="external text external">2016009254</a>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text"><cite id="CITEREFRossSmith1997" class="citation journal cs1">Ross FB, Smith MT (1997). "The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated". <i>Pain</i>. <b>73</b> (2): 151–157. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0304-3959%2897%2900093-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0304-3959%2897%2900093-6'" tppabs="https://doi.org/10.1016%2FS0304-3959%2897%2900093-6" class="external text external">10.1016/S0304-3959(97)00093-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9415500  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9415500'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9415500" class="external text external">9415500</a>.</cite></span></li><li id="cite_note-68"> <span id="mw-reference-text-cite_note-68" class="mw-reference-text"><cite id="CITEREFSmith_MT2008" class="citation journal cs1">Smith MT (2008). "Differences between and combinations of opioids re-visited". <i>Curr Opin Anesthesiol</i>. <b>21</b> (5): 596–601. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FACO.0b013e32830a4c4a  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FACO.0b013e32830a4c4a'" tppabs="https://doi.org/10.1097%2FACO.0b013e32830a4c4a" class="external text external">10.1097/ACO.0b013e32830a4c4a</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18784485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18784485'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18784485" class="external text external">18784485</a>.</cite></span></li><li id="cite_note-pmid17961923-69"> <span id="mw-reference-text-cite_note-pmid17961923-69" class="mw-reference-text"><cite id="CITEREFKalso_E2007" class="citation journal cs1">Kalso E (2007). "How different is oxycodone from morphine?". <i>Pain</i>. <b>132</b> (3): 227–228. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pain.2007.09.027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pain.2007.09.027'" tppabs="https://doi.org/10.1016%2Fj.pain.2007.09.027" class="external text external">10.1016/j.pain.2007.09.027</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17961923  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17961923'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17961923" class="external text external">17961923</a>.</cite></span></li><li id="cite_note-pmid16533506-70"> <span id="mw-reference-text-cite_note-pmid16533506-70" class="mw-reference-text"><cite id="CITEREFNozakiSaitohKamei2006" class="citation journal cs1">Nozaki C, Saitoh A, Kamei J (2006). "Characterization of the antinociceptive effects of oxycodone in diabetic mice". <i>Eur. J. Pharmacol</i>. <b>535</b> (1–3): 145–151. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejphar.2006.02.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejphar.2006.02.002'" tppabs="https://doi.org/10.1016%2Fj.ejphar.2006.02.002" class="external text external">10.1016/j.ejphar.2006.02.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16533506  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16533506'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16533506" class="external text external">16533506</a>.</cite></span></li><li id="cite_note-pmid17292346-71"> <span id="mw-reference-text-cite_note-pmid17292346-71" class="mw-reference-text"><cite id="CITEREFNozakiKamei2007" class="citation journal cs1">Nozaki C, Kamei J (2007). "Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice". <i>Eur. J. Pharmacol</i>. <b>560</b> (2–3): 160–162. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejphar.2007.01.021  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejphar.2007.01.021'" tppabs="https://doi.org/10.1016%2Fj.ejphar.2007.01.021" class="external text external">10.1016/j.ejphar.2007.01.021</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17292346  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17292346'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17292346" class="external text external">17292346</a>.</cite></span></li><li id="cite_note-72"> <span id="mw-reference-text-cite_note-72" class="mw-reference-text">Analgesic Expert Group. Therapeutic Guidelines: Analgesic. Version 4. Melbourne: Therapeutic Guidelines Ltd, 2007.</span></li><li id="cite_note-Oxycodone-73"> <span id="mw-reference-text-cite_note-Oxycodone-73" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00497'" tppabs="https://www.drugbank.ca/drugs/DB00497" class="external text external">"Oxycodone"</a>. <i>www.drugbank.ca</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 January</span> 2019</span>.</cite></span></li><li id="cite_note-pmid14516487-74"> <span id="mw-reference-text-cite_note-pmid14516487-74" class="mw-reference-text"><cite id="CITEREFMooreRamcharitarLevineFowler2003" class="citation journal cs1">Moore KA, Ramcharitar V, Levine B, Fowler D (September 2003). <a href="javascript:if(confirm('https://doi.org/10.1093/jat/27.6.346  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jat/27.6.346'" tppabs="https://doi.org/10.1093/jat/27.6.346" class="external text external">"Tentative identification of novel oxycodone metabolites in human urine"</a>. <i>J Anal Toxicol</i>. <b>27</b> (6): 346–52. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjat%2F27.6.346  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjat%2F27.6.346'" tppabs="https://doi.org/10.1093%2Fjat%2F27.6.346" class="external text external">10.1093/jat/27.6.346</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14516487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14516487'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14516487" class="external text external">14516487</a>.</cite></span></li><li id="cite_note-AnzenbacherZanger2012-75"> <span id="mw-reference-text-cite_note-AnzenbacherZanger2012-75" class="mw-reference-text"><cite id="CITEREFPavel_AnzenbacherUlrich_M._Zanger2012" class="citation book cs1">Pavel Anzenbacher; Ulrich M. Zanger (29 May 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=ulcB7zYIresC&pg=PA420  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ulcB7zYIresC&pg=PA420'" tppabs="https://books.google.com/books?id=ulcB7zYIresC&pg=PA420" class="external text external"><i>Metabolism of Drugs and Other Xenobiotics</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>420–. ISBN<span>&nbsp;</span><bdi>978-3-527-32903-8</bdi>.</cite></span></li><li id="cite_note-pmid15625333-76"> <span id="mw-reference-text-cite_note-pmid15625333-76" class="mw-reference-text"><cite id="CITEREFGascheDaaliFathiChiappe2004" class="citation journal cs1">Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J (December 2004). "Codeine intoxication associated with ultrarapid CYP2D6 metabolism". <i>N. Engl. J. Med</i>. <b>351</b> (27): 2827–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa041888  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa041888'" tppabs="https://doi.org/10.1056%2FNEJMoa041888" class="external text external">10.1056/NEJMoa041888</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15625333  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15625333'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15625333" class="external text external">15625333</a>.</cite></span></li><li id="cite_note-pmid8477556-77"> <span id="mw-reference-text-cite_note-pmid8477556-77" class="mw-reference-text"><cite id="CITEREFOttonWuJoffeCheung1993" class="citation journal cs1">Otton SV, Wu D, Joffe RT, Cheung SW, Sellers EM (April 1993). "Inhibition by fluoxetine of cytochrome P450 2D6 activity". <i>Clin. Pharmacol. Ther</i>. <b>53</b> (4): 401–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fclpt.1993.43  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fclpt.1993.43'" tppabs="https://doi.org/10.1038%2Fclpt.1993.43" class="external text external">10.1038/clpt.1993.43</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8477556  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8477556'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8477556" class="external text external">8477556</a>.</cite></span></li><li id="cite_note-SamerDaali2010-78"> <span id="mw-reference-text-cite_note-SamerDaali2010-78" class="mw-reference-text"><cite id="CITEREFSamerDaaliWagnerHopfgartner2010" class="citation journal cs1">Samer, CF; Daali, Y; Wagner, M; Hopfgartner, G; Eap, CB; Rebsamen, MC; Rossier, MF; Hochstrasser, D; Dayer, P; Desmeules, JA (2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935998'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935998" class="external text external">"Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety"</a>. <i>British Journal of Pharmacology</i>. <b>160</b> (4): 919–930. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1476-5381.2010.00709.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1476-5381.2010.00709.x'" tppabs="https://doi.org/10.1111%2Fj.1476-5381.2010.00709.x" class="external text external">10.1111/j.1476-5381.2010.00709.x</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0007-1188  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0007-1188'" tppabs="https://www.worldcat.org/issn/0007-1188" class="external text external">0007-1188</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935998'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935998" class="external text external">2935998</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20590588  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20590588'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20590588" class="external text external">20590588</a>.</cite></span></li><li id="cite_note-AHFS-79"> <span id="mw-reference-text-cite_note-AHFS-79" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/oxycodone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/oxycodone.html'" tppabs="https://www.drugs.com/monograph/oxycodone.html" class="external text external">"Oxycodone"</a>. <i>The American Society of Health-System Pharmacists</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 April</span> 2011</span>.</cite></span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00497'" tppabs="https://www.drugbank.ca/drugs/DB00497" class="external text external">"Oxycodone"</a>. <i>www.drugbank.ca</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 January</span> 2019</span>.</cite></span></li><li id="cite_note-DavisCladis2016-81"> <span id="mw-reference-text-cite_note-DavisCladis2016-81" class="mw-reference-text"><cite id="CITEREFPeter_J._DavisFranklyn_P._Cladis2016" class="citation book cs1">Peter J. Davis; Franklyn P. Cladis (15 October 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=SGljDQAAQBAJ&pg=PA234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=SGljDQAAQBAJ&pg=PA234'" tppabs="https://books.google.com/books?id=SGljDQAAQBAJ&pg=PA234" class="external text external"><i>Smith's Anesthesia for Infants and Children E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>234–. ISBN<span>&nbsp;</span><bdi>978-0-323-38869-6</bdi>.</cite></span></li><li id="cite_note-pmid16678548-82"> <span id="mw-reference-text-cite_note-pmid16678548-82" class="mw-reference-text"><cite class="citation journal cs1">Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD (May 2006). "Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites". <i>Clin. Pharmacol. Ther</i>. <b>79</b> (5): 461–79. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clpt.2006.01.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clpt.2006.01.009'" tppabs="https://doi.org/10.1016%2Fj.clpt.2006.01.009" class="external text external">10.1016/j.clpt.2006.01.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16678548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16678548'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16678548" class="external text external">16678548</a>.</cite></span></li><li id="cite_note-latimes2016-83"> <span id="mw-reference-text-cite_note-latimes2016-83" class="mw-reference-text"><cite id="CITEREFHarriet_RyanLisa_GirionScott_Glover2016" class="citation news cs1">Harriet Ryan; Lisa Girion; Scott Glover (7 July 2016). <a href="javascript:if(confirm('https://www.latimes.com/projects/oxycontin-part1/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.latimes.com/projects/oxycontin-part1/'" tppabs="https://www.latimes.com/projects/oxycontin-part1/" class="external text external">"You want a description of hell?' OxyContin's 12-hour problem"</a>. <i>Los Angeles Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 July</span> 2018</span>.</cite></span></li><li id="cite_note-oxycontinfiles-84"> <span id="mw-reference-text-cite_note-oxycontinfiles-84" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://documents.latimes.com/q12-workshops-2001/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://documents.latimes.com/q12-workshops-2001/'" tppabs="http://documents.latimes.com/q12-workshops-2001/" class="external text external">"<span class="cs1-kern-left">'</span>Q12' Workshops, 2001"</a>. <i>Los Angeles Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 July</span> 2018</span>.</cite></span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text"><a href="javascript:if(confirm('https://www.erowid.org/references/texts/show/8710docid7639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.erowid.org/references/texts/show/8710docid7639'" tppabs="https://www.erowid.org/references/texts/show/8710docid7639" class="external text external">"Why do pollinators become 'sluggish'? Nectar chemical constituents from Epipactis helleborine L. Crantz Orchidaceae".</a> Applied Ecology &amp; Environmental Research. 2005;3(2):29-38. Jakubska A, Przado D, Steininger M, Aniol-Kwiatkowska A, Kadej M.</span></li><li id="cite_note-86"> <span id="mw-reference-text-cite_note-86" class="mw-reference-text">Baselt, R. (2017) <i>Disposition of Toxic Drugs and Chemicals in Man</i>, 11th edition, Biomedical Publications, Foster City, CA, pp. 1604–1607.</span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFFreundSpeyer1916" class="citation journal cs1">Freund, Martin; Speyer, Edmund (24 November 1916). "Über die Umwandlung von Thebain in Oxycodeinon und dessen Derivate". <i>Journal für Praktische Chemie</i>. <b>94</b> (1): 135–178. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fprac.19160940112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fprac.19160940112'" tppabs="https://doi.org/10.1002%2Fprac.19160940112" class="external text external">10.1002/prac.19160940112</a>.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite class="citation journal cs1">"Martin Freund". <i>Berichte der deutschen chemischen Gesellschaft (A and B Series)</i>. <b>54</b> (5): A53–A79. 7 May 1921. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fcber.19210540533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fcber.19210540533'" tppabs="https://doi.org/10.1002%2Fcber.19210540533" class="external text external">10.1002/cber.19210540533</a>.</cite></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite class="citation book cs1"><span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/holocausthistory0000gilb  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/holocausthistory0000gilb'" tppabs="https://archive.org/details/holocausthistory0000gilb" class="external text external"><i>The Holocaust<span>&nbsp;</span>: a history of the Jews of Europe during the Second World War</i></a></span> (1st American ed.). Holt, Rinehart, and Winston. 1986. pp.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/holocausthistory0000gilb/page/346  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/holocausthistory0000gilb/page/346'" tppabs="https://archive.org/details/holocausthistory0000gilb/page/346" class="external text external">346</a>. ISBN<span>&nbsp;</span><bdi>0-03-062416-9</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">3 June</span> 2020</span>.</cite></span></li><li id="cite_note-ReferenceA-90"> <span id="mw-reference-text-cite_note-ReferenceA-90" class="mw-reference-text"><cite id="CITEREFDefalqueWright2003" class="citation journal cs1">Defalque, Ray; Wright, Amos (October 2003). "Schophedal (SEE) Was it a Fad or a Miracle Drug?". <i>Bulletin of Anesthesia History</i>. <b>21</b> (4): 12–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1522-8649%2803%2950051-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1522-8649%2803%2950051-8'" tppabs="https://doi.org/10.1016%2FS1522-8649%2803%2950051-8" class="external text external">10.1016/S1522-8649(03)50051-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17494237  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17494237'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17494237" class="external text external">17494237</a>.</cite></span></li><li id="cite_note-91"> <span id="mw-reference-text-cite_note-91" class="mw-reference-text">William S Burroughs 1952 letter to Allen Ginsburg concerning Eukodal, in Collected Correspondance, pp 141-2</span></li><li id="cite_note-92"> <span id="mw-reference-text-cite_note-92" class="mw-reference-text">Merck 1930 package insert for Skophedal (German)</span></li><li id="cite_note-93"> <span id="mw-reference-text-cite_note-93" class="mw-reference-text"><cite id="CITEREFBreitenbach2015" class="citation web cs1">Breitenbach, Dagmar (9 September 2015). <a href="javascript:if(confirm('http://www.dw.com/en/a-fresh-light-on-the-nazis-wartime-drug-addiction/a-18703678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.dw.com/en/a-fresh-light-on-the-nazis-wartime-drug-addiction/a-18703678'" tppabs="http://www.dw.com/en/a-fresh-light-on-the-nazis-wartime-drug-addiction/a-18703678" class="external text external">"A fresh light on the Nazis' wartime drug addiction"</a>. <i>Deutsche Welle</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2016-04-24</span></span>.</cite></span></li><li id="cite_note-94"> <span id="mw-reference-text-cite_note-94" class="mw-reference-text">Blitzed: Drugs In The Third Reich, Normal Ohler, 2017, pp 194 et seq</span></li><li id="cite_note-eop-95"> <span id="mw-reference-text-cite_note-eop-95" class="mw-reference-text"><cite id="CITEREFKeefe2017" class="citation web cs1">Keefe, Patrick Radden (2017-10-23). <a href="javascript:if(confirm('https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain'" tppabs="https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain" class="external text external">"The Family That Built an Empire of Pain"</a>. <i>The New Yorker</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0028-792X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0028-792X'" tppabs="https://www.worldcat.org/issn/0028-792X" class="external text external">0028-792X</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-02-02</span></span>.</cite></span></li><li id="cite_note-NewYorker_Keefe_20171023-96"> <span id="mw-reference-text-cite_note-NewYorker_Keefe_20171023-96" class="mw-reference-text"><cite class="citation news cs1">Keefe, Patrick Radden (23 October 2017). <a href="javascript:if(confirm('https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain'" tppabs="https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain" class="external text external">"The Family That Built an Empire of Pain"</a>. <i>The New Yorker</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0028-792X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0028-792X'" tppabs="https://www.worldcat.org/issn/0028-792X" class="external text external">0028-792X</a><span class="reference-accessdate">. Retrieved <span class="nowrap">18 November</span> 2017</span>.</cite></span></li><li id="cite_note-97"> <span id="mw-reference-text-cite_note-97" class="mw-reference-text"><cite id="CITEREFMeier2019" class="citation news cs1">Meier, Barry (2019-01-31). <a href="javascript:if(confirm('https://www.nytimes.com/2019/01/31/health/opioids-purdue-pharma-sackler.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2019/01/31/health/opioids-purdue-pharma-sackler.html'" tppabs="https://www.nytimes.com/2019/01/31/health/opioids-purdue-pharma-sackler.html" class="external text external">"Sackler Scion's Email Reveals Push for High-Dose OxyContin, New Lawsuit Disclosures Claim"</a>. <i>The New York Times</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0362-4331  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0362-4331'" tppabs="https://www.worldcat.org/issn/0362-4331" class="external text external">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-02-03</span></span>.</cite></span></li><li id="cite_note-98"> <span id="mw-reference-text-cite_note-98" class="mw-reference-text"><cite id="CITEREFMartha_BebingerChristine_Willmsen2019" class="citation news cs1">Martha Bebinger; Christine Willmsen (15 January 2019). <a href="javascript:if(confirm('https://www.wbur.org/commonhealth/2019/01/15/healey-purdue-oxycontin-sacklers-unredacted-complaint  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wbur.org/commonhealth/2019/01/15/healey-purdue-oxycontin-sacklers-unredacted-complaint'" tppabs="https://www.wbur.org/commonhealth/2019/01/15/healey-purdue-oxycontin-sacklers-unredacted-complaint" class="external text external">"Mass. AG Implicates Family Behind Purdue Pharma In Opioid Deaths"</a>. <i>WBUR Boston</i><span class="reference-accessdate">. Retrieved <span class="nowrap">19 September</span> 2019</span>.</cite></span></li><li id="cite_note-99"> <span id="mw-reference-text-cite_note-99" class="mw-reference-text"><cite id="CITEREFNik_DeCosta-Klipa2019" class="citation news cs1">Nik DeCosta-Klipa (17 September 2019). <a href="javascript:if(confirm('https://www.boston.com/news/politics/2019/09/17/maura-healey-purdue-settlement  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.boston.com/news/politics/2019/09/17/maura-healey-purdue-settlement'" tppabs="https://www.boston.com/news/politics/2019/09/17/maura-healey-purdue-settlement" class="external text external">"Maura Healey explains why she refused to join the Purdue Pharma settlement"</a>. <i>Boston.com</i>. Boston Globe Media Partners, LLC<span class="reference-accessdate">. Retrieved <span class="nowrap">19 September</span> 2019</span>.</cite></span></li><li id="cite_note-100"> <span id="mw-reference-text-cite_note-100" class="mw-reference-text"><cite id="CITEREFLeague_of_Nations1931" class="citation web cs1">League of Nations (1931). <a href="javascript:if(confirm('http://treaties.un.org/doc/Treaties/1931/07/19310713%2006-44%20AM/Ch_VI_8_ap.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://treaties.un.org/doc/Treaties/1931/07/19310713%2006-44%20AM/Ch_VI_8_ap.pdf'" tppabs="http://treaties.un.org/doc/Treaties/1931/07/19310713%2006-44%20AM/Ch_VI_8_ap.pdf" class="external text external">"Convention for limiting the manufacture and regulating the distribution of narcotic drugs"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-04</span></span>.</cite></span></li><li id="cite_note-SingleConvention-101"> <span id="mw-reference-text-cite_note-SingleConvention-101" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110817062450/http://treaties.un.org/doc/Treaties/1964/12/19641213%2002-14%20AM/Ch_VI_15p.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110817062450/http://treaties.un.org/doc/Treaties/1964/12/19641213%2002-14%20AM/Ch_VI_15p.pdf'" tppabs="https://web.archive.org/web/20110817062450/http://treaties.un.org/doc/Treaties/1964/12/19641213%2002-14%20AM/Ch_VI_15p.pdf" class="external text external">"United Nations conference for the adoption of a single convention on narcotic drugs. Final act"</a> <span class="cs1-format">(PDF)</span>. 1961. Archived from <a href="javascript:if(confirm('http://treaties.un.org/doc/Treaties/1964/12/19641213%2002-14%20AM/Ch_VI_15p.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://treaties.un.org/doc/Treaties/1964/12/19641213%2002-14%20AM/Ch_VI_15p.pdf'" tppabs="http://treaties.un.org/doc/Treaties/1964/12/19641213%2002-14%20AM/Ch_VI_15p.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2011-08-17<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-04</span></span>.</cite></span></li><li id="cite_note-102"> <span id="mw-reference-text-cite_note-102" class="mw-reference-text"><cite id="CITEREFCommonwealth_of_Australia" class="citation web cs1">Commonwealth of Australia. <a href="javascript:if(confirm('http://www.austlii.edu.au/au/legis/cth/consol_act/nda1967160/sch1.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.austlii.edu.au/au/legis/cth/consol_act/nda1967160/sch1.html'" tppabs="http://www.austlii.edu.au/au/legis/cth/consol_act/nda1967160/sch1.html" class="external text external">"Narcotic Drugs Act 1967 – first schedule"</a>. Australasian Legal Information Institute<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-06</span></span>.</cite></span></li><li id="cite_note-103"> <span id="mw-reference-text-cite_note-103" class="mw-reference-text"><cite id="CITEREFAustralian_Government._Department_of_Health_and_Aging._Therapeutic_Goods_Administration2008" class="citation book cs1">Australian Government. Department of Health and Aging. Therapeutic Goods Administration (June 2008). <a href="javascript:if(confirm('http://www.comlaw.gov.au/ComLaw/Legislation/LegislativeInstrument1.nsf/0/3BBB39C4645284BCCA2574A6001C711F/$file/PoisonsStandard2008.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.comlaw.gov.au/ComLaw/Legislation/LegislativeInstrument1.nsf/0/3BBB39C4645284BCCA2574A6001C711F/$file/PoisonsStandard2008.pdf'" tppabs="http://www.comlaw.gov.au/ComLaw/Legislation/LegislativeInstrument1.nsf/0/3BBB39C4645284BCCA2574A6001C711F/$file/PoisonsStandard2008.pdf" class="external text external"><i>Standard for the uniform scheduling of drugs and poisons no. 23</i></a> <span class="cs1-format">(PDF)</span>. Canberra: Commonwealth of Australia. ISBN<span>&nbsp;</span><bdi>978-1-74186-596-7</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-06</span></span>.</cite></span></li><li id="cite_note-CanadaCDSA-104"> <span id="mw-reference-text-cite_note-CanadaCDSA-104" class="mw-reference-text"><cite id="CITEREFCanada_Department_of_Justice2009" class="citation web cs1">Canada Department of Justice (2009-02-27). <a href="javascript:if(confirm('http://laws.justice.gc.ca/en/ShowFullDoc/cs/C-38.8///en  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://laws.justice.gc.ca/en/ShowFullDoc/cs/C-38.8///en'" tppabs="http://laws.justice.gc.ca/en/ShowFullDoc/cs/C-38.8///en" class="external text external">"Controlled Drugs and Substances Act (1996, c. 19)"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-03-23</span></span>.</cite></span></li><li id="cite_note-105"> <span id="mw-reference-text-cite_note-105" class="mw-reference-text">Olgilvie, Megan. <a href="javascript:if(confirm('https://www.thestar.com/news/canada/article/1133247--ontario-to-delist-oxycontin-and-its-substitute-from-drug-benefit-program  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thestar.com/news/canada/article/1133247--ontario-to-delist-oxycontin-and-its-substitute-from-drug-benefit-program'" tppabs="https://www.thestar.com/news/canada/article/1133247--ontario-to-delist-oxycontin-and-its-substitute-from-drug-benefit-program" class="external text external">"Ontario delisting OxyContin and its substitute from drug benefit program"</a> Toronto Star (2012-02-17)</span></li><li id="cite_note-106"> <span id="mw-reference-text-cite_note-106" class="mw-reference-text"><a href="javascript:if(confirm('http://www.health.gov.on.ca/en/public/programs/drugs/ons/ons_legislation.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.health.gov.on.ca/en/public/programs/drugs/ons/ons_legislation.aspx'" tppabs="http://www.health.gov.on.ca/en/public/programs/drugs/ons/ons_legislation.aspx" class="external text external">Narcotics Safety and Awareness Act</a>. 2010. Ministry of Health and Long Term Care.</span></li><li id="cite_note-107"> <span id="mw-reference-text-cite_note-107" class="mw-reference-text"><cite id="CITEREFDhallaBorn2012" class="citation web cs1">Dhalla, Irfan; Born, Karen (2012-02-22). <a href="javascript:if(confirm('https://web.archive.org/web/20150321100652/http://healthydebate.ca/2011/02/_mailpress_mailing_list_healthydebate-news/opioids  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150321100652/http://healthydebate.ca/2011/02/_mailpress_mailing_list_healthydebate-news/opioids'" tppabs="https://web.archive.org/web/20150321100652/http://healthydebate.ca/2011/02/_mailpress_mailing_list_healthydebate-news/opioids" class="external text external">"Opioids"</a>. <i>healthydebate.ca</i>. Archived from <a href="javascript:if(confirm('http://healthydebate.ca/2011/02/_mailpress_mailing_list_healthydebate-news/opioids  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://healthydebate.ca/2011/02/_mailpress_mailing_list_healthydebate-news/opioids'" tppabs="http://healthydebate.ca/2011/02/_mailpress_mailing_list_healthydebate-news/opioids" class="external text external">the original</a> on March 21, 2015.</cite></span></li><li id="cite_note-108"> <span id="mw-reference-text-cite_note-108" class="mw-reference-text"><a href="javascript:if(confirm('http://www.huffingtonpost.ca/2012/02/20/ontario-oxycontin-rules-national-regulations_n_1288375.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.huffingtonpost.ca/2012/02/20/ontario-oxycontin-rules-national-regulations_n_1288375.html'" tppabs="http://www.huffingtonpost.ca/2012/02/20/ontario-oxycontin-rules-national-regulations_n_1288375.html" class="external text external">Ontario OxyContin Rules: New Restrictions Applauded But National Rules Needed</a>. Huffington Post. Canadian Press (2012-02-20)</span></li><li id="cite_note-109"> <span id="mw-reference-text-cite_note-109" class="mw-reference-text"><cite id="CITEREFWeeksHowlett2015" class="citation news cs1">Weeks, Carly; Howlett, Karen (August 4, 2015). <a href="javascript:if(confirm('https://www.theglobeandmail.com/news/national/new-oxycodone-rules-would-give-drug-maker-a-monoply-in-canada-experts-warn/article25820214/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theglobeandmail.com/news/national/new-oxycodone-rules-would-give-drug-maker-a-monoply-in-canada-experts-warn/article25820214/'" tppabs="https://www.theglobeandmail.com/news/national/new-oxycodone-rules-would-give-drug-maker-a-monoply-in-canada-experts-warn/article25820214/" class="external text external">"New oxycodone rules would give drug maker a monopoly in Canada, experts warn"</a>. <i>Globe and Mail</i>. Toronto, Ontario<span class="reference-accessdate">. Retrieved <span class="nowrap">December 15,</span> 2015</span>.</cite></span></li><li id="cite_note-GermanNarcoticsAct-110"> <span id="mw-reference-text-cite_note-GermanNarcoticsAct-110" class="mw-reference-text"><cite id="CITEREFGerman_Federal_Ministry_of_Justice2009" class="citation web cs1">German Federal Ministry of Justice (2009-01-19). <a href="javascript:if(confirm('http://bundesrecht.juris.de/btmg_1981/BJNR106810981.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://bundesrecht.juris.de/btmg_1981/BJNR106810981.html'" tppabs="http://bundesrecht.juris.de/btmg_1981/BJNR106810981.html" class="external text external">"Act on the circulation of narcotics (Narcotics Act – BtMG)"</a> (in German)<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-06</span></span>.</cite></span></li><li id="cite_note-HKOrdinance-111"> <span id="mw-reference-text-cite_note-HKOrdinance-111" class="mw-reference-text"><cite id="CITEREFHong_Kong_Special_Administrative_Region,_People's_Republic_of_China" class="citation web cs1">Hong Kong Special Administrative Region, People's Republic of China. <a href="javascript:if(confirm('https://web.archive.org/web/20071215204612/http://www.hklii.org/hk/legis/en/ord/cur/134.txt  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20071215204612/http://www.hklii.org/hk/legis/en/ord/cur/134.txt'" tppabs="https://web.archive.org/web/20071215204612/http://www.hklii.org/hk/legis/en/ord/cur/134.txt" class="external text external">"Dangerous drugs ordinance – chapter 134"</a>. Hong Kong Legal Information Institute. Archived from <a href="javascript:if(confirm('http://www.hklii.org/hk/legis/en/ord/cur/134.txt  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hklii.org/hk/legis/en/ord/cur/134.txt'" tppabs="http://www.hklii.org/hk/legis/en/ord/cur/134.txt" class="external text external">the original</a> on 2007-12-15<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-08</span></span>.</cite></span></li><li id="cite_note-112"> <span id="mw-reference-text-cite_note-112" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.japantoday.com/category/crime/view/toyotas-american-pr-chief-arrested-on-suspected-drug-violation  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.japantoday.com/category/crime/view/toyotas-american-pr-chief-arrested-on-suspected-drug-violation'" tppabs="http://www.japantoday.com/category/crime/view/toyotas-american-pr-chief-arrested-on-suspected-drug-violation" class="external text external">"Toyota's American PR chief arrested for suspected drug violation"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">11 February</span> 2018</span>.</cite></span></li><li id="cite_note-113"> <span id="mw-reference-text-cite_note-113" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20150619204445/http://www.msn.com/en-us/money/topstocks/toyota-american-exec-did-not-intend-to-break-japan-law/ar-AAbP7OC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150619204445/http://www.msn.com/en-us/money/topstocks/toyota-american-exec-did-not-intend-to-break-japan-law/ar-AAbP7OC'" tppabs="https://web.archive.org/web/20150619204445/http://www.msn.com/en-us/money/topstocks/toyota-american-exec-did-not-intend-to-break-japan-law/ar-AAbP7OC" class="external text external">"Toyota: American exec did not intend to break Japan law"</a>. Archived from <a href="javascript:if(confirm('https://www.msn.com/en-us/money/topstocks/toyota-american-exec-did-not-intend-to-break-japan-law/ar-AAbP7OC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.msn.com/en-us/money/topstocks/toyota-american-exec-did-not-intend-to-break-japan-law/ar-AAbP7OC'" tppabs="https://www.msn.com/en-us/money/topstocks/toyota-american-exec-did-not-intend-to-break-japan-law/ar-AAbP7OC" class="external text external">the original</a> on 19 June 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">11 February</span> 2018</span>.</cite></span></li><li id="cite_note-114"> <span id="mw-reference-text-cite_note-114" class="mw-reference-text"><span>Misuse of Drugs Act</span><span> </span><span>(</span><a href="javascript:if(confirm('https://sso.agc.gov.sg/Act/MDA1973  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://sso.agc.gov.sg/Act/MDA1973'" tppabs="https://sso.agc.gov.sg/Act/MDA1973" class="external text external">Cap.<span>&nbsp;</span>185,<span> </span>2008<span>&nbsp;</span>Rev. Ed.</a><span>)</span> (Singapore), section 6(1).</span></li><li id="cite_note-115"> <span id="mw-reference-text-cite_note-115" class="mw-reference-text">Misuse of Drugs Act (Singapore), section 5(1).</span></li><li id="cite_note-UKAct-116"> <span id="mw-reference-text-cite_note-UKAct-116" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20070205105239/http://www.homeoffice.gov.uk/documents/cdlist.pdf?view=Binary  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070205105239/http://www.homeoffice.gov.uk/documents/cdlist.pdf?view=Binary'" tppabs="https://web.archive.org/web/20070205105239/http://www.homeoffice.gov.uk/documents/cdlist.pdf?view=Binary" class="external text external">"List of drugs currently controlled under the Misuse of Drugs legislation"</a> <span class="cs1-format">(PDF)</span>. UK. Home Office. 2009. Archived from <a href="javascript:if(confirm('http://www.homeoffice.gov.uk/documents/cdlist.pdf?view=Binary  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.homeoffice.gov.uk/documents/cdlist.pdf?view=Binary'" tppabs="http://www.homeoffice.gov.uk/documents/cdlist.pdf?view=Binary" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2007-02-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-08</span></span>.</cite></span></li><li id="cite_note-UKClassABC-117"> <span id="mw-reference-text-cite_note-UKClassABC-117" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20070804233232/http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070804233232/http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/'" tppabs="https://web.archive.org/web/20070804233232/http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/" class="external text external">"Class A, B and C drugs"</a>. UK. Home Office. Archived from <a href="javascript:if(confirm('http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/'" tppabs="http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/" class="external text external">the original</a> on 2007-08-04<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-08</span></span>.</cite></span></li><li id="cite_note-UKRegs-118"> <span id="mw-reference-text-cite_note-UKRegs-118" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.opsi.gov.uk/si/si2001/20013998.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.opsi.gov.uk/si/si2001/20013998.htm'" tppabs="http://www.opsi.gov.uk/si/si2001/20013998.htm" class="external text external">"Statutory instrument 2001 No. 3998. The Misuse of Drugs regulations 2001"</a>. UK. Office of Public Sector Information<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-08</span></span>.</cite></span></li><li id="cite_note-119"> <span id="mw-reference-text-cite_note-119" class="mw-reference-text"><cite id="CITEREFDEA" class="citation web cs1">DEA. <a href="javascript:if(confirm('https://web.archive.org/web/20151121093241/http://www.dea.gov/druginfo/ds.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151121093241/http://www.dea.gov/druginfo/ds.shtml'" tppabs="https://web.archive.org/web/20151121093241/http://www.dea.gov/druginfo/ds.shtml" class="external text external">"Controlled substance scheduling"</a>. <i>Drug information and scheduling</i>. Drug Enforcerment Administration. Archived from <a href="javascript:if(confirm('http://www.dea.gov/druginfo/ds.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.dea.gov/druginfo/ds.shtml'" tppabs="http://www.dea.gov/druginfo/ds.shtml" class="external text external">the original</a> on 21 November 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">23 November</span> 2015</span>.</cite></span></li><li id="cite_note-Examples-120"> <span id="mw-reference-text-cite_note-Examples-120" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.deadiversion.usdoj.gov/schedules/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.deadiversion.usdoj.gov/schedules/'" tppabs="http://www.deadiversion.usdoj.gov/schedules/" class="external text external">"DEA Diversion Control CSA"</a>. US Dept of Justice – DEA<span class="reference-accessdate">. Retrieved <span class="nowrap">23 May</span> 2013</span>.</cite></span></li><li id="cite_note-121"> <span id="mw-reference-text-cite_note-121" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.webmd.com/pain-management/features/oxycontin-pain-relief-vs-abuse  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.webmd.com/pain-management/features/oxycontin-pain-relief-vs-abuse'" tppabs="http://www.webmd.com/pain-management/features/oxycontin-pain-relief-vs-abuse" class="external text external">"OxyContin: Pain Relief vs. Abuse"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">11 February</span> 2018</span>.</cite></span></li><li id="cite_note-122"> <span id="mw-reference-text-cite_note-122" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://newlifehouse.com/top-10-commonly-abused-prescription-medications/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://newlifehouse.com/top-10-commonly-abused-prescription-medications/'" tppabs="http://newlifehouse.com/top-10-commonly-abused-prescription-medications/" class="external text external">"Top 10 Most Commonly Abused Prescription Medications"</a>. 28 April 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">11 February</span> 2018</span>.</cite></span></li><li id="cite_note-123"> <span id="mw-reference-text-cite_note-123" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20151222103656/http://www.grunenthal.com/cms/cda/file/Drug+Development+%26+Delivery+October+2013+Vol+13+No+8.pdf?fileID=273800346&cacheFix=1383822554000&__k=3870fc7ab9c0252c7a9c8547fb47de75  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151222103656/http://www.grunenthal.com/cms/cda/file/Drug+Development+%26+Delivery+October+2013+Vol+13+No+8.pdf?fileID=273800346&cacheFix=1383822554000&__k=3870fc7ab9c0252c7a9c8547fb47de75#'" tppabs="https://web.archive.org/web/20151222103656/http://www.grunenthal.com/cms/cda/file/Drug+Development+%26+Delivery+October+2013+Vol+13+No+8.pdf?fileID=273800346&cacheFix=1383822554000&__k=3870fc7ab9c0252c7a9c8547fb47de75#" class="external text external">"New Abuse Deterrent Formulation Technology for Immediate-Release Opiods"</a> <span class="cs1-format">(PDF)</span>. <i>Grünenthal Group</i>. Grünenthal Group Worldwide. 2010. Archived from <a href="javascript:if(confirm('http://www.grunenthal.com/cms/cda/file/Drug+Development+%26+Delivery+October+2013+Vol+13+No+8.pdf?fileID=273800346&cacheFix=1383822554000&__k=3870fc7ab9c0252c7a9c8547fb47de75  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.grunenthal.com/cms/cda/file/Drug+Development+%26+Delivery+October+2013+Vol+13+No+8.pdf?fileID=273800346&cacheFix=1383822554000&__k=3870fc7ab9c0252c7a9c8547fb47de75'" tppabs="http://www.grunenthal.com/cms/cda/file/Drug+Development+%26+Delivery+October+2013+Vol+13+No+8.pdf?fileID=273800346&cacheFix=1383822554000&__k=3870fc7ab9c0252c7a9c8547fb47de75" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2015-12-22<span class="reference-accessdate">. Retrieved <span class="nowrap">December 15,</span> 2015</span>.</cite></span></li><li id="cite_note-124"> <span id="mw-reference-text-cite_note-124" class="mw-reference-text"><cite id="CITEREFDiep2013" class="citation web cs1">Diep, Francie (May 13, 2013). <a href="javascript:if(confirm('https://www.popsci.com/science/article/2013-05/science-un-crushable-oxycontin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.popsci.com/science/article/2013-05/science-un-crushable-oxycontin'" tppabs="https://www.popsci.com/science/article/2013-05/science-un-crushable-oxycontin" class="external text external">"How Do You Make a Painkiller Addiction-Proof"</a>. <i>Popular Science</i>. Bonnier Corporation<span class="reference-accessdate">. Retrieved <span class="nowrap">January 30,</span> 2019</span>.</cite></span></li><li id="cite_note-125"> <span id="mw-reference-text-cite_note-125" class="mw-reference-text"><cite id="CITEREFCoplan2012" class="citation conference cs1">Coplan, Paul (2012). <a href="javascript:if(confirm('https://web.archive.org/web/20130614115419/http://www.nascsa.org/Conference2012/Presentations/Coplan.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130614115419/http://www.nascsa.org/Conference2012/Presentations/Coplan.pdf'" tppabs="https://web.archive.org/web/20130614115419/http://www.nascsa.org/Conference2012/Presentations/Coplan.pdf" class="external text external"><i>Findings from Purdue's Post-Marketing Epidemiology Studies of Reformulated OxyContin's Effects</i></a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20130512052124/http://www.nascsa.org/conference2012.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130512052124/http://www.nascsa.org/conference2012.htm'" tppabs="https://web.archive.org/web/20130512052124/http://www.nascsa.org/conference2012.htm" class="external text external">NASCSA 2012 Conference</a>. Scottsdale, Arizona. Archived from <a href="javascript:if(confirm('http://www.nascsa.org/Conference2012/Presentations/Coplan.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nascsa.org/Conference2012/Presentations/Coplan.pdf'" tppabs="http://www.nascsa.org/Conference2012/Presentations/Coplan.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on June 14, 2013.</cite></span></li><li id="cite_note-126"> <span id="mw-reference-text-cite_note-126" class="mw-reference-text">
<cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm348252.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm348252.htm'" tppabs="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm348252.htm" class="external text external">"Press Announcements; FDA approves abuse-deterrent labeling for reformulated OxyContin"</a>. US Government – FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">23 May</span> 2013</span>.</cite></span></li><li id="cite_note-127"> <span id="mw-reference-text-cite_note-127" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://press.pfizer.com/press-release/pfizer-and-acura-announce-fda-approval-oxectatm-oxycodone-hcl-usp-cii  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://press.pfizer.com/press-release/pfizer-and-acura-announce-fda-approval-oxectatm-oxycodone-hcl-usp-cii'" tppabs="http://press.pfizer.com/press-release/pfizer-and-acura-announce-fda-approval-oxectatm-oxycodone-hcl-usp-cii" class="external text external">"Pfizer and Acura Announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII"</a>. <i>Pfizer News and Media</i>. Pfizer Inc<span class="reference-accessdate">. Retrieved <span class="nowrap">December 15,</span> 2015</span>.</cite></span></li><li id="cite_note-128"> <span id="mw-reference-text-cite_note-128" class="mw-reference-text"><cite id="CITEREFFiore2011" class="citation web cs1">Fiore, Kristina (June 20, 2011). <a href="javascript:if(confirm('https://web.archive.org/web/20151222095414/http://www.medpagetoday.com/ProductAlert/Prescriptions/27157  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151222095414/http://www.medpagetoday.com/ProductAlert/Prescriptions/27157'" tppabs="https://web.archive.org/web/20151222095414/http://www.medpagetoday.com/ProductAlert/Prescriptions/27157" class="external text external">"FDA Okays New Abuse-Resistant Opioid"</a>. <i>MedPage Today</i>. MedPage Today. Archived from <a href="javascript:if(confirm('http://www.medpagetoday.com/ProductAlert/Prescriptions/27157  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medpagetoday.com/ProductAlert/Prescriptions/27157'" tppabs="http://www.medpagetoday.com/ProductAlert/Prescriptions/27157" class="external text external">the original</a> on December 22, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 15,</span> 2015</span>.</cite></span></li><li id="cite_note-129"> <span id="mw-reference-text-cite_note-129" class="mw-reference-text"><cite id="CITEREFBlack_E2008" class="citation book cs1">Black E (2008). <a href="javascript:if(confirm('https://web.archive.org/web/20080721045101/http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/DRUG_TRENDS_1_NAT/$file/DT001.PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080721045101/http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/DRUG_TRENDS_1_NAT/$file/DT001.PDF'" tppabs="https://web.archive.org/web/20080721045101/http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/DRUG_TRENDS_1_NAT/$file/DT001.PDF" class="external text external"><i>Australian drug trends 2007. Findings from the Illicit Drug Reporting System (IDRS)</i></a> <span class="cs1-format">(PDF)</span>. Sydney: National Drug and Alcohol Research Centre, University of New South Wales. ISBN<span>&nbsp;</span><bdi>978-0-7334-2625-4</bdi>. Archived from <a href="javascript:if(confirm('http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/DRUG_TRENDS_1_NAT/$file/DT001.PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/DRUG_TRENDS_1_NAT/$file/DT001.PDF'" tppabs="http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/DRUG_TRENDS_1_NAT/$file/DT001.PDF" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2008-07-21.</cite></span></li><li id="cite_note-The_Star_2014-130"> <span id="mw-reference-text-cite_note-The_Star_2014-130" class="mw-reference-text"><cite id="CITEREFBoyle2014" class="citation cs2">Boyle, Theresa (7 July 2014), <a href="javascript:if(confirm('https://www.thestar.com/life/health_wellness/2014/07/07/opioid_deaths_soaring_study_finds.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thestar.com/life/health_wellness/2014/07/07/opioid_deaths_soaring_study_finds.html'" tppabs="https://www.thestar.com/life/health_wellness/2014/07/07/opioid_deaths_soaring_study_finds.html" class="external text external">"Opioid deaths soaring, study finds Opioid-related deaths in Ontario jumped by a whopping 242 per cent over two decades, according to a study by ICES and St. Mike's"</a>, <i>The Star</i>, Toronto, Ontario<span class="reference-accessdate">, retrieved <span class="nowrap">23 January</span> 2015</span></cite></span></li><li id="cite_note-The_Star_2009-131"> <span id="mw-reference-text-cite_note-The_Star_2009-131" class="mw-reference-text"><cite id="CITEREFDonovan2009" class="citation cs2">Donovan, Kevin (10 February 2009), <a href="javascript:if(confirm('https://www.thestar.com/life/health_wellness/2009/02/10/oxycodone_found_to_be_more_deadly_than_heroin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thestar.com/life/health_wellness/2009/02/10/oxycodone_found_to_be_more_deadly_than_heroin.html'" tppabs="https://www.thestar.com/life/health_wellness/2009/02/10/oxycodone_found_to_be_more_deadly_than_heroin.html" class="external text external">"Oxycodone found to be more deadly than heroin"</a>, <i>The Star</i>, Toronto, Ontario<span class="reference-accessdate">, retrieved <span class="nowrap">23 January</span> 2015</span></cite></span></li><li id="cite_note-132"> <span id="mw-reference-text-cite_note-132" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20091207/opioids_091207/20091207?hub=TopStoriesV2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20091207/opioids_091207/20091207?hub=TopStoriesV2'" tppabs="http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20091207/opioids_091207/20091207?hub=TopStoriesV2" class="external text external">"Study finds huge rise in oxycodone deaths"</a>. CTV News<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-12-07</span></span>.</cite></span></li><li id="cite_note-Oxyabuse-133"> <span id="mw-reference-text-cite_note-Oxyabuse-133" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20081117203212/http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-003642-2006.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20081117203212/http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-003642-2006.pdf'" tppabs="https://web.archive.org/web/20081117203212/http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-003642-2006.pdf" class="external text external">"OxyContin Fact Sheet"</a> <span class="cs1-format">(PDF)</span>. <i>ccsa.ca</i>. Archived from <a href="javascript:if(confirm('http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-003642-2006.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-003642-2006.pdf'" tppabs="http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-003642-2006.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2008-11-17<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-05-10</span></span>.</cite></span></li><li id="cite_note-134"> <span id="mw-reference-text-cite_note-134" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20111126013544/http://www.hc-sc.gc.ca/hc-ps/pubs/precurs/oxycodone/fs-fi/index-eng.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20111126013544/http://www.hc-sc.gc.ca/hc-ps/pubs/precurs/oxycodone/fs-fi/index-eng.php'" tppabs="https://web.archive.org/web/20111126013544/http://www.hc-sc.gc.ca/hc-ps/pubs/precurs/oxycodone/fs-fi/index-eng.php" class="external text external">"Health Canada – Misuse and Abuse of Oxycodone-based Prescription Drugs"</a>. <i>Hc-sc.gc.ca</i>. 2010-01-11. Archived from <a href="javascript:if(confirm('http://www.hc-sc.gc.ca/hc-ps/pubs/precurs/oxycodone/fs-fi/index-eng.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hc-sc.gc.ca/hc-ps/pubs/precurs/oxycodone/fs-fi/index-eng.php'" tppabs="http://www.hc-sc.gc.ca/hc-ps/pubs/precurs/oxycodone/fs-fi/index-eng.php" class="external text external">the original</a> on 2011-11-26<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-05-10</span></span>.</cite></span></li><li id="cite_note-135"> <span id="mw-reference-text-cite_note-135" class="mw-reference-text"><cite id="CITEREFKirkey2012" class="citation news cs1">Kirkey, Sharon (May 23, 2012). "OxyNEO another prescription for disaster?". <i>Globe and Mail</i>. Toronto, Ontario.</cite></span></li><li id="cite_note-136"> <span id="mw-reference-text-cite_note-136" class="mw-reference-text"><cite id="CITEREFCriger2015" class="citation web cs1">Criger, Erin (August 17, 2015). <a href="javascript:if(confirm('https://toronto.citynews.ca/2015/08/17/death-of-oxycontin-behind-rise-of-fentanyl/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://toronto.citynews.ca/2015/08/17/death-of-oxycontin-behind-rise-of-fentanyl/'" tppabs="https://toronto.citynews.ca/2015/08/17/death-of-oxycontin-behind-rise-of-fentanyl/" class="external text external">"Death of OxyContin behind rise of fentanyl?"</a>. <i>CityNews</i>. Rogers Digital Media<span class="reference-accessdate">. Retrieved <span class="nowrap">February 7,</span> 2019</span>.</cite></span></li><li id="cite_note-137"> <span id="mw-reference-text-cite_note-137" class="mw-reference-text"><cite id="CITEREFGatehouseMacdonald2015" class="citation web cs1">Gatehouse, Jonathon; Macdonald, Nancy (June 22, 2015). <a href="javascript:if(confirm('http://www.macleans.ca/society/health/fentanyl-the-king-of-all-opiates-and-a-killer-drug-crisis/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.macleans.ca/society/health/fentanyl-the-king-of-all-opiates-and-a-killer-drug-crisis/'" tppabs="http://www.macleans.ca/society/health/fentanyl-the-king-of-all-opiates-and-a-killer-drug-crisis/" class="external text external">"Fentanyl: The King of all Opiates, and a Killer Drug Crisis"</a>. <i>Macleans</i>. Rogers Media<span class="reference-accessdate">. Retrieved <span class="nowrap">December 15,</span> 2015</span>.</cite></span></li><li id="cite_note-Southwick-138"> <span id="mw-reference-text-cite_note-Southwick-138" class="mw-reference-text"><cite id="CITEREFSouthwick2015" class="citation news cs1">Southwick, Reid (December 2, 2015). <a href="javascript:if(confirm('https://web.archive.org/web/20151222143028/http://calgaryherald.com/news/crime/fentanyl-brings-tragedy-to-blood-tribe  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151222143028/http://calgaryherald.com/news/crime/fentanyl-brings-tragedy-to-blood-tribe'" tppabs="https://web.archive.org/web/20151222143028/http://calgaryherald.com/news/crime/fentanyl-brings-tragedy-to-blood-tribe" class="external text external">"Fentanyl brings tragedy to Blood Tribe"</a>. <i>Calgary Herald</i>. Calgary, Alberta. Archived from <a href="javascript:if(confirm('https://calgaryherald.com/news/crime/fentanyl-brings-tragedy-to-blood-tribe  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://calgaryherald.com/news/crime/fentanyl-brings-tragedy-to-blood-tribe'" tppabs="https://calgaryherald.com/news/crime/fentanyl-brings-tragedy-to-blood-tribe" class="external text external">the original</a> on December 22, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 15,</span> 2015</span>.</cite></span></li><li id="cite_note-Calgary_Herald_2015-139"> <span id="mw-reference-text-cite_note-Calgary_Herald_2015-139" class="mw-reference-text"><cite class="citation cs2"><a href="javascript:if(confirm('https://web.archive.org/web/20160124073724/http://calgaryherald.com/storyline/police-believe-organized-crime-is-behind-flooding-the-blood-tribe-reserve-with-an-illegal-drug-that-has-been-linked-to-10-deaths  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160124073724/http://calgaryherald.com/storyline/police-believe-organized-crime-is-behind-flooding-the-blood-tribe-reserve-with-an-illegal-drug-that-has-been-linked-to-10-deaths#'" tppabs="https://web.archive.org/web/20160124073724/http://calgaryherald.com/storyline/police-believe-organized-crime-is-behind-flooding-the-blood-tribe-reserve-with-an-illegal-drug-that-has-been-linked-to-10-deaths#" class="external text external"><i>Police believe organized crime is flooding the Blood Tribe reserve with an illegal drug that has been linked to 10 deaths</i></a>, Alberta, 23 January 2015, archived from <a href="javascript:if(confirm('https://calgaryherald.com/storyline/police-believe-organized-crime-is-behind-flooding-the-blood-tribe-reserve-with-an-illegal-drug-that-has-been-linked-to-10-deaths  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://calgaryherald.com/storyline/police-believe-organized-crime-is-behind-flooding-the-blood-tribe-reserve-with-an-illegal-drug-that-has-been-linked-to-10-deaths'" tppabs="https://calgaryherald.com/storyline/police-believe-organized-crime-is-behind-flooding-the-blood-tribe-reserve-with-an-illegal-drug-that-has-been-linked-to-10-deaths" class="external text external">the original</a> on 2016-01-24<span class="reference-accessdate">, retrieved <span class="nowrap">23 January</span> 2015</span></cite></span></li><li id="cite_note-140"> <span id="mw-reference-text-cite_note-140" class="mw-reference-text"><cite id="CITEREFGordon_T2008" class="citation news cs1">Gordon T (2008-03-30). "Scots' use of 'hillbilly heroin' rises by 430%". <i>Sunday Times (London)</i>.</cite></span></li><li id="cite_note-141"> <span id="mw-reference-text-cite_note-141" class="mw-reference-text"><cite id="CITEREFThompson_T2002" class="citation news cs1">Thompson T (2002-03-24). <a href="javascript:if(confirm('https://www.theguardian.com/society/2002/mar/24/drugsandalcohol  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theguardian.com/society/2002/mar/24/drugsandalcohol'" tppabs="https://www.theguardian.com/society/2002/mar/24/drugsandalcohol" class="external text external">"Epidemic fear as 'hillbilly heroin' hits the streets"</a>. <i>Society Guardian</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-16</span></span>.</cite></span></li><li id="cite_note-Girioin-142"> <span id="mw-reference-text-cite_note-Girioin-142" class="mw-reference-text"><cite id="CITEREFGirioinHaely,_Melissa2013" class="citation news cs1">Girioin, Lisa; Haely, Melissa (11 September 2013). "FDA to require stricter labeling for pain drugs". <i>Los Angeles Times</i>. pp.<span>&nbsp;</span>A1 and A9.</cite></span></li><li id="cite_note-NIDA-deaths-143"> <span id="mw-reference-text-cite_note-NIDA-deaths-143" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates'" tppabs="http://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates" class="external text external">"Overdose Death Rates"</a>. <i>www.drugabuse.gov</i>. 29 January 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">11 May</span> 2019</span>.</cite></span></li><li id="cite_note-144"> <span id="mw-reference-text-cite_note-144" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf'" tppabs="https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf" class="external text external">"ER/LA Opioid Analgesic Class Labeling Changes and Postmarket Requirements"</a> <span class="cs1-format">(PDF)</span>. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">12 September</span> 2013</span>.</cite></span></li><li id="cite_note-145"> <span id="mw-reference-text-cite_note-145" class="mw-reference-text"><a href="javascript:if(confirm('http://www.sfchronicle.com/news/article/Now-a-counselor-she-went-from-stoned-to-straight-6605620.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.sfchronicle.com/news/article/Now-a-counselor-she-went-from-stoned-to-straight-6605620.php'" tppabs="http://www.sfchronicle.com/news/article/Now-a-counselor-she-went-from-stoned-to-straight-6605620.php" class="external text external">Now a counselor, she went from stoned to straight</a>, San Francisco Chronicle, November 2. 2015.</span></li><li id="cite_note-146"> <span id="mw-reference-text-cite_note-146" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://consumer.healthday.com/encyclopedia/substance-abuse-38/drug-abuse-news-210/oxycontin-and-addiction-648264.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://consumer.healthday.com/encyclopedia/substance-abuse-38/drug-abuse-news-210/oxycontin-and-addiction-648264.html'" tppabs="http://consumer.healthday.com/encyclopedia/substance-abuse-38/drug-abuse-news-210/oxycontin-and-addiction-648264.html" class="external text external">"Oxycontin and Addiction"</a>. <i>consumer.healthday.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2016-04-24</span></span>.</cite></span></li><li id="cite_note-147"> <span id="mw-reference-text-cite_note-147" class="mw-reference-text"><a href="javascript:if(confirm('https://web.archive.org/web/20120105112147/http://www.cdc.gov/HomeandRecreationalSafety/pdf/PolicyImpact-PrescriptionPainkillerOD.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120105112147/http://www.cdc.gov/HomeandRecreationalSafety/pdf/PolicyImpact-PrescriptionPainkillerOD.pdf'" tppabs="https://web.archive.org/web/20120105112147/http://www.cdc.gov/HomeandRecreationalSafety/pdf/PolicyImpact-PrescriptionPainkillerOD.pdf" class="external text external">Policy Impact: Prescription Pain Killer Overdoses</a> Centers for Disease Control and Prevention. Retrieved 24 December 2013.</span></li><li id="cite_note-148"> <span id="mw-reference-text-cite_note-148" class="mw-reference-text"><a href="javascript:if(confirm('http://www.pharmaceutical-journal.com/news-and-analysis/news/reformulated-oxycontin-reduces-abuse-but-many-addicts-have-switched-to-heroin/20068119.article  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharmaceutical-journal.com/news-and-analysis/news/reformulated-oxycontin-reduces-abuse-but-many-addicts-have-switched-to-heroin/20068119.article'" tppabs="http://www.pharmaceutical-journal.com/news-and-analysis/news/reformulated-oxycontin-reduces-abuse-but-many-addicts-have-switched-to-heroin/20068119.article" class="external text external">Reformulated OxyContin reduces abuse but many addicts have switched to heroin</a>, The Pharmaceutical Journal, 16 March 2015.</span></li><li id="cite_note-INCB2009-149"> <span id="mw-reference-text-cite_note-INCB2009-149" class="mw-reference-text"><cite id="CITEREFInternational_Narcotics_Control_Board2009" class="citation book cs1">International Narcotics Control Board (2009). <a href="javascript:if(confirm('http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2008/Narcotics_drugs_publication2008.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2008/Narcotics_drugs_publication2008.pdf'" tppabs="http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2008/Narcotics_drugs_publication2008.pdf" class="external text external"><i>Narcotic drugs: estimated world requirements for 2009; statistics for 2007. Report E/INCB/2008/2</i></a> <span class="cs1-format">(PDF)</span>. New York: United Nations. ISBN<span>&nbsp;</span><bdi>978-92-1-048124-3</bdi>.</cite></span></li><li id="cite_note-UNPainpolicy-150"> <span id="mw-reference-text-cite_note-UNPainpolicy-150" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120426005126/http://www.painpolicy.wisc.edu/publicat/monograp/philippines08.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120426005126/http://www.painpolicy.wisc.edu/publicat/monograp/philippines08.pdf'" tppabs="https://web.archive.org/web/20120426005126/http://www.painpolicy.wisc.edu/publicat/monograp/philippines08.pdf" class="external text external">"Availability of Opioid Analgesics in the World and Asia, With a special focus on: Indonesia, Philippines, Thailand"</a> <span class="cs1-format">(PDF)</span>. <i>University of Wisconsin Pain &amp; Policy Studies Group/World Health Organization (WHO) Collaborating Center for Policy and Communications in Cancer Care</i>. United Nations. Archived from <a href="javascript:if(confirm('http://www.painpolicy.wisc.edu/publicat/monograp/philippines08.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.painpolicy.wisc.edu/publicat/monograp/philippines08.pdf'" tppabs="http://www.painpolicy.wisc.edu/publicat/monograp/philippines08.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 26 April 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">27 November</span> 2011</span>.</cite></span></li><li id="cite_note-151"> <span id="mw-reference-text-cite_note-151" class="mw-reference-text"><a href="javascript:if(confirm('http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2011/Part_FOURTH_Comments_NAR-Report-2011_English.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2011/Part_FOURTH_Comments_NAR-Report-2011_English.pdf'" tppabs="http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2011/Part_FOURTH_Comments_NAR-Report-2011_English.pdf" class="external text external">Narcotic Drugs: Estimated World Requirements for 2012 and Statistics for 2010</a>. International Narcotics Control Board (2011).</span></li><li id="cite_note-152"> <span id="mw-reference-text-cite_note-152" class="mw-reference-text"><a href="javascript:if(confirm('http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2011/Part_FOUR_Comments_NAR-Report-2011_English.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2011/Part_FOUR_Comments_NAR-Report-2011_English.pdf'" tppabs="http://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2011/Part_FOUR_Comments_NAR-Report-2011_English.pdf" class="external text external">Narcotic Drugs: Estimated World Requirements for 2012 and Statistics for 2010</a>. International Narcotics Control Board (2011).</span></li><li id="cite_note-Eddy1973-153"> <span id="mw-reference-text-cite_note-Eddy1973-153" class="mw-reference-text"><cite id="CITEREFEddy_NB1973" class="citation book cs1">Eddy NB (1973). <i>The National Research Council involvement in the opiate problem, 1928–1971</i>. Washington: National Academy of Sciences.</cite></span></li><li id="cite_note-MayJacobson-154"> <span id="mw-reference-text-cite_note-MayJacobson-154" class="mw-reference-text"><cite id="CITEREFMayJacobson1989" class="citation journal cs1">May EL, Jacobson AE (1989). "The Committee on Problems of Drug Dependence: a legacy of the National Academy of Sciences. A historical account". <i>Drug Alcohol Depend</i>. <b>23</b> (3): 183–218. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0376-8716%2889%2990083-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0376-8716%2889%2990083-5'" tppabs="https://doi.org/10.1016%2F0376-8716%2889%2990083-5" class="external text external">10.1016/0376-8716(89)90083-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2666074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2666074'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2666074" class="external text external">2666074</a>.</cite></span></li><li id="cite_note-155"> <span id="mw-reference-text-cite_note-155" class="mw-reference-text"><cite id="CITEREFUnited_Nations_Educational,_ScientificCultural_Organization2005" class="citation web cs1">United Nations Educational, Scientific; Cultural Organization (2005). <a href="javascript:if(confirm('http://unesdoc.unesco.org/images/0014/001425/142594m.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://unesdoc.unesco.org/images/0014/001425/142594m.pdf'" tppabs="http://unesdoc.unesco.org/images/0014/001425/142594m.pdf" class="external text external">"International convention against doping in sport"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-04</span></span>.</cite></span></li><li id="cite_note-MEDMARX-156"> <span id="mw-reference-text-cite_note-MEDMARX-156" class="mw-reference-text"><cite id="CITEREFHicksBeckerCousins2008" class="citation book cs1">Hicks RW, Becker SC, Cousins DD, eds. (2008). <a href="javascript:if(confirm('http://www.usp.org/pdf/EN/medmarx/2008MEDMARXReport.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.usp.org/pdf/EN/medmarx/2008MEDMARXReport.pdf'" tppabs="http://www.usp.org/pdf/EN/medmarx/2008MEDMARXReport.pdf" class="external text external"><i>MEDMARX data report. A report on the relationship of drug names and medication errors in response to the Institute of Medicine's call for action</i></a> <span class="cs1-format">(PDF)</span>. Rockville, MD: Center for the Advancement of Patient Safety, US Pharmacopeia<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-04</span></span>.</cite></span></li><li id="cite_note-157"> <span id="mw-reference-text-cite_note-157" class="mw-reference-text"><cite id="CITEREFpostlethwaite" class="citation web cs1">postlethwaite, Julia. <a href="javascript:if(confirm('https://www.gwh.nhs.uk/media/168380/oxycodone_longtec_patient_leaflet_sept_14.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.gwh.nhs.uk/media/168380/oxycodone_longtec_patient_leaflet_sept_14.pdf'" tppabs="https://www.gwh.nhs.uk/media/168380/oxycodone_longtec_patient_leaflet_sept_14.pdf" class="external text external">"Oxycodone Longtec Patient Leaflet"</a> <span class="cs1-format">(PDF)</span>. <i>Great Western Hospitals NHS Foundation Trust</i>. Great Western Hospitals NHS Foundation Trust<span class="reference-accessdate">. Retrieved <span class="nowrap">23 March</span> 2019</span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFColuzzi,_F.Mattia,_C.2005" class="citation journal cs1">Coluzzi, F.; Mattia, C. (July–August 2005). <a href="javascript:if(confirm('https://web.archive.org/web/20060309000726/http://www.minervamedica.it/pdf/R02Y2005/R02Y2005N07A0451.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060309000726/http://www.minervamedica.it/pdf/R02Y2005/R02Y2005N07A0451.pdf'" tppabs="https://web.archive.org/web/20060309000726/http://www.minervamedica.it/pdf/R02Y2005/R02Y2005N07A0451.pdf" class="external text external">"Oxycodone. Pharmacological profile and clinical data in chronic pain management"</a> <span class="cs1-format">(PDF)</span>. <i>Minerva Anestesiol</i>. <b>71</b> (7–8): 451–60. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16012419  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16012419'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16012419" class="external text external">16012419</a>. Archived from <a href="javascript:if(confirm('http://www.minervamedica.it/pdf/R02Y2005/R02Y2005N07A0451.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.minervamedica.it/pdf/R02Y2005/R02Y2005N07A0451.pdf'" tppabs="http://www.minervamedica.it/pdf/R02Y2005/R02Y2005N07A0451.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on March 9, 2006.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/oxycodone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/oxycodone'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/oxycodone" class="external text external">"Oxycodone"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Analgesics_(N02A,_N02B)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Analgesics_(N02A,_N02B)" style="font-size:114%;margin:0 4em">Analgesics (N02A, N02B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Opioids</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Opiates/opium</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a><sup>#</sup> (+paracetamol, +aspirin)</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a><sup>#</sup> (+naltrexone)</li>
<li>Opium</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Laudanum  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Laudanum'" tppabs="https://ptable.com/wiki/compounds/A/Laudanum" title="Laudanum">Laudanum</a></li>
<li>Paregoric</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Semisynthetic</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine'" tppabs="https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine" title="Acetyldihydrocodeine">Acetyldihydrocodeine</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Benzylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Benzylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Benzylmorphine" title="Benzylmorphine">Benzylmorphine</a></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a> (+naloxone)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydrocodeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrocodeine" title="Dihydrocodeine">Dihydrocodeine</a> (+paracetamol)</li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Ethylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Ethylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Ethylmorphine" title="Ethylmorphine">Ethylmorphine</a></li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a> (+paracetamol, +ibuprofen, +aspirin)</li>
<li><a href="Hydromorphinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphinol" title="Hydromorphinol">Hydromorphinol</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>Nicocodeine</li>
<li>Nicodicodine</li>
<li>Nicomorphine</li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a> (+paracetamol, +aspirin, +ibuprofen, +naloxone, <span class="new">+naltrexone</span>)</li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li>Thebacon</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Synthetic</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Alfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfentanil" title="Alfentanil">Alfentanil</a></li>
<li><a href="Prodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prodine" title="Prodine">Alphaprodine</a></li>
<li><a href="Anileridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anileridine" title="Anileridine">Anileridine</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li><a href="Carfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Carfentanil" title="Carfentanil">Carfentanil</a></li>
<li><a href="Dextromoramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromoramide" title="Dextromoramide">Dextromoramide</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Dipipanone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipipanone" title="Dipipanone">Dipipanone</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a><sup>#</sup> (+fluanisone)</li>
<li>Ketobemidone</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li>Lofentanil</li>
<li>Meptazinol</li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a><sup>#</sup></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li>NFEPP</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenadoxone</li>
<li>Phenazocine</li>
<li>Piminodine</li>
<li>Piritramide</li>
<li>Propiram</li>
<li><a href="Remifentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Remifentanil" title="Remifentanil">Remifentanil</a></li>
<li><a href="Sufentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Sufentanil" title="Sufentanil">Sufentanil</a></li>
<li>Tapentadol</li>
<li>Tilidine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Paracetamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Paracetamol" title="Paracetamol">Paracetamol</a>-type</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Acetanilide.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetanilide" title="Acetanilide">Acetanilide</a><sup>‡</sup></li>
<li><a href="Bucetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bucetin" title="Bucetin">Bucetin</a><sup>‡</sup></li>
<li><span class="new">Butacetin</span><sup>‡</sup></li>
<li><a href="Paracetamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Paracetamol" title="Paracetamol">Paracetamol (acetaminophen)</a><sup>#</sup></li>
<li><span class="new">Parapropamol</span><sup>‡</sup></li>
<li><a href="Phenacetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenacetin" title="Phenacetin">Phenacetin</a><sup>‡</sup></li>
<li>Propacetamol<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">NSAIDs</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Propionates</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Fenoprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenoprofen" title="Fenoprofen">Fenoprofen</a></li>
<li><a href="Flurbiprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Flurbiprofen" title="Flurbiprofen">Flurbiprofen</a></li>
<li><a href="Ibuprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibuprofen" title="Ibuprofen">Ibuprofen</a><sup>#</sup></li>
<li><a href="Ketoprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoprofen" title="Ketoprofen">Ketoprofen</a></li>
<li><a href="Naproxen.htm" tppabs="https://ptable.com/wiki/compounds/A/Naproxen" title="Naproxen">Naproxen</a></li>
<li><a href="Oxaprozin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaprozin" title="Oxaprozin">Oxaprozin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Oxicams</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Meloxicam.htm" tppabs="https://ptable.com/wiki/compounds/A/Meloxicam" title="Meloxicam">Meloxicam</a></li>
<li><a href="Piroxicam.htm" tppabs="https://ptable.com/wiki/compounds/A/Piroxicam" title="Piroxicam">Piroxicam</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Acetates</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Diclofenac.htm" tppabs="https://ptable.com/wiki/compounds/A/Diclofenac" title="Diclofenac">Diclofenac</a></li>
<li><a href="Indometacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Indometacin" title="Indometacin">Indometacin</a></li>
<li><a href="Ketorolac.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketorolac" title="Ketorolac">Ketorolac</a></li>
<li><a href="Nabumetone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nabumetone" title="Nabumetone">Nabumetone</a></li>
<li><a href="Sulindac.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulindac" title="Sulindac">Sulindac</a></li>
<li><a href="Tolmetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolmetin" title="Tolmetin">Tolmetin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">COX-2 inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Celecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Celecoxib" title="Celecoxib">Celecoxib</a></li>
<li><a href="Etoricoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoricoxib" title="Etoricoxib">Etoricoxib</a></li>
<li><a href="Lumiracoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Lumiracoxib" title="Lumiracoxib">Lumiracoxib</a></li>
<li>Parecoxib</li>
<li><a href="Rofecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Rofecoxib" title="Rofecoxib">Rofecoxib</a> <sup>‡</sup></li>
<li><a href="Valdecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Valdecoxib" title="Valdecoxib">Valdecoxib</a> <sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Fenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenamic_acid" title="Fenamic acid">Fenamates</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Meclofenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><a href="Mefenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mefenamic_acid" title="Mefenamic acid">Mefenamic acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">Salicylates</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">Aspirin (acetylsalicylic acid)</a><sup>#</sup> (+paracetamol/caffeine)</li>
<li>Benorylate</li>
<li><a href="Diflunisal.htm" tppabs="https://ptable.com/wiki/compounds/A/Diflunisal" title="Diflunisal">Diflunisal</a></li>
<li><a href="Ethenzamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethenzamide" title="Ethenzamide">Ethenzamide</a></li>
<li>Magnesium salicylate</li>
<li><a href="Salicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicin" title="Salicin">Salicin</a></li>
<li><a href="Salicylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylamide" title="Salicylamide">Salicylamide</a></li>
<li><a href="Salsalate.htm" tppabs="https://ptable.com/wiki/compounds/A/Salsalate" title="Salsalate">Salsalate</a></li>
<li>Wintergreen (<a href="Methyl_salicylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_salicylate" title="Methyl salicylate">methyl salicylate</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pyrazolones</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Aminophenazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminophenazone" title="Aminophenazone">Aminophenazone</a><sup>‡</sup></li>
<li><a href="Ampyrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ampyrone" title="Ampyrone">Ampyrone</a></li>
<li><a href="Metamizole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metamizole" title="Metamizole">Metamizole (dipyrone)</a></li>
<li><a href="Nifenazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifenazone" title="Nifenazone">Nifenazone</a></li>
<li><a href="Phenazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenazone" title="Phenazone">Phenazone</a></li>
<li>Propyphenazone (+paracetamol/caffeine)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Glafenine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glafenine" title="Glafenine">Glafenine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cannabinoids</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Cannabis</li>
<li><a href="Nabilone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nabilone" title="Nabilone">Nabilone</a></li>
<li>Nabiximols</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol (dronabinol)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ion channel<br>modulators</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Calcium blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li>Alcohol (ethanol)</li>
<li><a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li>Gabapentin enacarbil</li>
<li>Mirogabalin</li>
<li><a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">Pregabalin</a></li>
<li>Ziconotide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Sodium blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li>Lacosamide</li>
<li>Local anesthetics (e.g., <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>, <a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">lidocaine</a>)</li>
<li><a href="Mexiletine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mexiletine" title="Mexiletine">Mexiletine</a></li>
<li>Nefopam</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a><sup>#</sup>)</li></ul>

<ul><li><i>Na<sub>v</sub>1.7/1.8-selective:</i> DSP-2230<sup>§</sup></li>
<li>Funapide<sup>§</sup></li>
<li>PF-05089771<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Potassium openers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;width: auto;"><div style="padding:0em 0.25em">
<ul><li>Flupirtine<sup>‡</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Myorelaxants</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Carisoprodol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carisoprodol" title="Carisoprodol">Carisoprodol</a></li>
<li><a href="Chlorzoxazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorzoxazone" title="Chlorzoxazone">Chlorzoxazone</a></li>
<li><a href="Cyclobenzaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclobenzaprine" title="Cyclobenzaprine">Cyclobenzaprine</a></li>
<li>Mephenoxalone</li>
<li><a href="Methocarbamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Methocarbamol" title="Methocarbamol">Methocarbamol</a></li>
<li><a href="Orphenadrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Analgesic adjuvant</li>
<li>Analgecine</li>
<li><a href="Camphor.htm" tppabs="https://ptable.com/wiki/compounds/A/Camphor" title="Camphor">Camphor</a></li>
<li><a href="Capsaicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Capsaicin" title="Capsaicin">Capsaicin</a></li>
<li><a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="Menthol.htm" tppabs="https://ptable.com/wiki/compounds/A/Menthol" title="Menthol">Menthol</a></li>
<li><a href="Methoxyflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxyflurane" title="Methoxyflurane">Methoxyflurane</a></li>
<li>Nefopam</li>
<li>Proglumide</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Recreational_drug_use" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;"><div id="Recreational_drug_use" style="font-size:114%;margin:0 4em">Recreational drug use</div></th></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Major<br> recreational<br> drugs</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Depressants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a></li>
<li>Benzodiazepines</li>
<li>Carbamates</li>
<li>Ethanol (alcohol)
<ul><li>Alcoholic drinks</li>
<li>Beer</li>
<li>Wine</li></ul></li>
<li>Gabapentinoids</li>
<li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a></li>
<li>Inhalants
<ul><li>Medical
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li></ul></li>
<li>Hazardous solvents
<ul><li>contact adhesives</li>
<li>Gasoline</li>
<li>nail polish remover</li>
<li>Paint thinner</li></ul></li>
<li>Other
<ul><li>Freon</li></ul></li></ul></li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a></li>
<li>Nonbenzodiazepines</li>
<li>Quinazolinones</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Opioids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a>
<ul><li>Suboxone</li>
<li>Subutex</li></ul></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a>
<ul><li>Krokodil</li></ul></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a>
<ul><li>Darvocet</li>
<li>Darvon</li></ul></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine</a>
<ul><li>Heroin</li></ul></li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a>
<ul><li>Dilaudid</li></ul></li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Mitragyna speciosa
<ul><li>Kratom</li></ul></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a>
<ul><li>Opium</li></ul></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a>
<ul><li>/paracetamol</li></ul></li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Stimulants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a>
<ul><li>Areca</li></ul></li>
<li>Betel</li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a>
<ul><li>Coffee</li>
<li>Energy drinks</li>
<li>Tea</li></ul></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a>
<ul><li>Khat</li></ul></li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a>
<ul><li>Coca</li>
<li>Crack</li></ul></li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a>
<ul><li><a href="Ephedra.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedra" title="Ephedra">Ephedra</a></li></ul></li>
<li>MDPV</li>
<li>Mephedrone</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>Methylone</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a>
<ul><li>Tobacco</li></ul></li>
<li><a href="Theobromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Theobromine" title="Theobromine">Theobromine</a>
<ul><li>Cocoa</li>
<li>Chocolate</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Entactogens</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C series</li>
<li>6-APB
<ul><li>Benzofury</li></ul></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">AMT</a></li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>
<ul><li>Ecstasy</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Hallucinogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">Bufotenin</a>
<ul><li>Psychoactive toads</li>
<li>Vilca</li>
<li>Yopo</li></ul></li>
<li>DMT
<ul><li>Ayahuasca</li></ul></li>
<li>LSA</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD-25</a></li>
<li>Mescaline
<ul><li>Peruvian torch</li>
<li>Peyote</li>
<li>San Pedro</li></ul></li>
<li>Psilocybin / <a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">Psilocin</a>
<ul><li>Psilocybin mushrooms</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Dissociatives</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">DXM</a></li>
<li>Glaucine</li>
<li>Inhalants
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>alkyl nitrites</li>
<li>poppers</li>
<li><a href="Amyl_nitrite.htm" tppabs="https://ptable.com/wiki/compounds/A/Amyl_nitrite" title="Amyl nitrite">amyl nitrite</a></li></ul></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>MXE</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Muscimol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Muscimol'" tppabs="https://ptable.com/wiki/compounds/A/Muscimol" title="Muscimol">Muscimol</a>
<ul><li>Amanita muscaria</li></ul></li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">PCP</a></li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a>
<ul><li><a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">Salvia divinorum</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Deliriants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a> and <a href="Scopolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Scopolamine" title="Scopolamine" class="mw-redirect">Scopolamine</a>
<ul><li>Atropa belladonna</li>
<li>Datura</li>
<li>Hyoscyamus niger</li>
<li>Mandragora officinarum</li></ul></li>
<li><a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabinoids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>JWH-018</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>
<ul><li>Cannabis</li>
<li>Hashish</li>
<li>Hash oil</li>
<li>Marijuana</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Oneirogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Calea zacatechichi</li>
<li>Silene capensis</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Club drugs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Quaaludes</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a> (Ecstasy)</li>
<li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>Poppers</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug culture</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabis culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>420</li>
<li>Cannabis cultivation</li>
<li>Cannabis smoking</li>
<li>Head shop</li>
<li>Legal history of cannabis in the United States</li>
<li>Legality of cannabis</li>
<li>Marijuana Policy Project</li>
<li>Medical cannabis</li>
<li>NORML</li>
<li>Cannabis and religion</li>
<li>Stoner film</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Coffee culture</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coffee break</li>
<li>Coffeehouse</li>
<li>Latte art</li>
<li>Tea house</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drinking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bartending</li>
<li>Beer culture</li>
<li>Beer festival</li>
<li>Binge drinking</li>
<li><a href="Diethyl_ether.htm#Recreational_use" tppabs="https://ptable.com/wiki/compounds/A/Diethyl_ether#Recreational_use" title="Diethyl ether">Diethyl ether</a></li>
<li>Drinking games</li>
<li>Drinking song</li>
<li>Happy hour</li>
<li>Hip flask</li>
<li>Nightclub</li>
<li>Pub</li>
<li>Pub crawl</li>
<li>Sommelier</li>
<li>Sports bar</li>
<li>Tailgate party</li>
<li>Wine bar</li>
<li>Wine tasting</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelia</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Psychonautics</li>
<li>Art</li>
<li>Drug</li>
<li>Era</li>
<li>Experience</li>
<li>Literature</li>
<li>Music</li>
<li>Microdosing</li>
<li>Therapy</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Smoking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cigarette card</li>
<li>Fashion cigarettes</li>
<li>Cloud-chasing</li>
<li>Loosie</li>
<li>Smokeasy</li>
<li>Smoking fetishism</li>
<li>Tobacco smoking</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Club drug</li>
<li>Counterculture of the 1960s</li>
<li>Dance party</li>
<li>Drug paraphernalia</li>
<li>Drug tourism</li>
<li>Entheogen</li>
<li>Hippie</li>
<li>Needle sharing</li>
<li>Nootropic</li>
<li>Party and play</li>
<li>Poly drug use</li>
<li>Rave</li>
<li>Religion and drugs</li>
<li>Self-medication</li>
<li>Sex and drugs</li>
<li>Whoonga</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug<br> production<br> and trade</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug<br> production</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coca production in Colombia</li>
<li>Drug precursors</li>
<li>Opium production in Afghanistan</li>
<li>Rolling meth lab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug trade</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Illegal drug trade
<ul><li>Colombia</li></ul></li>
<li>Darknet market</li>
<li>Drug distribution
<ul><li>Beer shop</li>
<li>Cannabis shop</li>
<li>Liquor store</li>
<li>Liquor license</li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Issues with<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abuse</li>
<li>Date rape drug</li>
<li>Impaired driving</li>
<li>Drug harmfulness
<ul><li>Effects of cannabis</li></ul></li>
<li>Addiction</li>
<li>Dependence
<ul><li>Prevention</li>
<li>Opioid replacement therapy</li>
<li>Rehabilitation</li>
<li>Responsible use</li></ul></li>
<li>Drug-related crime</li>
<li>Fetal alcohol spectrum disorder</li>
<li>Long-term effects of cannabis</li>
<li>Neurotoxicity</li>
<li>Overdose</li>
<li>Passive smoking
<ul><li>of tobacco or other substances</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Legality of<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">International</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1961 Narcotic Drugs</li>
<li>1971 Psychotropic Substances</li>
<li>1988 Drug Trafficking</li>
<li>Council of the European Union decisions on designer drugs</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">State level</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Drug policy
<ul><li>Decriminalization</li>
<li>Prohibition</li>
<li>Supply reduction</li></ul></li>
<li>Policy reform
<ul><li>Demand reduction</li>
<li>Drug Policy Alliance</li>
<li>Harm reduction</li>
<li>Law Enforcement Action Partnership</li>
<li>Liberalization
<ul><li>Latin America</li></ul></li>
<li>Students for Sensible Drug Policy</li>
<li>Transform Drug Policy Foundation</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug policy<br>by country</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Australia</li>
<li>Canada</li>
<li>Germany</li>
<li>India</li>
<li>Netherlands</li>
<li>Portugal</li>
<li>Slovakia</li>
<li>Soviet Union</li>
<li>Sweden</li>
<li>Switzerland</li>
<li>United States
<ul><li>Just Say No</li>
<li>Office of National Drug Control Policy</li>
<li>School district drug policies</li>
<li>California</li>
<li>Colorado</li>
<li>Maryland</li>
<li>Virginia</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Arguments for and against drug prohibition</li>
<li>Capital punishment for drug trafficking</li>
<li>Cognitive liberty</li>
<li>Designer drug</li>
<li>Drug court</li>
<li>Drug possession</li>
<li>Drug test</li>
<li>Narc</li>
<li>Politics of drug abuse</li>
<li>War on Drugs
<ul><li>Mexican Drug War</li>
<li>Plan Colombia</li>
<li>Philippine Drug War</li></ul></li>
<li>Zero tolerance</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Lists of<br> countries by...</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alcohol legality
<ul><li>Alcohol consumption</li></ul></li>
<li>Anabolic steroid legality</li>
<li>Cannabis legality
<ul><li>Annual use</li>
<li>Lifetime use</li></ul></li>
<li>Cigarette consumption</li>
<li>Cocaine legality
<ul><li>Cocaine use</li></ul></li>
<li>Methamphetamine legality</li>
<li>Opiates use</li>
<li>Psilocybin mushrooms legality</li>
<li>Salvia legality</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Opioid_receptor_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Opioid_receptor_modulators" style="font-size:114%;margin:0 4em">Opioid receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>MOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists (abridged; see here for a full list):</i> 3-HO-PCP</li>
<li><span class="new">7-Acetoxymitragynine</span></li>
<li>7-Hydroxymitragynine</li>
<li><span class="new">ψ-Akuammigine</span></li>
<li>α-Chlornaltrexamine</li>
<li><span class="new">α-Narcotine</span></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine'" tppabs="https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine" title="Acetyldihydrocodeine">Acetyldihydrocodeine</a></li>
<li>Acetylfentanyl</li>
<li>Acrylfentanyl</li>
<li>Adrenorphin (metorphamide)</li>
<li>AH-7921</li>
<li>Akuammicine</li>
<li><span class="new">Akuammidine</span></li>
<li><a href="Alfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfentanil" title="Alfentanil">Alfentanil</a></li>
<li><a href="Anileridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anileridine" title="Anileridine">Anileridine</a></li>
<li>Apparicine</li>
<li>β-Endorphin</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Benzhydrocodone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Benzylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Benzylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Benzylmorphine" title="Benzylmorphine">Benzylmorphine</a></li>
<li><a href="Bezitramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezitramide" title="Bezitramide">Bezitramide</a></li>
<li>Biphalin</li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>Butyrfentanyl</li>
<li>BW373U86</li>
<li><a href="Carfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Carfentanil" title="Carfentanil">Carfentanil</a></li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li>Chloroxymorphamine</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li>DADLE</li>
<li>DAMGO (DAGO)</li>
<li>Dermorphin</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a></li>
<li><a href="Dextromoramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromoramide" title="Dextromoramide">Dextromoramide</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene (propoxyphene)</a></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Dimenoxadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenoxadol" title="Dimenoxadol">Dimenoxadol</a></li>
<li>Dimethylaminopivalophenone</li>
<li>Eluxadoline</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydrocodeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrocodeine" title="Dihydrocodeine">Dihydrocodeine</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diphenoxylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenoxylate" title="Diphenoxylate">Diphenoxylate</a></li>
<li><a href="Dipipanone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipipanone" title="Dipipanone">Dipipanone</a></li>
<li>Dynorphin A</li>
<li><a href="Embutramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Embutramide" title="Embutramide">Embutramide</a></li>
<li>Endomorphin-1</li>
<li>Endomorphin-2</li>
<li>Eseroline</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Ethylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Ethylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Ethylmorphine" title="Ethylmorphine">Ethylmorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Fluorophen</li>
<li>Frakefamide</li>
<li>Furanylfentanyl</li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li>Hodgkinsine</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphinol" title="Hydromorphinol">Hydromorphinol</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>IBNtxA</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketobemidone</li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Lefetamine</li>
<li>Leu-enkephalin</li>
<li><a href="Levacetylmethadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levacetylmethadol" title="Levacetylmethadol">Levacetylmethadol</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li><a href="Loperamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Loperamide" title="Loperamide">Loperamide</a></li>
<li><span class="new">Loxicodegol</span></li>
<li>Matrine</li>
<li>Meptazinol</li>
<li>Met-enkephalin (metenkefalin)</li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Metkefamide</li>
<li>Metopon</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li>Morphiceptin</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalmexone</li>
<li>Naltalimide</li>
<li><span class="new">Neopine</span></li>
<li>NFEPP</li>
<li>Nicocodeine</li>
<li>Nicodicodine</li>
<li>Nicomorphine</li>
<li><span class="new">NKTR-181</span></li>
<li>Norketamine</li>
<li><a href="Octreotide.htm" tppabs="https://ptable.com/wiki/compounds/A/Octreotide" title="Octreotide">Octreotide</a></li>
<li>Oliceridine</li>
<li>OM-3-MNZ</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li>Oxymorphazone</li>
<li><span class="new">Oxymorphonazine</span></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><span class="new">Oxymorphone phenylhydrazone</span></li>
<li><span class="new">OxyPNPH</span></li>
<li><i>Papaver somniferum</i> (opium)</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>Pericine</li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Piminodine</li>
<li>Piritramide</li>
<li><span class="new">PL-017</span></li>
<li><a href="Prodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prodine" title="Prodine">Prodine</a></li>
<li>Propiram</li>
<li>PZM21</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li><a href="Remifentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Remifentanil" title="Remifentanil">Remifentanil</a></li>
<li><span class="new">Salsolinol</span></li>
<li>SC-17599</li>
<li><a href="Sinomenine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sinomenine" title="Sinomenine">Sinomenine</a></li>
<li><a href="Sufentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Sufentanil" title="Sufentanil">Sufentanil</a></li>
<li>Tapentadol</li>
<li>Tetrahydropapaveroline</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thienorphine</li>
<li>Tianeptine</li>
<li>Tilidine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li>Trimebutine</li>
<li>TRIMU 5</li>
<li><span class="new">TRV734</span></li>
<li><span class="new">Tubotaiwine</span></li>
<li>U-47700</li>
<li>Valorphin</li>
<li>Viminol</li>
<li>Xorphanol</li></ul>

<ul><li><i>PAMs:</i> <span class="new">BMS-986121</span></li>
<li><span class="new">BMS-986122</span></li></ul>

<ul><li><i>Antagonists:</i> (3S,4S)-Picenadol</li>
<li>2-(S)-N,N-(R)-Viminol</li>
<li><span class="new">3CS-nalmefene</span></li>
<li>4-Caffeoyl-1,5-quinide</li>
<li><span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>18-MC</li>
<li><span class="new">α-Gliadin</span></li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Akuammine</li>
<li><a href="Alvimopan.htm" tppabs="https://ptable.com/wiki/compounds/A/Alvimopan" title="Alvimopan">Alvimopan</a></li>
<li>AM-251</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>CTAP</li>
<li><span class="new">CTOP</span></li>
<li><span class="new">Cyclofoxy</span></li>
<li>Cyprodime</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Eptazocine</li>
<li>Gemazocine</li>
<li><span class="new">Ginsenoside R</span></li>
<li>Hyperoside</li>
<li>Ibogaine</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Lobeline</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">Methocinnamox</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylsamidorphan chloride</span></li>
<li>Naldemedine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Nalorphine dinicotinate</li>
<li>Naloxazone</li>
<li>Naloxegol</li>
<li>Naloxol</li>
<li>Naloxonazine</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><span class="new">Naltrexazone</span></li>
<li><span class="new">Naltrexonazine</span></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Oxilorphan</li>
<li>Pawhuskin A</li>
<li><a href="Rimonabant.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimonabant" title="Rimonabant">Rimonabant</a></li>
<li>Quadazocine</li>
<li>Samidorphan</li>
<li>Taxifolin</li></ul>

<ul><li><i>Unknown/unsorted:</i> <a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>DOR</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>7-SIOM</li>
<li><span class="new">ADL-5747 (PF-04856881)</span></li>
<li><span class="new">ADL-5859</span></li>
<li>Alazocine (SKF-10047)</li>
<li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><span class="new">AR-M100390 (ARM390)</span></li>
<li><span class="new">AZD2327</span></li>
<li>β-Endorphin</li>
<li><span class="new">BAM-18P</span></li>
<li>Biphalin</li>
<li>BU-48</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>DADLE</li>
<li>Deltorphin A</li>
<li>Deltorphin I</li>
<li><span class="new">Deltorphin II</span></li>
<li>Desmethylclozapine</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>DPDPE</li>
<li>DPI-221</li>
<li>DPI-3290</li>
<li><span class="new">DSLET</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><span class="new">FIT</span></li>
<li>Fluorophen</li>
<li>Hemorphin-4</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>Ibogaine</li>
<li>Isomethadone</li>
<li><span class="new">JNJ-20788560</span></li>
<li><span class="new">KNT-127</span></li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leu-enkephalin</li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>Met-enkephalin (metenkefalin)</li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>N-Phenethyl-14-ethoxymetopon</li>
<li>Norbuprenorphine</li>
<li><span class="new">NalBzOH</span></li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Proglumide</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RWJ-394674</li>
<li>Samidorphan</li>
<li><span class="new">SB-235863</span></li>
<li>SNC-80</li>
<li><span class="new">SNC-162</span></li>
<li>TAN-67 (SB-205,607)</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thiobromadol (C-8813)</li>
<li>Tonazocine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li><span class="new">TRV250</span></li>
<li>Xorphanol</li>
<li>Zenazocine</li></ul>

<ul><li><i>Antagonists:</i> 4',7-Dihydroxyflavone</li>
<li><span class="new">5'-NTII</span></li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li><span class="new">α-Santolol</span></li>
<li>β-Chlornaltrexamine</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><span class="new">BNTX</span></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>Eluxadoline</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li><span class="new">ICI-154129</span></li>
<li><span class="new">ICI-174864</span></li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylnaltrindole</span></li>
<li><span class="new">N-Benzylnaltrindole</span></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltriben</li>
<li>Naltrindole</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>Quadazocine</li>
<li><span class="new">SDM25N</span></li>
<li>SoRI-9409</li>
<li>Taxifolin</li>
<li>Thienorphine</li></ul>

<ul><li><i>Unknown/unsorted:</i> 18-MC</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>KOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>8-CAC</li>
<li>18-MC</li>
<li>14-Methoxymetopon</li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Adrenorphin (metorphamide)</li>
<li><span class="new">Akuuamicine</span></li>
<li>Alazocine (SKF-10047)</li>
<li><span class="new">Allomatrine</span></li>
<li><span class="new">Apadoline</span></li>
<li>Asimadoline</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Big dynorphin</li>
<li>Bremazocine</li>
<li>BRL-52537</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Cebranopadol</li>
<li>Ciprefadol</li>
<li>CR665</li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>Cyclorphan</li>
<li><a href="Cyprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyprenorphine" title="Cyprenorphine">Cyprenorphine</a></li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li>Diacetylnalorphine</li>
<li>Difelikefalin</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>Dynorphin A</li>
<li>Dynorphin B (rimorphin)</li>
<li>Eluxadoline</li>
<li>Enadoline</li>
<li>Eptazocine</li>
<li><span class="new">Erinacine E</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li>Fedotozine</li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Gemazocine</li>
<li>GR-89696</li>
<li><span class="new">GR-103545</span></li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li><span class="new">HS665</span></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>HZ-2</li>
<li>Ibogaine</li>
<li>ICI-199,441</li>
<li>ICI-204,448</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketazocine</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leumorphin (dynorphin B-29)</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>LPK-26</li>
<li>Lufuradom</li>
<li>Matrine</li>
<li><span class="new">MB-1C-OH</span></li>
<li><a href="Menthol.htm" tppabs="https://ptable.com/wiki/compounds/A/Menthol" title="Menthol">Menthol</a></li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>Moxazocine</li>
<li><span class="new">MR-2034</span></li>
<li><span class="new">N-MPPP</span></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalfurafine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Naltriben</li>
<li>Niravoline</li>
<li>Norbuprenorphine</li>
<li>Norbuprenorphine-3-glucuronide</li>
<li>Noribogaine</li>
<li>Norketamine</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li>Oxilorphan</li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li>Proxorphan</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RB-64</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a> (<a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">salvia</a>)</li>
<li>Salvinorin B ethoxymethyl ether</li>
<li>Salvinorin B methoxymethyl ether</li>
<li>Samidorphan</li>
<li>Spiradoline (U-62,066)</li>
<li><span class="new">TH-030418</span></li>
<li>Thienorphine</li>
<li>Tifluadom</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, desipramine, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li>
<li>U-50488</li>
<li><span class="new">U-54,494A</span></li>
<li>U-69,593</li>
<li>Xorphanol</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>5'-GNTI</li>
<li>6'-GNTI</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>β-Chlornaltrexamine</li>
<li>Buprenorphine/samidorphan</li>
<li><a href="Amentoflavone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amentoflavone" title="Amentoflavone">Amentoflavone</a></li>
<li><span class="new">ANTI</span></li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li><span class="new">Arodyne</span></li>
<li>AT-076</li>
<li>Aticaprant</li>
<li>Axelopran</li>
<li><span class="new">AZ-MTAB</span></li>
<li>Binaltorphimine</li>
<li>BU09059</li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>CERC-501 (LY-2456302)</li>
<li>Clocinnamox</li>
<li><span class="new">Cyclofoxy</span></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><span class="new">DIPPA</span></li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>ECG</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Hyperoside</li>
<li>JDTic</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">LY-2444296</span></li>
<li>LY-2459989</li>
<li><span class="new">LY-2795050</span></li>
<li><span class="new">MeJDTic</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">ML190</span></li>
<li><span class="new">ML350</span></li>
<li><span class="new">MR-2266</span></li>
<li><span class="new">N-Fluoropropyl-JDTic</span></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Norbinaltorphimine</li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>PF-4455242</li>
<li>RB-64</li>
<li>Quadazocine</li>
<li>Taxifolin</li>
<li><span class="new">UPHIT</span></li>
<li>Zyklophin</li></ul>

<ul><li><i>Unknown/unsorted:</i> Akuammicine</li>
<li>Akuammine</li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Ibogamine</li>
<li>Tabernanthine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>NOP</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">(Arg14,Lys15)Nociceptin</span></li>
<li><span class="new">((pF)Phe<sup>4</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">(Phe<sup>1</sup>Ψ(CH<sub>2</sub>-NH)Gly<sup>2</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRWK-NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRIK-NH<sub>2</sub></span></li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li>Cebranopadol</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><span class="new">JNJ-19385899</span></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>MCOPPB</li>
<li><span class="new">MT-7716</span></li>
<li>NNC 63-0532</li>
<li>Nociceptin (orphanin FQ)</li>
<li><span class="new">Nociceptin (1-11)</span></li>
<li><span class="new">Nociceptin (1-13)NH<sub>2</sub></span></li>
<li>Norbuprenorphine</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>Ro64-6198</li>
<li><span class="new">Ro65-6570</span></li>
<li><span class="new">SCH-221510</span></li>
<li><span class="new">SCH-486757</span></li>
<li><span class="new">SR-8993</span></li>
<li><span class="new">SR-16435</span></li>
<li><span class="new">TH-030418</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">(Nphe<sup>1</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li>AT-076</li>
<li><span class="new">BAN-ORL-24</span></li>
<li>BTRX-246040 (LY-2940094)</li>
<li>J-113,397</li>
<li>JTC-801</li>
<li><span class="new">NalBzOH</span></li>
<li><span class="new">Nociceptin (1-7)</span></li>
<li><span class="new">Nocistatin</span></li>
<li>SB-612,111</li>
<li><span class="new">SR-16430</span></li>
<li>Thienorphine</li>
<li><span class="new">Trap-101</span></li>
<li><span class="new">UFP-101</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>β-Casomorphins</li>
<li>Amidorphin</li>
<li><span class="new">BAM-20P</span></li>
<li>Cytochrophin-4</li>
<li><span class="new">Deprolorphin</span></li>
<li>Gliadorphin (gluteomorphin)</li>
<li>Gluten exorphins</li>
<li>Hemorphins</li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a> constituents</li>
<li><span class="new">MEAGL</span></li>
<li><span class="new">MEAP</span></li>
<li><a href="N-Ethylmaleimide.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Ethylmaleimide" title="N-Ethylmaleimide">NEM</a></li>
<li>Neoendorphins</li>
<li>Nepetalactone (catnip)</li>
<li><span class="new">Peptide B</span></li>
<li><span class="new">Peptide E</span></li>
<li><span class="new">Peptide F</span></li>
<li><span class="new">Peptide I</span></li>
<li>Rubiscolins</li>
<li><span class="new">Soymorphins</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Enkephalinase inhibitors:</i> Amastatin</li>
<li><span class="new">BL-2401</span></li>
<li><a href="Candoxatril.htm" tppabs="https://ptable.com/wiki/compounds/A/Candoxatril" title="Candoxatril">Candoxatril</a></li>
<li><a href="Phenylalanine.htm#D-,_L-_and_DL-phenylalanine" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine#D-,_L-_and_DL-phenylalanine" title="Phenylalanine"><span style="font-size:90%;">D </span>-Phenylalanine</a></li>
<li><span class="new">Dexecadotril (retorphan)</span></li>
<li>Ecadotril (sinorphan)</li>
<li>Kelatorphan</li>
<li><a href="Racecadotril.htm" tppabs="https://ptable.com/wiki/compounds/A/Racecadotril" title="Racecadotril">Racecadotril (acetorphan)</a></li>
<li>RB-101</li>
<li>RB-120</li>
<li>RB-3007</li>
<li><span class="new">Opiorphan</span></li>
<li>Selank</li>
<li>Semax</li>
<li>Spinorphin</li>
<li><a href="Thiorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiorphan" title="Thiorphan">Thiorphan</a></li>
<li>Tynorphin</li>
<li><a href="Ubenimex.htm" tppabs="https://ptable.com/wiki/compounds/A/Ubenimex" title="Ubenimex">Ubenimex (bestatin)</a></li></ul>

<ul><li><i>Propeptides:</i> β-Lipotropin (proendorphin)</li>
<li>Prodynorphin</li>
<li>Proenkephalin</li>
<li><span class="new">Pronociceptin</span></li>
<li>Proopiomelanocortin (POMC)</li></ul>

<ul><li><i>Others:</i> Kyotorphin (met-enkephalin releaser/degradation stabilizer)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Signaling peptide/protein receptor modulators</i></div></td></tr></tbody></table></div>










<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>